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Abstract 
The pharmaceutical research is facing several obstacles in the development of drug products for the oral 
delivery. The main problem deals with the intrinsic chemical nature of the new drug candidates, which are 
often poorly soluble and barely absorbed in the gastro-intestinal tract. Furthermore, they are usually 
degraded before they are absorbed. These combined factors considerably reduce the bioavailability of 
many active ingredients. Several strategies have been developed to overcome these challenges. One of 
them are microfabricated drug delivery devices. Microreservoir based-systems are characterized by small 
dimensions (100-500 µm), mucoadhesive properties, asymmetric geometry and unidirectional drug release. 
In the fabrication of these microcontainers, an important task is the drug loading. The state of the art in this 
field is based on traditional methods used in microtechnology, which for this application in most cases are 
cost ineffective and unsuitable for large scale production.  
The goal of this project was to develop novel techniques for loading of poorly soluble drugs and 
macromolecules in microcontainers. The research focused on simple and cost effective methods, suitable 
for a large group of drugs and with the perspective of mass production. 
In a first instance, the suitability of inkjet printing as filling method was elucidated. Solutions containing 
furosemide and lipid based formulations of insulin were dispensed into microcontainers. Secondly, this 
technique was successfully utilized for the deposition of polymer matrices in microcontainers, which 
afterwards were loaded with the drug. For this purpose, inkjet printing of solutions of 
poly(vinylpyrrolidone) was developed. The polymer deposition was homogeneous and reproducible, which 
demonstrated that inkjet printing is a valuable technology to dispense controlled amounts of polymer into 
microcontainers. Subsequently, polymer filled-containers were loaded with drug. To achieve this, 
supercritical impregnation technology was successfully employed. Furthermore, in vitro drug dissolution 
studies showed that the loading yields and the release properties of the microdevices can be tuned. The 
effect of different impregnation process parameters on the loading yields was studied, and the drug-
polymer interactions were characterized with various spectroscopic techniques. This technique allowed 
loading of large arrays of the microcontainers in one single operation with high accuracy and repeatability. 
Furthermore, the combination of inkjet printing and supercritical impregnation allows to minimize the 
waste of possibly expensive active ingredients. 
A successful process for the definition of micropatterns of poly(vinylpyrrolidone) hydrogel by means of UV 
photolithography was developed. The fabrication of polymer patterns was optimized and loading with both 
small hydrophobic drugs and proteins was demonstrated. Finally, structural properties of hydrogels were 
elucidated by rheology and NMR with the perspective of controlling the drug release. 
The loading techniques developed in this thesis represent a novelty in the field of microfabricated drug 
delivery devices. The methods utilized in this research work are potentially integrated in the fabrication 
process of biopolymer microcontainers.  
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Danske Resumé 
Den farmaceutiske industri står overfor adskillige forhindringer i forbindelse med udvikling af lægemidler til 
oral indtagelse. Det største problem handler om selve den kemiske beskaffenhed af de nye lægemidler, 
som ofte er vanskeligt opløselige og som absorberes dårligt i mave-tarmsystemet. Desuden bliver de som 
regel nedbrudt, før de absorberes. Disse faktorer reducerer i vid udstrækning biotilgængeligheden af 
mange af de aktive ingredienser. Mange strategier er blevet udviklet for at overkomme disse udfordringer. 
Et eksempel herpå er de såkaldte micro-fabrikerede doserings-devices. 
Systemer baseret på micro-reservoirs er karakteriseret ved: Små dimensioner (100-500 µm), evnen til at 
klæbe på slimhinder, usymmetrisk geometri og frigivelse kun i én retning. Under fremstillingen af disse 
micro-beholdere består en vigtig udfordring i, hvordan de skal fyldes med lægemidlet. Den mest anvendte 
metode baserer sig på traditionelle micro-teknologiske teknikker, som ofte er dyre og uegnede til 
produktion i stor skala. 
Formålet med dette projekt har været at undersøge nye teknikker til påfyldning af svært opløselige og 
ustabile lægemidler i disse micro-beholdere. Dette forskningsforsøg har fokuseret på simple og kost-
effektive metoder, som er velegnede til masseproduktion for en stor gruppe af lægemidler. 
I den første del er egnetheden af inkjet-printning som påfyldningsmetode blevet undersøgt. Opløsninger 
med furosemid- og lipidbaserede formuleringer af insulin blev fyldt i micro-beholderne. Herefter er denne 
teknik med succes blevet anvendt til fremstilling af polymer-matricer inde i micro-beholdere, hvori 
lægemidlet blev påfyldt efterfølgende. Inkjet-printning blev testet med opløsninger af poly(vinylpyrrolidon). 
Mængden af deponeret polymer viste sig at være homogen og reproducérbar, hvilket demonstrerede at 
inkjet-printning er en teknologi, der egner sig til påfyldning af nøjagtige mængder af polymer i micro-
beholdere med næsten intet spild.  
Dernæst blev micro-beholderne påfyldt lægemiddel. Hertil blev superkritisk imprægneringsteknologi 
anvendt med succes. Desuden viste in vitro forsøg med opløsning af lægemidler, at det er muligt at tilpasse 
dels mængden af påfyldt lægemiddel og dels micro-beholdernes frigivelse af lægemidlet. Indflydelsen af 
forskellige operationsparametre (tryk, temperatur og tid) på den påfyldte mængde blev undersøgt, og 
interaktionerne imellem lægemiddel og polymer blev karakteriseret vha. forskellige spektroskopiske 
teknikker. Den nævnte teknik muliggjorde samtidig påfyldning af mange micro-beholdere på én gang, og 
med stor nøjagtighed samt repetérbarhed. 
En velegnet proces til at definere micro-mønstrene i en poly(vinylpyrrolidon) hydrogel blev udviklet vha. UV 
fotolitografi. Fremstillingen af polymermønstre blev optimeret, og der blev foretaget effektive påfyldninger 
med både små, hydrofobiske lægemidler og med proteiner. Til sidst blev hydrogelernes strukturelle 
egenskaber belyst med det formål at kontrollere frigivelsen af lægemidlet. 
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Watch your thoughts; they become words. 
Watch your words; they become actions. 
Watch your actions; they become habits. 
Watch your habits, they become character. 
Watch your character; it becomes your destiny. 
 
by Laozi 
 
 
Degrees of ability vary, but the basic principle remains the same: 
 the degree of a man’s independence, initiative and personal love 
for his work determines his talent as a worker and his worth as a 
man. Independence is the only gauge of human virtue and value. 
[...]  There is no substitute for personal dignity. 
 There is no standard of personal dignity except independence. 
 
from"Fountainhead" 
by Ayn Rand 
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1. Introduction 
1.1 Current challenges in oral drug delivery 
One of the most demanding challenges in the pharmaceutical research is finding safe, less invasive and 
effective solutions for the administration of active pharmaceutical ingredients (APIs). The oral route is still 
the preferred administration form, avoiding pain, offering good patient compliance and usually requiring no 
assistance by trained health care staff. However, the pharmaceutical industry is presently facing several 
severe obstacles when developing oral drug delivery systems, primarily because of the intrinsic physico 
chemical nature of the new drug candidates.  
Traditionally, oral dosage forms have been produced by powder technology and the most popular oral 
delivery systems are tablets and pills. Tablets are manufactured by compression of powders. Their 
manufacturing process is performed with granulation (in a dry or wet regime) and subsequent compression 
[1]. The main advantage of dry granulation is that the powders are not exposed to moisture, but on the 
other hand the applied mechanical stresses may cause phase transitions [2]. Furthermore, when materials 
to be compacted exhibit low bulk density or poor flow properties their compression is tricky [3].  
In a wet granulator a blend of API and excipients undergoes wet massing followed by sieving and drying 
steps [4]. In this case, a typical drawback is the occurrence of crystalline polymorphism in the API [5]. Costs 
of the tabletting process can be reduced when the granulation process is avoided and the tablet 
manufacturing is performed with a direct compression of powders [6]. However, in this case lower 
manufacturing costs are compromised by the need of filler materials, whose physical properties are highly 
critical for the final compression result: particle size, compactability, flowability and bulk density are crucial 
parameters [3, 7]. Nowadays, the most used fillers are microcrystalline cellulose sucrose and lactose. Direct 
compression of powders requires a very accurate selection of fillers, and its main limitation is that it does 
not allow a drug loading higher than 30% [7]. 
Besides the complexity of the fabrication process, tablets usually have large sizes, because of the presence 
of different components, like for instance tablet disintegrants, wetting agents, absorption enhancers, and 
enteric and bioadhesive coatings. Thus, the tablets can be hard to swallow especially for elderly and early 
age patients [8].  
Between the oral ingestion and the final effect of the API, there is a sequence of barriers which the active 
compound must overcome in order to execute its action [9]. Starting from the mouth, any ingested 
material is exposed to the action of biological metabolism [10]: Typically an API encounters enzymatic 
degradation, hydrolysis and chemical deactivation in the acidic gastric environment. Once in the small 
intestine, many active compounds exhibit a poor solubility in the intestinal fluid, and slow dissolution 
compared to a relatively rapid peristaltic flow in the upper intestine. Finally, drug molecules often exhibit a 
limited permeation through the mucosa. In all these passages, an increasing fraction of the API is lost and 
the bioavailability of the therapeutic agent is considerably reduced. A direct consequence of this fact is that 
often frequent administrations are needed in order to maintain an efficient therapeutic action. Also, high 
drug doses are used, increasing the probability of serious adverse effects which for certain substances are 
unavoidable [11]. 
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1.2 Poorly soluble drugs: trends, challenges and perspectives 
One of the most important factors influencing the bioavailability of orally delivered drug is solubility in the 
physiological fluids. In the Biopharmaceutical Classification System (BCS) standard, drugs are divided into 
four main groups (see figure 1.1), based on their solubility and permeability in the gastro-intestinal tract 
(GIT) [12]. A drug is classified as having high solubility, if the correspondent therapeutic dose (for humans) 
can be dissolved in 250 mL of water in a pH interval between 1 and 7.5. A drug is highly permeable if the 
absorbed fraction is more than 90% of the assumed dose. More than 90% of active compounds discovered 
and approved since 1995 belong either to class II or IV [13]. Moreover, the general trend in pharmaceutical 
research is towards APIs with high molecular weight which often means low solubility and permeability. 
Another very important parameter besides the solubility is the dissolution rate of a drug. According to Hsia 
and coworkers [14], the dissolution process can be considered as the sum of four main consecutive steps: 
surface wetting, crystal lattice destruction, solute molecule solvation and diffusion in the bulk liquid phase. 
The most energy-demanding process is the breakdown of the crystal structure, which can be considered as 
a transition from a solid to a liquid phase in a heterogeneous environment. Therefore, it is clear that the 
solubility of the drug in the receptor phase plays an important role.  
In the field of pharmaceutical technology, several strategies have been developed in order to enhance both 
solubility and dissolution rate of APIs. These approaches include the modification of both physical and 
chemical properties of the API [15]. The physical modification focuses mostly on the reduction of particle 
size [16] and on the crystallinity of the solid phase of the drug. Other strategies act instead on the chemical 
solvation mechanism, e.g. by means of surfactants or complexation with cyclodextrins [17].  
 
 
Figure 1.1: Schematic illustration of the BCS dividing 
drugs into four groups according to their aqueous 
solubility and permeability through the intestinal 
membrane.  
 
1.2.1 Drug crystallinity and stability 
Drug crystallinity has a strong influence on both its solubility and dissolution rate. The preparation of 
amorphous drug is an important achievement for poorly soluble drugs, since amorphous forms have 
enhanced solubility and dissolution rate compared to more stable crystalline solid forms. However, long 
term stability is frequently a challenge for amorphous drugs and usually represents a big concern for the 
pharmaceutical industry. For instance, Abbott launched the drug ‘Ritonavir’ in 1996. The active ingredient 
was in a crystalline form now called form I, but after two years a more stable (and less soluble) polymorph 
of the drug (form II) was discovered. Since the transition from polymorph I to polymorph II was very fast 
and entailed a substantial decrease of therapeutic effect, the company decided the withdrawal of the 
medicine from the market [18]. 
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The main factors influencing drug stability are: Humidity, heat, oxidation agents and light.  
Humidity can have a relevant effect on the stability of pharmaceutical products. Shibata and coworkers [19] 
have studied the effect of moisture uptake on the recrystallization of drugs in solid dispersions with 
crospovidone [19], discovering that high humidity may cause a faster crystal growth. 
Oxidation of solid dosage forms is usually due to the effect of atmospheric oxygen. To avoid this, particular 
chemicals with anti-oxidizing properties are included in the formulation product [20]. A reduced interfacial 
area with the surrounding environment or an impermeable and inert coating may also have a beneficial 
effect. The effect of heat on drug stability is in general related to the kinetics of the recrystallization 
process: it is generally believed that at temperatures above the glass transition temperature (Tg), 
amorphous drugs tend to crystallize at a higher rate than below Tg because of the higher mobility of 
molecules in the crystal growth process. This mobility can also be enhanced by means of a isothermal heat 
transfer as shown by Yoshioka et al. [20]. It is well known that the exposure to light  affects the stability of 
pharmaceuticals, especially in the UV wavelength range [21].The main effects are chemical degradation of 
the active ingredient [22], the formation of potentially harmful sub products [23, 24], and changes of 
physico chemical properties [25]. 
In light of the abovementioned limitations, one possible way to reduce and delay drug recrystallization 
would be to protect the API with a coating or shell with inert and impermeable properties. 
1.2.2 Particle size reduction 
The alternative physical method to enhance dissolution is micronization, where the API and binders are 
encapsulated into particles with dimensions in the micro and nano scale. Reduction of particle size can be 
performed with two principal approaches: association of molecularly dispersed drug or comminution of 
previously formed larger particles e.g. by mechanical grinding [26]. In several years of research in particle 
engineering a large variety of methods has been developed with the aim of preparing solid dispersions [27]. 
Challenges in this field include: control of flow properties within the pipeline, online monitoring of 
materials in upscaled unit operations [28] and avoidance of particle agglomeration due to charging [29] to 
which the stability of the solid form of API is tightly connected.  In many cases, particles generated by 
micronization techniques still show a wide size distribution [26]. In figure 1.2, as an example of 
polydispersity, the size distributions of cilostazol particles are plotted, as a result of different milling 
operations [30]. 
 
 
Figure 1.2: The median particle diameters of cilostazol in the 
hammer-milled (squares), the jet-milled (diamonds) and the 
commercial spray dried (triangles) (adapted from [30]). 
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1.2.3. Particle asymmetry and mucoadhesive properties  
Independent of the crystallinity or the particle size, there is a further aspect limiting the bioavailability of 
any drug, but particularly those with poor solubility: a spherical microparticle floating in the luminal fluid 
releases the drug in any directions with a consequent inevitable loss of substance. An asymmetric drug 
carrier, in some way, would reduce drug waste in the luminal flow. Furthermore, one additional solution to 
improve drug release location and increase retention time in the intestine was found by applying 
mucoadhesive properties to formulations of micro- and nanoparticles [31, 32] or tablets [33, 34].  
1.3 Microdevices for oral drug delivery 
Due to the challenges discussed in the previous sections, improvements are still needed and possible.  
Recently, the interest in microfabricated drug delivery devices is increasing [35, 36]. In light of the biological 
barriers of the human gut and the open questions regarding design and manufacturing of traditional oral 
dosage forms, a new concept for an oral drug delivery device of a poorly soluble drugs would aim to 
address the following needs: 
• be easy to swallow 
• provide protection of the API against gastrointestinal barriers with a resistant shell 
• deliver the API at a specific absorptive region in the GIT (preferably the small intestine) 
• have small dimensions falling in the range of microns with a narrow size distribution 
• limit drug dispersion and loss in the intestine by means of a combination of unidirectional release 
and adhesion to the intestinal walls 
• enhance retention time 
• preserve the stability of the formulation 
Such a device can be conceived as a microreservoir containing a drug formulation. The microreservoir 
supplies an inert shell protecting the API from destabilizing and degrading agents. It has an opening on one 
side, from which the drug is released. A schematic of the microcontainer concept is illustrated in Figure 1.3. 
 
 
Figure 1.3: Schematic representation of a microcontainer in the intestinal environment. 
Microcontainer 
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As a formal requirement, materials and procedures for fabrication of the microdevice should be approved  
for oral administration by the Food and Drug Administration (FDA). Assuming that only the API should be 
absorbed in the body, all the other materials of the device should be biocompatible and not accumulated in 
the body. Preferably, they should be biodegradable so that the products of their degradation are expelled. 
Among FDA approved polymers, poly(L-lactic acid) (PLLA) and polycaprolactone (PCL) are used for oral 
products. To determine the optimal size of the microdevice, it is worth to make the following 
considerations. The fluid regime in the intestine is far from being steadily laminar [37] because the efflux 
from the stomach is discontinuous. Peristalsis contractions further reduce the lumen section and therefore 
the flux out of the stomach is accelerated An usual problem for tablets is an incomplete drug release  
combined to a relatively short retention time in the upper intestine as a result of the drag force applied by 
the fluid to the large tablet. This is one more justification for reducing the size of drug delivery devices. On 
the other hand, microcontainers size should not be below 500 nm, in order to avoid cellular endocytosis by 
the intestinal epithelium [38]. The microcontainer size should also be defined taking into account other 
important issues like fabrication limitations with proposed materials and processes and the loading 
capacity. These topics will be discussed in the following section.  
1.4 Overview of the NAMEC Drug Delivery project 
The present PhD project is carried out as part of a larger research consortium called NAMEC –
NanoMEChanical sensor and actuators, fundamentals and new directions – a VKR Centre of Excellence 
financed by the Villum Kann Rasmussen Foundation, working on drug delivery microdevices and 
pharmaceutical applications of micro- and nanosensors. The partners of the drug delivery project belong to 
the Department of Micro- and Nanotechnology, the Department of Electrical Engineering and Department 
of Applied Mathematics and Computer Science (all from Technical University of Denmark, DTU) and the 
Department of Pharmacy (University of Copenhagen, KU).  
According to the requirements discussed in section 1.3, it was decided that the microdevice for oral drug 
delivery should include the following elements (figure 1.3):  
 
• an asymmetric shell providing protection of the drug  
• a drug matrix with a given formulation 
• a permeable or degradable membrane to be opened at the absorption site 
• a conformal mucoadhesive coating to ensure attachment and unidirectional release through the 
intestinal epithelium 
 
According to these features, the drug delivery device has been developed in separate but coordinated 
tasks: (1) microcontainer fabrication, (2) drug formulation and loading, (3) deposition of lid and 
mucoadhesive coating. These are the main tasks that the multidisciplinary team in NAMEC has addressed. 
The research activities were initiated in the fall 2009, and the main results regarding the development of 
the microcontainer concept are presented below. 
The fabrication of cylindrical microcontainers was developed by Nagstrup et al. [39]: thousands of 
containers with defined dimensions can be fabricated in the biodegradable polymers poly(L-lactic acid) 
(PLLA) and polycaprolactone (PCL) by means of hot embossing. Typically the containers have an outer 
diameter of 300 µm and a cavity depth of 65 µm (see figure 1.4). More recently, a “hot punching” 
technique was developed as a technical solution to remove the microdevices from the residual material 
after the hot embossing process.  
Introduction 
6 
 
  
Figure 1.4: SEM image of en embossed PLLA 
microcontainer. The well diameter is 300 
µm and cavity depth is 65 µm [39]. 
Figure 1.5: Microcontainer with a lid of 
Eudragit L 100. 
 
The effect of spatial confinement on formulation stability has been studied. Nielsen et al. [40] have shown 
that the crystallization of amorphous indomethacin can be slowed down when the API is confined inside 
microcontainers compared to bulk formulation. Furthermore, the smaller the microwells are, the higher is 
the drug stability. In another study the effect of the drug amorphization procedure on stability inside 
microcontainers was elucidated [41]. The application of an enteric polymer coating based on Eudragit L 100 
(see figure 1.5) on the open face of drug filled microcontainers has shown that the drug can be protected 
from degradation in the gastric environment and that the release can be triggered at a specific region of 
the GIT according to the pH of the surrounding fluid. 
Furthermore, several oral drug formulations have been designed with the purpose of delivering 
therapeutics using microcontainers as a carrier: amorphous furosemide salts [42] and insulin laden SNEDDS 
(Self Emulsifying Drug Delivery Systems) [43]. However, the development of a feasible, robust and effective 
loading procedure for microcontainers has been proven to be a non trivial task. Several trials were 
accomplished with the use of hot embossing: a thin layer of drug-polymer matrix was embossed into 
microcontainers and residual portions between the containers were subsequently removed by Reactive Ion 
Etching (RIE). This technique has the advantage of being quite simple, but entails a large loss of material. 
Also, if the containers have initially been fabricated with a similar embossing process (e.g. using 
biopolymers), there is a narrow temperature window where the embossing can be performed without 
deforming the containers. Finally, the used drug might be damaged or degraded due to elevated 
temperatures during embossing as well as RIE. 
An alternative technique for filling containers using screen printing [44] has shown interesting results: a 
stencil mask with holes matching the inner diameter of containers is aligned on top of a wafer with 
microcontainers. Next the drug powder is pressed through the stencil and afterwards the stencil is removed 
with any excess powder. The main drawback of this method lies in the need of alignment of the stencil on 
top of the substrate and its stabilization during the powder compression. This point might be improved by 
designing a specific system for alignment and stencil clamping. However, the procedure is difficult to 
standardize (quantity and homogeneity of filling) and to automate with the available instrumentation.  
Another procedure for container filling developed in our research group, deals with solvent casting. A liquid 
solution containing the drug and excipient is poured on top of the containers and the liquid is distributed 
on the entire surface by manual tilting. The drug solution fills container cavities driven by the surface 
tension, while the excess solution runs off the substrate. Again an advantage of this approach is the 
simplicity, but it also implies substantial limitations. Firstly, the material deposited outside the containers 
represents a waste of material. Secondly, once casted, the solvent in the liquid formulation needs to 
evaporate, which often causes drug recrystallization. Finally, there is a problem related to the use of 
organic solvent, which for hydrophobic drugs is often a choice difficult to avoid. Given the difficulties 
encountered in the abovementioned loading methods, before the achievements described in this thesis, 
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the “state of the art” in NAMEC project, respect to microcontainers filling, consisted in manual pressing the 
drug powder into the devices (without stencil), and blowing away the residual powder in between the 
devices with an air gun. This method entailed a large waste of materials and therefore needed to be 
replaced with a more efficient technique. 
1.5 State of the art of the existing research 
In section 1.3 the main concepts of a device for oral delivery for poorly bioavailable therapeutics have been 
explained. It is deductable that it is very unlikely that methods traditionally used in the field of 
pharmaceutical technology can address all these tasks in one or a couple of steps. This is especially evident, 
when we think about having an asymmetric drug release and a conformal bioadhesive coating. In order to 
bestow such complex features to a single device, multiple steps are required. They have to be performed in 
a logic sequence in order to be compatible with each other, not compromising the final result. The common 
bottom up design itself, with tuning of accurate mixing and transformation of chemical compounds seems 
quite difficult to apply for our purpose. Fabrication methods with a top-down approach seem more 
appropriate.  
A device with the features listed in section 1.3 has been originally conceived in a patent filed 07.01.2000 
and later presented as research work. [45]. The first microdevices developed with these features were 
realized using porous silicon microparticles loaded with protein-based therapeutics as a proof of concept 
[46, 47]. At a later stage, several groups around the world have contributed substantially to this research 
field with innovative microfabricated systems for oral drug delivery. Particular interest was aroused by 
reservoir-based microdevices for water unsoluble compounds and protein-based therapeutics. In the 
following paragraphsan overview of the current state of the art of reservoir-based microfabricated devices 
for oral drug delivery is given, with particular focus on the drug loading. 
The group of Tejal Desai at the University of California (San Francisco) has developed many prototypes of 
microfabricated devices for oral drug delivery. Their achievements can be considered the state of the art in 
this field. The first devices were manufactured in silicon [48]. In this feasibility study, a bioadhesive coating, 
based on surface functionalization with lectins, was tested on microwells for the first time. In later works in 
vitro experiments were performed on CaCo-2 cell monolayers to measure bioadhesion [49]. Also, further 
surface chemistry protocols were developed, becoming one of their most advanced competences. Several 
more advanced prototypes were developed over a period of 13 years using various materials: poly(methyl 
methacrylate) (PMMA) [50], poly(lactic-co-glycolic acid) (PLGA) and gelatin [51]. Typical dimensions of 
these devices are 50-200 µm in width and 3-15 µm in height. The volume available for the drug loading is 
9.6-19 pL [50, 52]. In 2002, a first prototype was developed in silicon (see figure 1.6a and b) [53]. More 
recently, a multilayered microdevice for controlled release of different therapeutics was fabricated in SU-8 
shown in figure 1.7a [54]. The latest prototype developed is a bioadhesive microcontainer in PMMA with 
multiple drug reservoirs (see figure 1.7b) [52]. This design allows the loading of different therapeutics (see 
picture 1.7a and b) which can be delivered either sequentially, simultaneously, or independently and with 
tunable release kinetics. All these devices have in common a flat geometry, which has a relevant advantage 
both from operation and fabrication perspectives. Indeed, a thin and flat microdevice was demonstrated to 
have a stronger adhesion to a cell monolayer simulating the intestinal epithelium as compared to spherical 
microparticles [50]. The low thickness is also an advantage for the definition of the cavity depth, when 
using relatively slow technologies like wet chemical etching [53] or dry ion etching [52]. A wide and flat 
compartment also allows a relatively easy drug loading step, which can be carried out by dispensing a drug 
solution on large arrays of devices or by spin-coating and subsequent selective UV-crosslinking [52]. On the 
other hand a small cavity volume entails a low loading capacity and therefore a larger amount of 
microdevices is needed for a certain drug dose. The influence of particle size and shape on the shear stress 
in the intestine is still a point of discussion, and a compromise between dimension and loading volume 
must be found. The main issue regarding the abovementioned loading techniques is that they are strictly 
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dependent on the solvent properties: figure 1.6 shows that the filling with water solution (figure 1.6a) 
works fine, but with the oil (figure 1.6b) it is much less controllable. The combination of spin-coating and 
UV-crosslinking allows a more precise filling: A mixture of protein and polymer is casted on the 
microdevices. Spinning is applied to the microdevices and a thin layer is leveled. Thereafter, the portions of 
the layer inside the microdevices cavities are exposed to UV light and crosslinked.The uncrosslinked 
portions are lost. In figure 1.7a a multi-layered squared microcontainer, loaded with different labeled 
proteins is shown [54]. Different proteins are loaded in the same container cavity at different depths. 
Figure 1.7b shows a container with multiple reservoirs, each loaded with a different fluorophore tagged-
protein. In this case each cavity can be crosslinked independently, which allows control of the release 
kinetics of the drug. Spin coating deposition can be controlled by modulating parameters like spin rate, 
acceleration, time, and viscosity and surface tension of the liquid. Nevertheless, the drawback lies in the 
large amount of material which is typically required to obtain a uniform coating. By experience, more than 
50% of the dispensed solution is lost during spinning. The exposure to UV light is also critical for 
photosensitive APIs, causing degradation and potentially generating unsafe byproducts [55, 56]. 
The group of Derek Hansford Ohio State University has carried out remarkable research within the field of 
self folding microcapsules for oral drug delivery [57-59]. Material used in this case are PLGA, poly(ethylene 
glycol methacrylate) (PEGMA), and chitosan [57]. Typical sizes for the microstructures fall in the range of 
45-90 µm wide containers containing reservoirs of 3-7 µm in depth. The volume available for drug loading is 
in the picoliter scale (2-7 pL). To fill the microreservoirs, the authors have used discontinous dewetting, 
which exploits the different wetting properties of the drug solutions on the hydrophilic microstructures 
compared to the hydrophobic surrounding surface. In figure 1.8 an optical micrograph of PEGMA 
microwells loaded with NaCl crystals is shown [57]. This technique is rapid and uniform, although it is 
generally dependent on the solvent surface tension. Moreover, if the solution to be loaded is more viscous, 
for example when the drug is mixed with a stabilizing polymer, the discontinuous dewetting will most likely 
be complicated and less accurate.  
The group of David H. Gracias at John Hopkins University has developed different self-folding microcarriers 
for drug delivery [60-62]. These devices are generally prepared by deposition of one or more layers of 
polymer solution on a flat substrate, micropatterning with the desired geometry and release by dissolution 
of an underlaying sacrificial layer. Figure 1.9 shows an SU-8 microcube with PCL hinges. The folding from 2D 
to a 3D arrangement is driven by surface tension: the microstructures are heated above the melting point 
of the hinge material and the faces close like shown in figure 1.9b. Azam and coworkers [60] have 
succeeded in encapsulating living biological components like bacteria and mammalian cells (see figure 
1.9a). The loading is carried out by immersion of the microdevices in the culture media and the 
encapsulation is obtained by energetic tumbling. In this case the loading mechanism is based on self 
assembly and thus it appears less controllable. In addition, the use of SU-8 entails always a cytotoxicity 
issue, which for the therapeutic delivery of cells is rather relevant. 
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Figure 1.6: (a) Time series of water-based loading of 
squared silicon microdevices with micro-injection. (b) 
Microcontainers filled with oil-based solution (modified 
from [53]) 
 
 
 
Figure 1.7: (a) Fluorescent micrograph of a squared SU-8 
microcontainer filled with layered hydrogel loaded with 
three different labeled BSA (top) and with single labeled 
BSA (bottom) (from [54]). (b) Fluorescent micrograph of 
a multi-reservoir container, showing the presence of one 
single model drug (top) and three different model drugs 
in separate reservoirs (bottom) (from [52]) 
 
 
 
 
 
 
Figure 1.8: Optical micrograph of microdevices made in 
resins of PEGMA and PEGDMA, loaded by discontinuous 
dewetting with water solution of NaCl. The inset shows 
an enlarged microdevice containing NaCl crystals (from 
[57] ). 
Figure 1.9: Cubic self-folding microcapsule in SU-8 and 
PCL filled with E. coli 24 h after staining (modified from 
[60]) 
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1.6 Aim of the PhD and thesis outline 
The goal of my PhD project was the development of methods and techniques for the loading of poorly 
soluble and fragile biological macromolecules into microcontainers. The research in drug loading was 
applied to a device fabricated with the epoxy resin SU-8, a material not approved by FDA for oral ingestion. 
The reason for this choice was the fact that the development of biodegradable devices (carried out in 
another PhD project running in parallel) was not yet concluded. The SU-8 container has instead an 
optimized and relatively fast fabrication and was therefore chosen as a prototype in this project to test 
different loading techniques.  
In this work the attention was focused on small model molecules belonging to BCS type IV (low solubility 
and permeability) and type II (low solubility and high permeability). In the final part of the project the 
loading of biomacromolecules was investigated. The research work aimed to address the following issues: 
1. to investigate the suitability of inkjet printing as a technique for microcontainer filling and loading 
2. to develop loading methods that can be up scaled to a production level 
3. to characterize materials and technologies in light of developing a controlled release device 
4. to combine loading methods with existing optimized formulations for oral delivery of poorly soluble 
and fragile APIs 
The present thesis is structured as follows:  
• Chapter 2: In this chapter the fabrication process of SU-8 microcontainers is illustrated. The utilized 
experimental techniques are described each with a concise theoretical background needed for a 
complete understanding of the results.  
• Chapter 3: This chapter is dedicated to a feasibility study of inkjet printing as a technology for the 
filling of microcontainers with different drug formulations. 
• Chapter 4: Here the application of supercritical impregnation of PVP with ketoprofen is described 
as a drug loading technique for microcontainers. A section is dedicated to the in depth 
characterization of this technology with respect to drug loading yield and influence of the process 
parameters. The drug-excipient molecular interactions are investigated with different experimental 
techniques. 
• Chapter 5: In this chapter a new fabrication approach is developed, based on the patterning of 
micro-hydrogels by means of UV photocrosslinking. The microgels are meant to be the polymer 
matrix hosting the drug after loading. Gel matrix features are elucidated in terms of drug loading 
capacity and release properties.  
• Chapter 6: The final chapter comments on the overall PhD project, the unsolved issues and the 
future perspectives for the combination of the achievements in the drug loading with the 
fabrication steps of biodegradable microdevices. 
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2. Theory and methods  
This chapter covers all the microfabrication processes and the main characterization methods used in this 
PhD project. A first section describes the technologies involved in the fabrication of arrays of 
microcontainers made in SU-8 on custom-made silicon substrates to facilitate the following loading steps. 
The process regarding the fabrication of silicon slides and arrays of SU-8 microcontainers was published in 
the full paper ´”Inkjet printing as a technique for filling of micro-wells with biocompatible polymers”, where 
also the use of inkjet printing as a filling method is presented (see Appendix 1). 
A second section is dedicated to the fabrication of PCL and PLA microdevices, for which few tests were 
performed mainly to investigate the applicability of the developed loading methods.  
The third section deals with the fabrication of glass masks utilized for the definition of micro hydrogels by 
means of UV photocrosslinking. The microfabrication processes of SU-8 microcontainers and glass masks 
were performed at the DTU Danchip clean room facilities.  
The supercritical experiments were performed in the laboratories of ChemiPilots A/S (Farum, Denmark) and 
in collaboration with the Department of Industrial Engineering and Information Technology, University of 
Trieste (Italy). The X-ray spectroscopy activities and the dissolution experiments were performed in the 
laboratories situated of the Department of Pharmacy at the University of Copenhagen. 
The rheological measurements and the NMR experiments were carried out at the University of Trieste 
(Italy). Additional rheological tests were performed at the Department of Chemical Engineering at DTU. 
2.1 Fabrication of microcontainers 
2.1.1 Microcontainers in SU-8 
SU-8 is a negative photoresist (SU-8 2075, Microchem, USA) based on an epoxy resin which is commonly 
used in micro and nanotechnology for fabrication of high aspect-ratio microstructures [1, 2]. This material 
was originally patented by IBM in 1989 [3] and since then its use has been widely investigated and 
nowadays SU-8 processing is established in the field.  
SU-8 was chosen as material for microcontainer because of the simplicity of the fabrication process: The 
chosen microdevice dimensions are far from the resolution limits for patterning of this material, which 
allows the use of standard fabrication equipment.  
SU-8 was utilized is several drug delivery microdevices [4-6] and its currently most diffused application in 
drug delivery is in the fabrication of molds for polymer microneedles in transdermal delivery [7-9]. 
Several studies showed that SU-8 does not inhibit cell growth [10], and allows cell cultures persisting for 
more than 3 months [11]. Subcutaneous in vivo implantations of SU-8-coated drug eluting devices induced 
a limited leukocyte adhesion in rats after 21 days [12]. On the other hand it has been known that SU-8 
hydrophobicity limits cell attachments [13, 14] and therefore the depositions of white cells on the 
photoresist might not be a reliable parameter for tracing immune response. As a consequence, the 
biocompatibility and safety of SU-8 is not proven, and thus, as mentioned in chapter 1, SU-8 is not yet 
approved by FDA for drug delivery. 
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In this work the fabrication of microcontainers has been performed on silicon wafers. As a first step, 
trenches were etched (see figure 2.1a and b) to facilitate the partition into fragments for further 
esperiments. In particular, the etching trenches were designed to allow to cleave the wafer manually into 
rectangular slides, fitting the tray of an inkjet printer as shown in figure 2.1c. Each slide can further be 
cleaved into squared chips, containing 625 microwells, aligned into a 25×25 matrix, as depicted in the SEM 
micrograph in figure 2.1d. 
 
  
  
  
Fig. 2.1: (a) Silicon wafer etched with trenches, (b) zoom of trenches and squared chips with 625 containers, (c) silicon 
slide fitting the slots of an inkjet printer tray, (d) SEM micrograph of microcontainer arrays. 
 
The fabrication process of SU-8 microwells is composed by two main steps. (I) Anisotropic etching is used to 
define trenches in a silicon substrate in order to obtain easy-breakable rectangular substrates fitting into 
the slots of the inkjet printer tray, (II) negative photolithography is used for the definition of the micro-
wells. In figure 2.2 the overall fabrication process is schematically illustrated step by step. 
On a silicon wafer an oxide layer (2 μm) was deposited by LPCVD (figure 2.2a). A positive photoresist (AZ 
5214e) was spin coated on the front side and patterned by photolithography (figure 2.2b). Afterwards, the 
same resist was spin coated on the back side. The resist pattern on the front side and the back side layer 
acted as protective mask for the etching of the silicon oxide layer (BHF for 30 min) (figure 2.2c). The resist 
was then stripped and an anisotropic etching in KOH (4 h, 80 °C) defined the trenches for the aligned 
cleavage of the wafer after microwell fabrication (figure 2.2d). The remaining oxide layer was then removed 
in BHF (4 min) to improve SU-8 adhesion in the next fabrication step. For the container fabrication, a first 
layer of SU-8 2075 (thickness 35 μm) was spin coated (figure 2.2e) and selectively exposed to define the 
bottom of the microwells (figure 2.2f). A second layer (255 μm) of the same resist was spin coated and 
patterned (g). Finally, the uncrosslinked resist was developed in propylene glycol methyl ether acetate 
(PGMEA). The silicon wafer was cleaved along the trenches into rectangular slides (figure 2.2h). Slides sizes 
A B 
C D 
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are designed to fit into the slots of the inkjet printer tray, as depicted in the optical picture in figure 2.1c. 
Each slide contains ten squares, each having 625 containers (see figure 2.1a). The containers are aligned 
into a 25 × 25 matrix. Microwells are fabricated with cavity diameters of 50 μm, 100 μm, 200 μm, 300 μm 
corresponding to a cylindrical cavity volumes of approximately 0.5, 2, 8, 18 nL respectively. The width of the 
well walls is 50 μm and the center-to-center spacing is 450 μm for all wells. 
 
 
Fig. 2.2: Process flow for the fabrication of microcontainers on Si microscope slides: (a) LPCVD (2 µm) on silicon 
wafer; (b) photolithography with positive resist on the front side (2.2 µm), spin coating of the resist (2.2 µm) on the 
back side; (c) wet etching of oxide in BHF; (d) resist stripping and wet etching of Si in KOH; (e) SU-8 spin coating (35 
µm), (f) selective UV exposure, (g) spin coating of second layer of SU-8 (255 µm) and masked exposure; (h) SU-8 
development; chips are cleaved in microscope slides. 
 
2.1.2 Microcontainers in PCL and PLLA 
Poly(lactic acid) (PLLA) and poly(caprolactone) (PCL) are biodegradable polymers approved by FDA for oral 
dosage forms. Thus, these materials are eligible for microcontainer fabrication. This project has not dealt 
with the fabrication process described in this paragraph, but since feasibility tests on the drug loading of 
these devices were performed, it is worth to briefly discuss the technology used for their preparation, 
which was developed in the Nanoprobes group. 
Many different techniques for polymer microstructuring exist, such as injection molding, micromilling, 
three dimensional printing, etching, laser cutting, laser writing, and embossing. The main criteria driving 
the choice for manufacturing of microcontainers were the simplicity and the potential for large production. 
Hot embossing has been considered one the most suitable methods for this purpose [15, 16].  
The principle of hot embossing relies on thermoplasticity that is the ability of polymers of turning from stiff 
to pliable and moldable when a certain temperature, called glass transition temperature (Tg), is crossed. 
Above this temperature and up to the melting point, the polymer is in a rubbery state, and can be 
deformed and shaped with a mold if pressure is applied. The transition is often reversible, therefore when 
the polymer is cooled below Tg, it recovers the initial stiffness maintaining the shaped during the molding. 
A polymer film is heated up to a defined temperature and a stamp is pressed onto the film, for a period of 
time. Finally, the polymer is cooled down and afterwards the pressure of the stamp is released. Important 
parameters for a good pattern transfer are the temperature, the pressure and the time of embossing. For 
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PLLA microstructuring, the embossing temperature was found to have a relevant influence on the shape of 
the microdevice. The Tg of PLLA is around 60°C and a good molding was obtained at 120°C. The glass 
transition of PCL occurs around -60°C and at room temperature the polymer is in rubbery state. The 
technical limitation of the available embossing tool did not allow to work at room temperature, therefore 
the embossing was performed close to the melting temperature (Tm=60°C). In this case the heating rate was 
very important because of the proximity to the melting point: the polymer melting must be avoided in 
order to have a complete release of the stamp from the polymer film. An optimal setting of 60°C at 5°C/min 
was found.  
For any other steps subsequent to container fabrication, like for instance the drug loading, microcontainers 
should not be processed at temperatures higher than the polymer glass transition in order not to 
compromise the shape transferred by hot embossing. 
2.1.3 Fabrication of glass masks 
Glass masks were used to study the reaction of photocrosslinking of PVP solutions, which is discussed in 
chapter 5. The masks were fabricated by means of reverse photolithography, metal deposition and lift-off. 
Several designs of masks were produced, with circular pattern with different sizes and center-to center 
distance. The basic steps of the process flow are schematically shown in figure 2.3.  
A pyrex glass 4 inch wafers was dipped in buffered hydrofluoric acid (BHF) bath for 60 sec to improve the 
adhesion of resist on glass in the next fabrication step. A positive resist (AZ 5214e) was spin coated (2.2 µm) 
on the front side (figure 2.3a), baked in oven at 90°C for 60 sec, and patterned by photolithography (49 
mJ/cm2) with a similar mask used for the fabrication of microcontainers (figure 2.3b). The wafer was then 
put on a hotplate at 120°C for 120 sec to activate the crosslinking of the exposed areas (figure 2.3c). 
Afterwards the resist was exposed to UV light without mask (figure 2.3d) and the resist previously not 
exposed is made soluble in developer in the following development step. 
A thin cromium layer (100 nm) is then deposited by E-beam metal evaporation onto the wafer front side. 
Finally, the pattern with the metal coating on top was lifted off in acetone with ultrasound for 30 min (f) 
and the wafer was rinsed in a water bath for 3 min and then dried. In alternative to the initial pretreatment 
in BHF, the wafers can be put in an oven for 20 min at 250°C. The obtained mask is then diced into square 
chips for further utilization (figure 2.4). 
 
 
Figure 2.3: Fabrication process flow of glass masks. (a) Spin coating of positive resist (2.2 µm), (b) selective UV 
exposure, (c) inversal bake, (d) flood UV exposure, (e) development and E-beam metal deposition, (f) lift off in 
acetone. 
(a)
UV
(b)
(c)
(d)
HEAT
(e)
(f)
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Figure 2.4: Image of diced square of glass mask chip 
(12.8×12.8 mm). 
Figure 2.5: Image of a dispensing tip placed on top of 
an array of microcontainers. 
2.2 Inkjet printing technology  
2.2.1 Introduction 
Inkjet printing is a familiar technology which originally was designed to transfer electronic data onto flexible 
substrates and overhead transparencies. Recently, more and more applications were investigated for this 
technology and versatile tools were developed to dispense accurate minute amounts of a broad range of 
materials for various manufacturing processes. Inkjet has become one of the most promising technologies 
in several fields. It has been employed for high precision deposition of polymers onto MEMS switches [17], 
metallic solders in micro-electronic soldering [18], and UV curable epoxy resins for micro-optical 
applications [19], representing a valuable mold-free manufacturing technique to fabricate large arrays of 
3D micro-objects [20]. In these last years the use of inkjet printing has been extended to the fields of 
biotechnology and pharmacy, finding application in large screening of genomic material [21] for cell 
culturing [22, 23], for functionalization of Bio MEMS [24] and drug delivery [25-27]. The main advantage of 
this technique lies in the accuracy and throughput of fluids. Nano and picoliter droplets of liquid can be 
dispensed onto very precisely localized positions with high uniformity which makes this equipment capable 
of producing precise micro features [28, 29]. 
Inkjet operation can be fundamentally divided into two operations modes: continuous jet mode, and drop-
on-demand mode (DOD). In continuous mode, a liquid is subjected to pressure and ejected through a 
nozzle; the main application of this mode is in graphics. In DOD mode the fluid jet is subjected to a pulsed 
perturbation which deforms the jet creating droplets. Martin and coworkers have described the physics of 
this operation in a very valuable publication [30]. The perturbation of the fluid jet is induced by stimuli of 
different physical natures: thermal, piezoelectric, electrostatic and acoustic.  
In the following section the basics of the operating system used in this work are discussed with respect to 
its use as a loading method for microcontainers.  
2.2.2 Equipment description and operations 
In this work an inkjet printer (Nanoplotter NP 2.1, GeSiM, Germany) equipped with piezo-driven pipettes 
was utilized for the loading of microcontainers; a dispensing tip on top of microcontainers arrays is shown 
in figure 2.5. In the equipment in use the pipette aspires the liquid from a titer plate and dispenses the 
liquid by ejection. In the piezo driven-dispenser the fluid ejection is actuated by the deformation of the 
piezoelectric material in response to a voltage pulse: the change in volume of the piezo causes pressure 
waves in the fluid contained in the pipette, which results in a droplets being ejected from the orifice [31]. 
In piezo-driven injection, crucial properties for the liquid to be dispensed are viscosity, surface tension and 
density [32]. These fluid properties determine the formation mechanism, the shape and the size of the 
2 mm 
2 mm 
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liquid droplets formed by a voltage pulse. From a physical perspective fluid characteristics can be described 
by the dimensionless numbers: the Weber number (We), comparing inertial and capillary forces, and the 
Reynolds number (Re), comparing inertial and viscous forces. The Ohnesorge number (Oh) is another 
dimensionless number, which is defined as the ratio of the square root of the Weber number and the 
Reynolds number. 
 We = ρDυ2
γ
    ;       Re = ρDυ
η
    ;       Oh = η
�Dργ (2.1) 
 
Where υ is the average travel velocity of the sprayed droplet, ρ is the density, γ is the surface tension, η is 
the viscosity of the fluid in the nozzle and D is the characteristic dimension of the geometry (here the 
orifice diameter) respectively. Jang et al. [32] have studied the printability of fluids relating the in situ 
droplet formation dynamics to the dimensionless number Z, defined as the inverse of the Ohnesorge 
number. In that investigation, a good quality of printing was defined by the formation of a single droplet, 
positional accuracy, minimum stand-off distance and maximum allowable jetting frequency. A printable 
range fulfilling these requirements, was found to be 2<Z<14. For the chosen test solutions (water and 
ethylene glycol), the most decisive parameter, influencing the Z value within the printable range, is 
viscosity. The viscosity limit for the printer used in this work is 5 mPa·s. In order to dispense more viscous 
liquids, it is possible to use heatable pipettes, in which the aspired sample can be heated up to 120°C. 
Further considerations on the importance of viscosity on inkjet printing of lipid based and polymer 
solutions will be discussed in chapter 3. 
The most important operating parameters in the piezo-triggered inkjetting are voltage amplitude, width 
and frequency of the impulse generating the droplets. Typically droplet ejection speed and volume are 
linear functions of the applied voltage, while the dependency from pulse duration and frequency is more 
complex [33]. In this project, inkjet printing was used to dispense various solutions of the water insoluble 
drug furosemide, lipid based formulations, and solutions of PVP.  
2.3 Supercritical technology  
2.3.1 Principles of supercritical processing  
A supercritical process is a technology which utilizes one or more chemical compounds above the critical 
point. In thermodynamics a critical point is defined as conditions in which the boundaries between phases 
in equilibrium disappear. Typically the vapor-liquid critical point is referred to, as it is the most broadly 
studied. When a substance crosses the critical point, gas and liquid merge together in a homogeneous 
phase characterized by a density close to the liquid, and viscosity, thermal conductivity, interfacial tension 
and diffusivity similar to a gas. In figure 2.6 the phase diagram with the supercritical state is illustrated 
(from [34]). A fluid above its critical pressure and temperature is called supercritical (sc). By virtue of these 
properties, the use of sc fluids has been widely explored in the field of pharmaceutical technology. The 
liquid-like solvent properties are beneficial in drug solubilization, polymer plasticization, and extraction of 
solvent and impurities, while the gas-like behavior enhances mass transfer, promoting extraction or 
reaction selectivity. A further advantage of sc state is the high compressibility of fluid near the critical 
region, which enables to tune the solvent power of the fluid within microseconds by a simple change of 
pressure or temperature. For most of polar chemicals, the transition to supercritical state occurs at high 
temperatures, which makes it prohibitive for pharmaceutical manufacturing. In this work supercritical 
carbon dioxide was used as a solvent to impregnate a model hydrophobic drug in a polymer matrix 
previously fixed inside microcontainers by inkjet printing. In this process the drug is first solubilized in the sc 
fluid and then impregnated into the polymer. The dissolution in supercritical CO2 is a crucial step for this 
Theory and methods 
21 
 
application, and therefore it is worth to mention the conditions required to accomplish scCO2 assisted 
impregnation. 
 
 
Figure 2.6: Schematic pressure–temperature phase 
diagram for a pure component showing the 
supercritical fluid (SCF) region (from [34]). 
 
2.3.2. Solubility of active ingredients in supercritical carbon dioxide 
Carbon dioxide is probably the most widespread chemical used at supercritical conditions in the 
pharmaceutical field. There are indeed many properties that make it a particularly attractive solvent, 
including non flammability, low toxicity, limited cost and environmental compatibility. The critical point of 
carbon dioxide is 73.8 bar at 31.1 °C. These are favorable conditions for the treatment of many 
thermolabile drugs. However, many drug substances and excipients exhibit low solubility in supercritical 
CO2. Despite its non polar properties, it is often the case that supercritical carbon dioxide is a poor solvent 
for many lipophilic molecules at pressures lower than 500 bar. There are though a large group of class II 
and IV drugs which have a discrete solubility in CO2 at moderate pressures. In a very interesting publication 
about sc fluids in drug product development [35], Panza and Beckman have identified the necessary 
properties for a compound to be soluble and miscible with CO2 at moderate pressures. The characteristics 
for scCO2-philic compounds are summarized in Table 2.1. 
 
Table 2.1: Important characteristics for CO2-soluble compounds (adapted from [35]) 
Characteristic Importance Reference 
Electron-donating 
functional groups 
Specific solute-solvent interaction (Lewis acid/base 
interactions, CO2 electron acceptor) 
[36-38]  
Electron-accepting 
functional groups 
Specific solute-solvent interaction (Lewis acid/base 
interactions, CO2 electron donor) 
[39] 
Polarity/partial dipoles Interact with the quadrupole moment of CO2 [40-42] 
Molecular architecture Free volume and flexibility as indicated by low glass 
transition temperatures 
[40, 42-45] 
Low surface tension Weak intramolecular interactions more significant than 
compound-CO2 interaction 
[38] 
Balance between entropy 
and enthalpy of mixing 
A point of diminishing return will be reached (too many 
favorable interactions leads to unfavorable entropy) 
[38, 44, 45] 
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The first important property is the presence of functional groups which can interact with the CO2 molecule 
by electron-donor groups (like carbonyl groups) or electron-acceptor groups (like Lewis bases). 
Although carbon dioxide is a non-polar molecule, its reciprocally neutralizing dipoles can interact with other 
compounds. Therefore, a substance eligible for dissolution in CO2 should contain some polar character [36, 
38, 39]. Regarding the molecular structure, large molecules, especially polymers, must exhibit large free 
volume with a high degree of flexibility which means a low glass transition temperature [40, 42]. 
Another feature for solubility in CO2 deals with having a low surface tension i.e. a low cohesive energy 
density close to the one of CO2. This means that the solute should not have strong interactions with itself 
due to hydrogen bonds, or Lewis acid/base or polar molecular bonds. 
Finally, interactions with CO2 are favoured in presence of a balance between enthalpy and entropy in the 
mixing. The presence of many interaction sites in the molecule reduces the enthalpy of mixing. However, 
too many hinders the increase of solution entropy, “freezing” the mixing inward CO2 [44, 45]. 
The solubility of solid solutes in supercritical fluids depends on temperature, pressure and eventual 
cosolvent concentration. In the regions below the critical point, the solubility initially decreases with 
increasing pressure, reaching a minimum, and then rises rapidly in the region of the critical pressure [46]. In 
supercritical conditions, the solubility, at constant temperature, is an increasing monotonic function of 
pressure. At isobaric conditions the dependence of solubility on temperature follows a more complex 
behavior. For pressures below a certain pressure PL
*, called lower crossover pressure, and above PU
*, upper 
crossover pressure, the solubility increases with temperature. On the contrary, between PL
*and PU
*, the 
solubility decreases with temperature. This is explained by the rapid decrease of the fluid density [47]. The 
overall phenomenon is due to competing effects of temperature. On one hand, a rise in temperature 
causes a density decrease and a consequent reduction in the fluid solvent power. On the other hand, a 
temperature rise produces an increase of the sublimation pressure of the solute, i.e. a higher volatility, 
which results in a higher solute molar pressure in the fluid. When the fluid pressure is equal to PL
*or PU
*, 
these competing effects balance each other, and the solubility isotherms intersect. The influence of 
temperature on solubility will be also deepened in chapter 4, with respect to the loading efficiency. 
As previously stated, scCO2 is far from being a super-solvent for hydrophobic APIs. Nevertheless, several 
solutions have been investigated to overcome this major limitation. Three methods have been developed: 
use of surfactants, use of cosolvents, and covalent modification of the insoluble compounds this so called 
CO2-philic “pony tails”[35]. 
The use of surfactants as solubilization enhancers is widely spread in pharmaceutical research. In the case 
of CO2, the surfactant is composed by a CO2-philic segment interacting with the CO2 and by a CO2-phobic 
segment that can be chosen among the compounds most akin to the solute to be dissolved. Several CO2-
surfactants have been created based on fluorinated polymers, silicon-based chemicals and CO2-philic 
hydrocarbons [48-51]. Also, CO2-surfactants have been synthesized for emulsification of large biomolecules 
like proteins and enzymes in scCO2. Johnston and colleagues [52] successfully included bovine serum 
albumin (BSA) in water-in-CO2 microemulsions. Ghenciu et al. extracted a protein from a cell culture media, 
preserving most of its biological activity [53]. Holmes and coworkers showed enzyme reactivity in water-in-
CO2 microemulsions [54]. 
The addition of cosolvents to CO2 is another strategy which potentially extends the use of this technology 
to a larger number of substances which dissolve in organic solvents but not in scCO2. The enhancement of 
solubility of many APIs by means of this method has been widely studied [55-58] and in some cases it has 
brought relevant advantages. While the presence of a second solvent (generally an organic solvent) 
facilitates the dissolution into CO2, it also modifies the physico-chemical properties of the supercritical fluid, 
in particular the density and diffusivity, which could entirely counterbalance the benefits accrued with the 
use of supercritical conditions. The use of certain cosolvents could also compromise the intrinsic 
advantages of non flammability, ecological sustainability and cost-effectiveness of the process.  
A less explored solution to dissolve essentially insoluble substances into CO2 is the modification of the 
compound by covalent attachment of CO2-philic functional groups. Ghenciu and Beckman [59] have 
synthesized a high affinity CO2-surfactant, chemically bonded to biotin, for the extraction of avidin. In that 
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work an emulsion encapsulating the protein was created in the CO2 phase, and then the protein was 
recovered by stripping liquid CO2, with a continuous removal of the biotin-avidin complex. Similarly, Panza 
et al. [60] covalently attached a CO2 amphiphilic molecule to a coenzyme, proving that after extraction of 
an enzyme in the supercritical phase, the biocatalytic action of the compound was still functional. 
2.3.3. Supercritical impregnation 
Polymers frequently require impractically high pressure to dissolve in CO2. Therefore, the absorption of CO2 
in polymers is often much more feasable. Supercritical CO2 is a well known impregnating agent for many 
materials of pharmaceutical and biomedical interest: poly(methyl methacrylate) (PMMA) [61, 62], 
poly(dimethylsiloxane) (PDMS) [63, 64], poly(lactic-co-glycolic) acid (PLGA) [65], hydroxypropyl 
methylcellulose (HPMC) [66], poly(ethylenglycole) (PEG) [67] polyvinylpyrrolidone (PVP) [68, 69], 
polycaprolactone (PCL) [70, 71], polylactide acide (PLA) [72], chitosan [73, 74], cyclodextrins [75], just to 
cite the most known.  
The mechanism of supercritical impregnation of polymers consists of three physicochemical steps, as 
suggested by Kazarian et al [35]: i) the solubilization of the solute in the supercritical CO2, ii) the swelling of 
the polymer matrix by supercritical solution and the introduction of the solute in the polymer, and iii) the 
polymer deswelling by CO2 depressurization fixing the solute in the matrix. The good success of the 
operation depends on the mutual molecular interaction between solute, polymer and supercritical fluid. In 
particular, the solute must form a stable solution with CO2 but at the same time have a strong affinity to 
the polymer, in order to be incorporated in the matrix and not being extracted when the fluid is removed. 
In this sense, the limited solubility of certain compounds in CO2 can reveal itself an advantage. Moreover, 
the polymer must be swelled by scCO2 but should not be dissolved, in order to avoid its removal during the 
fluid depressurization. All these constraints determine the suitability of the abovementioned materials, and 
limit the operation ranges of pressure and temperature for the impregnation. 
The effects of CO2 absorption in polymers are various: volumetric expansion [76], decrease of density and 
increase of porosity [77, 78], change of intrinsic diffusion coefficient [79, 80] and depression of Tg and Tm, 
with possible transitions to rubbery state and liquid state respectively [80]. This fact entails often significant 
changes in viscosity and surface tension of the polymer. Gerhardt and coworkers [81] have measured, by 
means of an extrusion rheometer modified for high pressure operations, the shear viscosity of CO2-swollen 
PDMS melts. They discovered that the absorption of CO2 resulted in a dramatic decrease of viscosity of 
nearly one order of magnitude. In the case of liquid polystyrene (PS), it was observed that CO2 uptake 
induced a decrease in surface tension on pendant droplets [82]. All these results clearly reveal that dense 
CO2 acts as effective plasticizers for polymers, increasing the free volume of chains and enhancing their 
mobility. Besides the pressure and temperature of CO2, the swelling of a polymer (or likewise the solubility 
of CO2 in a polymer) depends on intrinsic properties of the material, where polymer molecular weight [68] 
degree of crystallinity [76], degree of crosslinking [83] are the most important ones. 
2.4. Drug dissolution measurements 
2.4.1. Dissolution  
The dissolution speed of the active ingredient in the physiological fluid is an extremely important feature of 
a pharmaceutical product because it affects the time at which the therapeutical agent reaches the target. 
Dissolution is a kinetic property and the dissolution rate is the speed with which the drug is released from 
the delivery device to the solvent. Dissolution rate depends both on the physicochemical properties of the 
formulation and solvent compositions, and on the hydrodynamic regime in the dissolution medium, besides 
the physico-chemical properties of the drug delivery systems, as discussed in section 1.2. In vitro dissolution 
tests are used as a preliminary study, which should mimic what happens in vivo, where the drug is 
supposed to be released in the gastrointestinal tract. Several apparatuses are available for dissolution 
studies; the United States Pharmacopeia (USP) suggests different experimental methods and setting 
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according to the dosage form (tablets or capsules) and the hydrodynamic conditions [84, 85]. The 
dissolution apparatuses have different designs, and consequently different hydrodynamics. An important 
role is also attributed to agitation speed, solvent viscosity as well as volume and geometry of the vessel 
where the dissolution takes place [84, 86]. Within the intestine, there are various flow velocities, depending 
on the distance from the mucosa and this is a phenomenon difficult to simulate in vitro [87]. Nevertheless, 
dissolution results are still important to give indicative information about the drug dissolution behaviour for 
the in vivo performance. The dissolution tests presented in this thesis were performed with commercial 
dissolution equipment, which did not aim to provide information relevant for in vivo simulation, but to 
study the drug dissolution compared to other formulations.  
2.4.2 Dissolution equipment: µDISS profiler 
A µDISS Profiler™ (Pion, USA) is a dissolution apparatus for the detection of concentration of drugs, down 
to µg/mL. A photograph of the equipment is shown in figure 2.7a. The dissolution vessels, schematized in 
figure 2.7b can contain up to 20 mL. The instrument can measure up to six simultaneous dissolutions of 
occuring in respective vials. It has been shown that a μDISS profiler can be used for testing the dissolution 
behaviour and obtaining the dissolution rate of drugs [88]. A μDISS profiler has previously been used to 
evaluate apparent solubility and dissolution rate of poorly soluble drugs. The only requirement for the drug 
is a strong chromophore, detectable also in small concentration [88, 89]. The solute concentration is 
measured by means of in situ fiber optics UV probes as shown in figure 2.7b. The light beam is directed in 
the liquid through a slit of different width (0.5 mm in this study) and reflected from a mirror at the edge of 
the probe. Thus, the radiation passes through a layer with liquid gap equal to the double of the slit (i.e. 1 
mm). The absorption spectrum of the solute is shown in real time with an acquisition time ranging within 
50-100 ms. A wavelength between 200 and 780 nm can be selected, and the corresponding intensity in the 
absorption spectrum is translated to a concentration value. A rotation speed of 100 rpm and a temperature 
of 37°C were set during the dissolution experiments. Before each measurement, a calibration curve is 
carried out for each probe, with 20 concentration points. 
 
  
Figure 2.7: (a) Picture of the dissolution apparatus µDISS™ Profiler; (b) schematic 
of a dissolution vessel with a measuring probe immersed. 
2.5. Solid state characterization 
As discussed in section 1.2.1, the solid state of a formulation is an essential feature with regards to drug 
solubility and dissolution rate. When employing the amorphous form of a drug, it is necessary to monitor 
the stability of the drug over time, as it tends to recrystallize. It is often necessary to combine several 
methods of solid state analysis in order to have a complete characterization of the sample.  
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2.5.1 X-ray Powder Diffraction  
The diffraction of X-ray (XRPD) provides important understanding of the crystalline structure of the 
formulation, and characterization of crystal lattice properties. However, this technique does not give 
information about the chemical composition of the sample [90, 91]. XRPD is a non-destructive method, 
where a small quantity of sample is required (few milligrams), and can be used both for qualitative and 
quantitative purposes [92, 93]. The beam penetration is estimated to be in the range of hundreds of 
microns [94, 95] and the presence of minimum 5% of non-crystalline material in the sample can be 
quantified.  In this study, X-ray diffraction was used to investigate the solid state of the drug inside 
microcontainers after loading. The analyses were performed using an X'Pert PRO X-ray diffractometer 
(PANalytical, Almelo, The Netherlands), equipped with a Cu KR anode ( λ = 1.541 Å;45 kV; 40 mA). 
2.5.2 Raman spectroscopy 
In Raman spectroscopy monochromatic radiation is projected on the sample, and an inelastic scattering is 
produced. The difference in energy between the incident and the scattered light results in a characteristic 
Raman shift [90, 96]. The nature of the scattering depends on the chemical structure of the sample, and 
two cases can occur: the irradiated light is scattered back with the same wavenumber (Rayleigh scattering), 
or with a different wavenumber (Raman scattering). In the Raman scattering the wavenumber of scattered 
radiation can be higher than the incident one (anti-Stokes scattering), or more often lower (Stokes 
scattering). The difference in wavenumber corresponds to a transition in the vibrational energy of the 
molecule and this occurs if there is a change in the electron polarisability of the analyte [97, 98]. For drug 
solid state analysis Raman scattering represent a powerful tool, since typical functional groups of drug 
molecules are good Raman scatterers. 
Raman spectroscopy is a non destructive method, and offers the advantage of analyzing samples of small 
dimensions. The sample volume submitted to radiation exposure is few cubic microns. The transparency of 
glass and water allows to avoid the distortion of the signal, and to perform experiments in aqueous 
environments, e.g. to perform measurements of crystal precipitation during dissolutions [90]. The exposure 
of small sampling areas to radiation entails nonetheless unwanted effects like local heating, photo 
bleaching and fluorescent emissions, which may considerably affect the results. To amend this 
inconvenience, it is possible to choose among several excitation wavelengths and filters [91].  
In this study, Raman spectroscopy was used to elucidate the presence of interaction of the drug with 
excipients after the loading. For the analyses descrbed in this thesis, were performed with DXR Raman 
microscope (Thermo Scientific, Germany) equipped with a frequency-stabilized single mode diode laser 
(780 nm). 
2.5.3 Attenuated Total Reflection Infrared Spectroscopy (ATR-IR) 
In IR spectroscopy, the radiation is absorbed in the sample, generating intramolecular vibrations. A 
transition from a ground state to a fundamental mode occurs at fundamental frequencies, which are 
characteristic for each bonds and functional goups, allowing the identification of the chemical structure of 
the sample, and eventual molecular interactions between components.  
The advantages of IR spectroscopy in an enhanced spatial resolution, which allows the detection of smaller 
particle sizes, often occurring in pharmaceutical formulations. The potential of applications of ATR-IR 
imaging for polymeric materials of industrial interest was illustrated recently [99, 100].  
The ATR-IR is a non destructive method requiring a small amount of sample, which can be in form of 
powder, paste, or liquid. The sample is placed in contact to a refractive crystal, and pressed onto it by 
means of a torque wrench. A good contact between the sample and the crystal is very important in order to 
obtain a reliable FT-IR image. Reflection IR imaging requires a very flat and smooth surface of the sample in 
order to produce a good signal-to-noise ratio (SNR) within a reasonable acquisition time. In ATR mode, 
infrared light is directed through a high refractive index material (the ATR crystal) and is totally internally 
reflected at the interface between a sample and the crystal. At this interface, the electric field of the IR light 
penetrates into the sample as an evanescent wave, which causes an attenuation effect on the incident 
wave. The attenuated radiation is detected in form of an IR spectrum (usually called the ATR-IR spectrum). 
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The typical penetration dephts of the evanescent wave travel in the analysis of a pharmaceutical or 
polymeric sample range from 0.2 µm to a few micrometers [101]. In this work, IR spectroscopy was used to 
study the chemical interactions of the drug after the loading. For the analyses a Spectrum100 spectrometer 
was used (Perkin Elmer, Germany) equipped with an MIR source and a TGS detector. 
2.6. Hydrogel characterization and imaging 
Hydrogels obtained by photocrosslinking are used in oral drug delivery as carriers for poorly soluble drugs 
and fragile biomacromolecules. An important feature of polymeric hydrogels is that they absorb large 
volumes of water, modifying their nanoscopic structure. They can be designed for drug delivery purposes, 
as they can release the APIs in a controlled manner. This is particularly interesting for drugs requiring a 
prolonged release, like for instance insulin. The correlation between drug release kinetics and mesh size of 
hydrogel network has been extensively elucidated [102-105]. Hence it is important to control the 
crosslinking density in a polymer network for a controlled release device. In this section, different methods 
for hydrogels characterization are discussed which will be used in chapter 5 to investigate their mechanical 
and the structural properties. The first group of methods investigates the nanometric structure of the 
material addressing the estimation of mesh size of the polymer network. To this group belong rotational 
rheometry and nuclear magnetic resonance. A second group of techniques were utilized for imaging and 
size measurement of gel micropatterns obtained by selective photocrosslinking of polymer films. For this 
purpose optical and contact profilometry, confocal microscopies as well as environmental scanning 
electron microscopy (e-SEM) were used. For rheometry and NMR spectroscopy, a deeper theoretical 
background was included in the respective introductive sections due to the complexity of the measured 
physical variables and for a more complete understanding of physical and numerical models used in the 
data treatment. 
2.6.1 Rheological characterization of hydrogels 
Rheology is the science that studies mechanical behaviour of fluids and correlates it with its structural 
properties. In detail the topic of the study is the deformation γ of a material, liquid or solid, under the 
action of an applied stress τ in flow conditions [106]. Rheometry refers to the experimental techniques 
used to determine the rheological properties of materials. From the mechanical response of the material, 
the structural properties of complex systems, like for instance dispersions, emulsion and gels, can be 
elucidated by means of elaborated theories and models. In particular for gels, the combination of 
measurements and modeling can reveal the mean mesh size of the polymer network.  
In this work, the rheological characterization was performed by a rotational rheometer HAAKE Rheostress 
RS-150™ (at the University of Trieste) equipped with a set of sensors with different geometries designed to 
stress the samples with different shear strains. Additional tests were performed at the Department of 
Chemical Engineering (DTU) with the PhD student Kaustav Goswami. A stress controlled rheometer was 
used (AR2000, TA Instruments), equipped with 25 mm parallel plate geometry. 
In a rheometer, a magnetic field applies a torque T to a rotating probe (rotor) put in contact with the 
sample (see figure 2.8). The sample is placed in between the rotating probe and a steady plate. The 
available geometries are parallel plates for high viscous samples, and cone-plate for low viscous samples. 
As the rotor is put in motion, the resistance of the material to the flow produces a displacement of the 
rotor in respect to the applied torque, which is recorded by the instrument.  
Given the softness of the gels under investigations, a parallel plate geometry was used in this work, with a 
rotor 20 mm in diameter and milled surface in order to minimize the slippage phenomena. The parallel 
plate geometry is designed to measure rheological properties of non-Newtonian fluids and for the 
characterization of viscoelastic materials. However, when using a rotational measuring system, special 
attention must be paid in order to limit systematic errors during the operative phase [107]. The commonest 
sources of errors are listed below. 
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• Inertial effects: at high shear rate, secondary fluxes occur within the sample lead to an 
overestimation of the viscous properties and, as consequence, the resulting torque moment is 
higher than real. This is an artifact not related to the rheological properties. 
• Geometrical effects: when an excessive amount of sample is placed, asymmetric edge effects are 
generated; others error can be generated by misalignment resulting in acentric rotation, and 
vertical oscillations of the rotor. 
• Instability effects: the applied torque is too high and produces a fracture in the material, resulting 
in loss of adherence, slippage, and loss of the sample by centrifugal forces. 
• Shear heating: due to energy dissipation, a non uniform temperature field can be present inside 
the gap. 
In order to ensure more consistent environmental conditions and to limit the evaporation, a glass bell 
(solvent trap) was used to cover the measuring device in all the experiments (see figure 2.9). 
 
  
Figure 2.8: Parallel plates system. The rotor and 
the plate surface have a milled surface to 
improve the contact with soft materials. 
Figure 2.9: The rotational 
rheometer HAAKE Rheostress 
RS-150™ equipped with a 
solvent trap. 
 
2.6.1.1 Stress sweep tests 
In the stress sweep test (SS) the storage modulus G’ (also known as elastic modulus) and the loss modulus 
G” (also called viscous modulus) are measured as a function of the applied stress. The first is related to the 
elastic energy stored in the material upon deformation, the second to the energy dissipation due to 
internal viscosity of the fluid. In the SS test the stress is applied with a sinusoidal pulse, with a constant 
frequency f (1Hz) and increasing amplitude. The strain γ, shear rate γ̇ and stress τ are related to the 
following equations:  
 
where ω is the angular frequency or pulsation (ω=2πf), δ is the phase shift between stress and deformation 
while γ0 , τ0 and  γ̇0 are the maximum strain, stress and shear rate during oscillation motion, respectively. 
The first term of equation (2.4), τ0 cosδ ∙ sin(ωt), is in phase with the strain to the elastic component, 
while the second τ0sinδ ∙ cos(ωt), is in phase the shear rate. In the limiting cases δ=0 and δ=π/2, we get 
the purely  elastic or purely viscous behaviours, respectively.  
 
τ = τ0sin(ωt) = Gγ0 ∙ sin(ωt) (for δ=0) (2.5) 
τ = τ0 cos(ωt) = ηγ̇0 cos(ωt) (for δ=π/2) (2.6) 
γ = γ0sin (ωt) (2.2) 
γ̇ = γ0ω cos(ωt) = γ̇0 cos(ωt) (2.3) 
τ = τ0sin(ωt + δ) = τ0 cosδ ∙ sin(ωt) + τ0sinδ ∙ cos(ωt) (2.4) 
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where G is the shear modulus and η the viscosity. Equation 2.4 can be rewritten by introducing the 
viscoelastic quantities G’ and G”: 
 
τ = G′γ0 ∙ sin(ωt) + G" γ0 ∙ cos(ωt)  (2.7) 
 
From equation (2.7) the stress τ can be expressed with a contribution in phase with the deformation and 
one in square phase with it, and with the storage modulus G’ and the dissipation modulus G” as the 
respective weights of these contributions. 
2.6.1.2 Plate-stage gap determination: short stress sweep (sSS) tests  
In rheometry, the placement of the sample on the plate is a very important step. Accordingly, in the case of 
systems that cannot be spread on the lower plate of the rheometer (this usually happens for gels), the 
system is first cut in a disc matching the rotor geometry, and the rotor is moved down until it gets in visible 
contact with the sample. A bad contact often results in a false value for the moduli (typically lower than 
real), and a rotor too close to the stage can squeeze the sample causing internal fractures, which 
compromise the measurement and the integrity of the material. The determination of optimal plate-stage 
distance is carried out by short stress sweep tests, gradually reducing the gap, and performed within the 
linear viscoelastic region, generally at τ=1 Pa and f=1 Hz, in order to avoid irreversible modification of the 
sample. The sequence of sSS starts with a large gap, and proceeds until a maximal value for G’ is reached 
and further changes produce a change lower than 10% of the maximal value. Then the gap obtained with 
this procedure is kept constant for all the further tests. A plot of elastic moduli measured at different gaps 
is shown in figure 2.10, for a gel 20% PVP in water. 
 
  
Figure. 2.10: Values of elastic modulus G’ measured at 
different plate-stage gaps (sSS test on a gel PVP 20%). 
Fig. 2.11: Typical mechanical spectrum of a strong gel 
(PVP 20% in water). 
 
2.6.1.3 Frequency sweep tests  
The frequency sweep tests (FS) consists in the application of a sine wave stress, with constant amplitude 
and variable frequency usually in the range 0.01-100 Hz. The stress amplitude value is chosen within the 
linear viscoelastic region. The plot of G’ and G” versus frequency are typically called mechanical spectra. In 
figure 2.11 a typical mechanical spectrum of a gel is shown. In a gel mechanical behaviour is characterized 
by having a G’ not depending on the frequency, and a G” showing a bending. A strong gel, in general, 
exhibits a G’ higher than G” of more than a decade being both G’ and G’’ frequency independent [106]. In a 
FS test, when the applied deformation lasts longer than the time necessary to the structure to relax 
(relaxation time λ), the time frame is long enough for the material to respond as a viscous-like system to 
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the applied stress. On the opposite side, with a deformation time shorter than the relaxation time, the 
elastic reaction is more pronounced. 
 
2.6.1.4 Correlation models 
Several models are used in theoretical rheology to describe the viscoelastic behaviour of fluids. Regarding 
interpretations of mechanical spectra, the most popular theory is the Maxwell´s model. According to this 
theory, a reaction of viscoelastic materials to stress, can be schematized by a dashpots and a spring in 
series (see figure 2.12a). This physical approximation, is described by the following equation (2.8): 
 
τ + ηg ∂τ∂t = −ηγ̇ (2.8) 
 
where τ is the stress, γ is the deformation, t is the time, η is the dashpot viscosity, g is the spring constant 
and λ=η/g is the relaxation time. The solution to the equation (2.8), in case of sin wave deformation, 
γ = γ0sin (ωt), leads to a stress defined as equation (2.7) τ = G′γ0 ∙ sin(ωt) + G" γ0 ∙ cos(ωt), where: 
 G′(ω) = g(λω)21 + (λω)2 (2.9) G"(ω) = gλω1 + (λω)2 (2.10) 
 
Equations (2.9) and (2.10) can be plotted as a function of ω in a bilogarithmic scale, and the point where 
the plots intersect each other is given by ω=1/λ, corresponding to the maximal value of G”. Generally the 
mechanical response of a viscoleastic material needs a more complex model. For this purpose, n Maxell 
elements can be combined in series (see figure 2.13b) building the so called generalized Maxwell model. 
Each element is characterized by a relaxation time λk, and a viscosity ηk (or, alternatively, the storage 
moduli gk= ηk/ λk). The moduli expressions result in: 
 G′(ω) = � gk(λkω)21 + (λkω)2nk=1  (2.11) G"(ω) = � gkλkω1 + (λkω)2nk=1  (2.12) 
 
In this model, a pure elastic element (a spring), GE, can be added besides the Maxwell elements. This 
element represents the asymptotic limit reached at low frequency, and is an element with infinite 
 
Fig. 2.12: (a) Maxwell element; (b) several Maxwell elements put in parallel with a pure elastic element. 
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relaxation time. The function gk(λk) is called relaxation spectrum. This model will be used to fit the 
mechanical spectra of gels. The parameters obtained from this fitting, will be used to estimate the average 
mesh size of the polymer network in the gel. 
2.6.1.5 Estimation of average mesh size from rheological studies 
As mentioned in the beginning of section 2.6, an important feature of a polymeric gel network, is the 
density of crosslinks, ρx, defined as the number of polymeric inter-chain junctions per gel unit volume 
expressed in moles. The crosslink density determines the diffusive properties of the gel and therefore the 
capability of releasing a loaded drug ina a controlled manner. In this sense, the rheological characterization 
is an important tool, as it allows to have a precise estimation of the average mesh size of the gel network 
from the values of the mechanical moduli as a function of the applied stress. From the Flory´s theory [108], 
a non compressible crosslinked gel subjected to swelling and deformation in the linear viscoelastic region, 
the shear modulus G is equal to one third of the Young modulus E [109], can be estimated from the sum of 
the Maxwell elastic element constant gk +GE:  
 G = GE + � gkN
k=1
 (2.13) 
 
In turn, always relaying on the Flory´s theory, the gel crosslink density ρx can be estimated [108]: 
 
ρx = 𝐺RT� νpνp0�23 (2.14) 
 
where R is the of ideal gas constant, T is the absolute temperature, while νp0 and νp are, respectively, the 
volumetric polymer fraction in the reference conditions (after crosslinking) and in the rheological 
measurement conditions (after swelling in water). νp0 can be evaluated on the basis of the polymer mass 
fraction, cp0, in the crosslinking solution. Indeed, we have: 
 cp0 = mpmp + mH2O = ρpVpρpVp + ρH2OVH2O (2.15) 
 
where mp and mH2O are, respectively, polymer and solvent mass while and ρp and ρH2O are, respectively, 
polymer and solvent density. At the same time, the following relation holds: 
 
νp0 = VpVp + VH2O = mp ρp⁄mp ρp⁄ + mH2O ρH2O⁄   (2.16) 
 
From equation (2.15) we can find a relationship for Vp (polymer volume) as a function of c0: 
 Vp = ρH2Oρp ∙ cp01 − cp0 VH2O  (2.17) 
 
Putting (2.17) into (2.16) we obtain an equation for νp0: 
 
νp0 = 11 + 1 − cp0cp0 ρpρH2O  (2.18) 
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Upon gel swelling due to water absorption, the polymer volume fraction νp will decrease from its initial 
value νp0. This difference can be evaluated measuring the gel relative weight change due to swelling as it 
can be assumed that the weight change is prominently due to the absorption of water (as was 
experimentally observed, see chapter 5):  
 
ΔW = ΔMH2OM0 = M − M0M0  (2.19) 
 
where M0 is the gel mass in the reference state and M gel mass after swelling/de-swelling. Thus, the 
correspondent volume change is given by: 
 
ΔVH2O = ΔMH2OρH2O =⏞eq.(2.19) ΔWρH2O M0 = ΔWρH2O �mp + mH2O� = ΔW � ρpρH2O Vp + VH2O� (2.20) 
 
νp is by definition: 
 
νp = VpVp + VH2O + ΔVH2O  (2.21) 
 
Substituting (2.20) and (2.17) in equation (2.21), we obtain an expression for νp which depends only on 
density values (known) and νp0, (i.e. from cp0 which is known as well): 
 
νp = νp0 ∙ ρH2O ∙ cp0ρH2O ∙ cp0 + ΔW ∙ ρp ∙ νp0  (2.22) 
 
Coming back to the density of crosslinks, in equation (2.14), according to the equivalent network theory, we 
can estimate the mean mesh size of the polymeric network, ξa [110] from the value of ρx. The product of 
crosslink density and the Avogadro’s number, (ρxNA), gives the number of crosslinks per unit volume, and 
therefore the inverse is the mean, spherical, volume assigned to each crosslink. 
 1
ρxNA = 43π �ξa2 �3 that gives:  ξa = � 6πρxNA3  (2.23) 
 
It is important to point out that ξa  is the average value of the mesh size in the network. The network might 
be not homogeneous and a mesh size distribution would be more representative. For this purpose, NMR 
spectroscopy is used. 
2.6.1.6 Alternative estimation method of average mesh size: The theory of Scherer 
As alternative term of comparison to rheology, another method for the estimation of the average mesh size 
ξa was considered. In an interesting work about polymeric networks like gels [111], Scherer proposed an 
equation to correlate the hydraulic radius of network mesh (Rh) with polymeric chains radius Rf (the index f 
stays for fiber, as polymer chains are often called) and the polymeric network average mesh size ξa on the 
basis of mesh shape (schematized as a cubic, octahedric or tetrahedric cell unit). This model turned out to 
be especially appropriate for NMR data interpretation as this technique is affected by Rh [112]. The model is 
represented by the following key equation: 
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RhRf = 2C0(1 − νp)2C1 �Rfξa�2 − 3C2 �Rfξa�3 (2.24) 
 
where Co, C1, C2 are constants relative to the cell geometry (here assumed as cubic, where the constant 
values are 1, 3π,8√2 respectively [111]). The model is valid for νp < 0.942 corresponding to a ratio Rf/ξa 
<0.5, that means for not too small mesh size. The author suggested also an approximation for Rh: 
 RhRf ≈ (1 − 0.58 νp)νp  (2.25) 
 
Rearranging (2.24), it follows: 
 RhRf = �ξaRf�2 C0(1 − νp)�C1 − 32 C2 Rfξa� and we have that Rh = ξa
2Rf C0(1 − νp)�C1 − 32 C2 Rfξa� (2.26) 
 
For large meshes, Rf/ξa ≈0 (this is the usual condition met in polymeric gels) and (2.26) can be 
approximated by the following expression: 
 Rh = ξa2Rf C0(1 − νp)C1  (2.27) 
 
By combining the two approximations (2.25) and (2.27) together, we obtain the mesh size ξa: 
 (1 − 0.58 νp)
νp
Rf = ξa2Rf C0(1 − νp)C1  , solving with respect to ξa : ξa = Rf�(1 − 0.58 νp)νp(1 − νp) C1C0 (2.28) 
 
Being νp known from equation (2.22), ξa can be calculated once and Rf is known. 
The molecular radius of PVP, Rf , was predicted using the techniques of mechanical/molecular dynamics, as 
follows. Ten different polymer chains were modelled using the method of rotational isomeric states [113], 
and thereafter, each of these has been optimized geometrically balanced by applying a molecular 
mechanics / heating cycles coupled to molecular dynamics. The polymer is assumed linear and atactic. The 
molecular size has been averaged over 10 configurations. The value obtained for Rf is 0.91 nm. All 
simulations were conducted using the software Materials Studio™.  
It is worth noting that the value of ξa from Scherer´s theory is purely theoretical, as it is derived by the 
assumption that the network is a lattice composed of regular cells (in our case cubic cells). Nonetheless, 
this theory was successfully used for the interpretation of NMR data by many works in this field [112]. For a 
more “real” picture of the gel structure, it is necessary to use the NMR technique to determine a 
distribution of mesh sizes in the network.  
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2.6.2. Nuclear magnetic resonance (NMR) spectroscopy 
NMR spectroscopy allows to quantify the interaction between water and the polymer network. More 
specifically, it provides an estimation of the response of water protons spin to a magnetic excitation, which 
is strictly connected to their degree of interaction with the polymer chains. This information, combined 
with the estimation of the average mesh size of the network ξa obtained from theoretical (Scherer) or semi-
empirical (Flory) models, allows to determine a mesh size distribution.  
In the following sections, the physical principles of NMR are described to allow for a complete 
understanding of gel characterization and results interpretation. Sections 2.6.2.1-2.6.2.4 provide the basic 
theoretical background behind NMR. In section 2.6.2.5 the NMR experiment and the models used in the 
data treatment are described. Finally section 2.6.2.6 explains how rheology and NMR are combined to 
estimate the nanoscopic structure of hydrogels. 
 
2.6.2.1 Quantum mechanics model for isolated nucleus 
The physical principles of Nuclear Magnetic Resonance (NMR) spectroscopy, are based on the magnetic 
behaviour of atomic nuclei [114]. According to quantum mechanics, the excitation of an atomic nucleus by 
an external magnetic field, produces a transition of the nucleus energy in quantized energetic levels. The 
nuclear magnetic energy is restricted to discrete values, called autovalues. The autovalues are associated to 
the autostates, also called steady states that are the only possible existing states of an elementary particle. 
The exposure of the nucleus to an electromagnetic radiation of appropriate frequency, induces a transition 
within steady states. The energetic absorption can be detected by the instrument and registered as a signal 
on a spectrum. This technique allows to obtain the spectrum of a compound that contains atoms with 
nuclear magnetic moment different from zero. The most analyzed nuclei are the protons 1H, fluorine 19F, 
the isotopes 14N and 15N of nitrogen and the isotope 13C of carbon [114]. Many atomic nuclei have an 
angular moment, P, that is responsible for the exhibition of a magnetic moment, µ [115]. The relation 
between P and μ is expressed by the following equation: 
 
μ = γ ∙ P (2.29) 
 
where γ is the gyromagnetic ratio, depending on the nucleus composition. According to quantum theory, 
the angular moment and the magnetic moment are quantized. The allowed autovalues of the angular 
moment maximum component in the z direction in an arbitrary Cartesian system, are defined by the 
equation: 
 Pz = h2πmI (2.30) 
 
where mI is the quantum number of the correspondent nucleus steady states and h is the Plank constant. 
The magnetic quantum number mI is related to the nuclear spin quantum number, I, and has the value of 
an integer number within +I and –I. 
As a consequence, the number of possible autostates (or energy levels) is equal to 2I+1. For the proton (1H), 
the nuclear spin quantum number is I = 1/2 and the z component of angular moment is given by: 
 Pz = h2π I (2.31) 
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The hydrogen nucleus can therefore exist only in two quantum states characterized by mI = +1/2 and mI = -
1/2. The magnetic moment in the z direction is given by: 
 
μz = γ h2πmI and the modules are: μz = ±γ h4π (2.32) 
 
In such a representation, the proton is represented as a magnetic dipole, where μz is parallel or antiparallel 
to the positive direction of the z axis as depicted in figure 2.13. Without an external magnetic field (figure 
2.13a), the two states are degenerated that is they have the same energy. In presence of an external 
magnetic field B0, (figure 2.13b), the interaction with μ causes an energetic splitting of the two states. If B0 
is parallel to the z axes, the magnetic dipole assumes an energy equal to +µz B0 when the dipole is oriented 
in the same direction of B0 , while the energy is -µz B0, when it is oriented in opposite direction. The energy 
difference between the two spin states is proportional to the intensity of B0, as follows: 
 
ΔE = 2μzB0 (2.33) 
 
The state at lower energy, mI = +1/2 is more stable, and the transition to the higher energy state mI = -1/2 
requires an energy ∆E by a radiation with the frequency given by: 
 
ν0 = ΔEh = γB02π  (2.34) 
ω0 =  γ·B0 (2.35) 
 
ν0 is called Larmor frequency and ω0 the angular frequency. The proton has a gyromagnetic ration of 
γH=2.675·108 T-1s-1. For a magnetic field of 1.41 T, the Larmor frequency is 60 MHz corresponding to a 
radiation of wavelength λ=5 meters, in the field of radio waves. For nuclei with I=1 the available quantum 
numbers are mI=-1, 0, +1 but the possible transitions are only from mI=+1↔ 0 and mI=0↔ -1, while 
transitions mI=+1↔ -1 are not allowed. 
 
 
Figure 2.13: Vectorial representation of the magnetic moment μ (a) in absence or (b) in presence of an external 
magnetic field B0. 
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2.6.2.2 Energy absorption mechanism: the resonance 
The typical representation of nuclei with I=1/2, such as the protons 1H, is a magnetic rod but. However, 
because of nuclei spin rotation, their behaviour is slightly different. Inside a static magnetic field B0, the 
rotating nucleus does not align its magnetic moment to the direction of the field. On the contrary, similar to 
a spinning top in the gravitational field (figure 2.14a), their spin axis assumes a precession movement 
around the magnetic field direction (figure. 2.14a). The precession frequency corresponds to the Larmor 
frequency as seen in equation (2.34) [114, 115]. 
An increase in magnetic field intensity, produces a faster precession. However, the orientation of the 
magnetic moment μ can be modified by the presence of a rotating magnetic field (B1) perpendicular to B0. 
When the rotation frequency νRF of B1 equals the precession frequency ν0, a resonance condition is 
established and the nucleus absorbs energy resulting in a variation of the angle θ between vector μ and the 
static magnetic field B0 (figure 2.15). This energy transfer does not change the precession frequency. 
 
  
Figure 2.14: (a) A spinner follow a precession in the 
gravitational field of the earth, (b) the nuclear magnetic 
moment precesses in a magnetic field. 
Figure 2.15: The application of a rotating 
magnetic field B1 perpendicular to B0 , moves the 
nuclear magnetic moment μ by an angle θ. 
 
2.6.2.3 Macroscopic magnetization 
When a sample is analyzed by NMR, a huge number of nuclei are subjected to a magnetic field. The nuclear 
magnetization defined as magnetic moment per unit volume, M, is a vector divided into three components: 
Mz, is conventionally aligned to B0 ; Mx and My, are perpendicular to B0. For a nucleus with I=1/2, all the 
magnetic moments precess at the same frequency. Because magnetization vectors are randomly oriented 
on x and y axis, they cancel themselves and the overall Mxy=0 (condition of no phase coherence). On the 
contrary, there is a small excess of nuclei parallel to the B0 direction (figure 2.16 a) in the z direction 
because the Boltzmann distribution favors the lower energy state. The difference between parallel and 
antiparallel magnetized nuclei populations (N1 and N2) (see figure 2.16b), generates a macroscopic 
magnetization Mz (figure 2.16). 
 Mz = γh(N1 − N2) (2.36) 
 
When an external rotating field B1 is applied, the spin resonance modifies the casual orientation of nuclei, 
and a magnetization component Mxy≠0 appears in the xy plane (condition of phase coherence) (figure 
2.16c). 
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Figure 2.16: (a) Vectorial representation of magnetic moments of I=1/2 nuclei, following a precess around the z axis 
(conventionally all vectors have a common origin) with overall magnetization Mz , no magnetization on xy plane Mxy. 
(b) Excess of nuclei with magnetic moment aligned with B0. (c) Spin system in phase coherence, Mxy≠0. 
 
2.6.2.4 The NMR experiment 
A schematic representation of NMR equipment is shown in figure 2.17. The sample is put in a cylindrical 
glass vial inside a slit in the middle of a coil which creates a highly homogeneous static magnetic field B0. 
The phase coherence within spins is induced by a rotating magnetic field (B1) perpendicular to B0 and the 
generation of a Mxy magnetization component with a ω0 precession (resonance frequency) (figure 2.18). 
When B1 is removed, magnetization undergoes a relaxation process, which causes the loss of phase 
coherence (Mxy≠0) and a restoring of the initial equilibrium situation (Mxy=0). The relaxation implies an 
exponential decay of Mxy characterized by a time constant T2 (transversal relaxation time). The result of the 
relaxation is a transient signal, captured by a sensor on the x axes, with ω0 frequency and decay speed of 
1/T2 called Free Induction Decay (FID) (figure 2.18) [116]. The NMR spectral signals are produced by the 
small displacement of resonance frequency ω0 in the nuclei population under analysis caused by the 
physico-chemical environment. When different ω0 and as a consequence different 1/T2 are present the 
resulting FID is a superimposition of all signals. The complex FID originating by multiple signals is solved 
using a Fourier Transformation (FT) that changes the transient signal in a normal spectrum (figure 2.18). 
The NMR spectrum is a diagram where intensity is a function of frequency, whereas in FID, the intensity is a 
function of time. The time domain and frequency domain are connected by the Fourier Transformation 
[116]. 
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Figure 2.17: Schematic representation of the NMR 
spectroscope. The sample is positioned within the 
magnetic field B0 generated by a magnet (N-S) and 
surrounded by a spire, tuned on the resonance frequency, 
that produces the B1 pulse (from [107]). 
Figure 2.18: (a) FID of two NMR signal. (b) The spectrum 
obtained applying the Fourier transform to the FID 
(adapted from [107]). 
 
Similarly to the precession in the B0 field, the precession concept can be extended to B1 using a conceptual 
artifact of a rotating reference system. With respect to this new rotating axis system, B1 becomes a static 
field. When B1 is applied (B1 is aligned to the rotating axes x’, the equilibrium magnetization M0, aligned to 
z, follows a precession around B1. The precession frequency of M0 is: 
 
ω1 = γ B1 (2.37) 
 
ω1 is and angular frequency (radiant s-1). M0 rotates with an angle given by: 
 
θ = γ B1 tp (2.38) 
 
where tp is the pulsation time for B1, and (γB1) is the pulse amplitude or power. After a pulse of 90° (π/2), 
Mxy=M0 (figure 2.19b). After a 180° pulse (π), Mz=-M0 (figure 2.19c). 
 
 
Figure 2.19: Effect of the rotating magnetic field B1 application on the magnetization M0 (x’ and y’ belong to a 
reference system rotating with the same frequency of B1. (a) Time zero; (b) after a 90° pulse; (c) after 180° pulse. 
 
To evaluate the effect of a B1 pulse on the nuclear levels populations, a system of two state levels α 
(parallel to B0) and β (antiparallel to B0) is considered, overall containing N nuclei that could be in one state 
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or in the other. For degenerate levels, there should be N/2 nuclei in each state. However, because the α 
magnetic has a lower energy compared to state β, there is a small excess of nuclei in the α state. Calling δ 
the excess of nuclei, the number of nuclei in each population can be written as (N+δ)/2 or (N-δ)/2 for α and 
for β respectively. 
With respect to a magnetization a macroscopic level, the nuclei situation it is better described by the Mz 
component. On the contrary, considering the α and β nuclei population, it is better to consider the 
deviation from N/2 defined as Pα=+δ/2 and Pβ=-δ/2. In every moment, Mz is proportional to the difference 
within levels: 
 Mz ∝ Pα − Pβ (2.39) 
 
or in other words Mz ∝ δ. Moreover, 
 Pα + Pβ = 0. (2.40) 
 
After the application of B1, Mz becomes: 
 Mz = M0 cosθ  (2.41) 
 
and, consequently: 
 Pα − Pβ = δ cosθ (2.42) 
 
that combined with equation (2.42) gives: 
 Pα = 𝛿 cos𝜃2  (2.43) Pβ = −δ cosθ2  (2.44) 
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When a magnetization pulse changes from π/2 to π, a change of population is induced, as shown by 
equations (2.18) and (2.29). For θ = π/2, Pα =0 and each state is equally populated. For θ = π, Pα =δ/2 and 
the populations are inverted.  
Equation (2.23) correlates the deflection angle caused by the pulse with the pulse amplitude (or intensity) 
γB1 and the pulse time tp. Both can be modified in order to obtain the desired deflection angle. When θ = 
90°, magnetization is on the xy plane and the signal has the maximum intensity (Fig. 2.20b). At θ = 180° the 
magnetization is inverted and becomes antiparallel to the z axis. 
Figure 2.20 illustrates in details the change of the magnetization during a pulsed NMR experiment in a 
rotating coordinate system. A rotating field deflects the vector Mz (same direction of B0) with a certain 
angle, generating the Mxy magnetization component. Mxy exponentially decays with the time constant T2 , 
emitting a signal which is detected on a receiving spire on the x axis. The signal collected is called free 
induction decay (FID). At the beginning the overall magnetization M0 is aligned to the magnetic field B0 
(figure 2.20a) After application of rotating field, the magnetization deflects by π/2 (90°), and the 
magnetization vector moves (figure 2.20b). For a pulse of sufficient duration, it reaches the final position on 
the x’y’ plane generating the Mxy magnetization component (figure 2.20c). At the end, when B1 is removed, 
the relaxation process starts and the phase coherency is lost, causing the decay of Mxy component (figure 
2.20d and e). This relaxation process is called transversal relaxation or spin-spin and it proceeds with a 
constant time T2 by the energy transfer within high energy nuclei without loss of energy [116]. 
 
 
Figure 2.20: Diagrams in the rotating coordinate system x’y’z’ showing the magnetization during an NMR 
experiment. (a) The overall magnetization M0 is aligned to B0. (b) and (c) A rotating field B1 is applied perpendicular 
to B0; the pulse length is sufficient to rotate the magnetization by 90°. (d) and (e) after B1 ceasing, the spins start to 
relax by a spin-spin mechanism on the x’y’ plane (time constant T2) and by a spin-lattice mechanism on the z’ 
direction (time constant T1). (f) After sufficient time, the starting equilibrium magnetization M0 is re-established. 
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The relaxation of Mxy decrease is given by 
 dMxydt = −MxyT2  (2.45) 
 
giving the following solution 
 Mxy = M0 ∙ e− tT2 (2.46) 
 
The value of T2 can be estimated by the middle height of the spectral peak (∆ν0.5) by the equation 
 
Δν0.5 = 1πT2 (2.47) 
 
Together with Mxy, also the longitudinal component of magnetization Mz returns during relaxation to the 
initial equilibrium magnetization M0. This type of relaxation process is known as longitudinal relaxation or 
spin-lattice and proceeds with a time constant T1. 
 dMzdt = −M0 − MzT1  (2.48) Mz = M0 ∙ �1 − e tT1� (2.49) 
2.6.2.5. Low field NMR 
Low field NMR provides informations on the structure of the material surrounding the interacting nuclei. 
NMR can be applied to both solid and liquid samples, suspension, gels and emulsions. It is non destructive 
method. The exciting field magnitude is between 0,23 and 1,53 T corresponding to 10 and 65 MHz 
respectively, and a temperature varying within -10 and +70°C. The shape and amplitude of the resonance 
signal are related to the physical environment surrounding the nuclei. The amplitude is a function of the 
nuclei degree of freedom of movement in the physical environment. This represents an useful information 
in polymer chemistry and solid state physics, as T2 depends on nucleus mobility. In solids, T2 is low (1-100 
ms) because the nuclei have a reduced mobility. In gel systems, water is trapped in small domains, and T2 
ranges from 200 and 800 ms. Iin liquids nuclei have complete mobility, and T2 is high (800-2500 ms). 
For the structural analysis of hydrogels, the time domain NMR spectrum of the 1H proton magnetization 
spectrum, allows to distinguish the different phases protons belong to, i.e. to polymer chain, water 
entrapped in the polymeric network, water in eventual microchannels and free water [117]. It is important 
to point out that in the samples under study, it was not possible to measure the relaxation of the protons 
belonging to the polymer backbone, since their relaxation resulted too fast to be detected by the 
equipment in use. That means that the first peak to the left in figure 2.21 was out of range for the tested 
systems. 
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Figure 2.21: Typical example of 1H relaxation spectrum of a non homogeneous 
hydrogel (adapted from [107]). 
 
2.6.2.6. Data analysis of NMR spectroscopy and calculation of mesh size distribution 
The NMR equipment used in this investigation is a Bruker Minispec mq20™, which operates at a frequency 
of 20 MHz (corresponding to ~0.47 T, for B0 which is the commonly accepted value corresponding to the 
1H 
Larmor precession frequency) and at controlled temperature. The measurement consists of a sequence of 
magnetic excitations, followed by an acquisition interval: first a 90° pulse, a time interval τ, a series of 180° 
pulses applied at 2τ intervals are forwarded by the last 180° pulse after a τ interval. The sequence is 
repeated 8 times every 5 seconds.  The T2 relaxations curves collected in the scanning, are fitted by a multi-
exponential function [118]: 
 
� Ake− tT2kN
k=1
 (2.50) 
 
where t is time, Ak is the pre-exponential factor of the k component, and T2k is the relaxation time of the k 
component. The total number of exponential functions, N, is the one minimizing the product (N·χ2), where 
χ2 is the sum of the squared difference between the fitting function (2.35) and the experimental data. The 
procedure which was followed for the data treatment described below was recently presented in the work 
of Pescosolido et al. [119] and here re-proposed for a better understanding. 
Once N, A1, .., AN, T2
1, .., T2
N are estimated by the best fitting, a continuous distribution of T2 can be 
calculated by fitting the time t decay of the experimental intensity signal Is related to the extinction of the 
x-y magnetization component Mxy according to: 
 
I(t) = � a(T2)e− tT2dT2T2max
T2
min
 (2.51) 
 
where I(t) is the theoretical estimation of Is, a(T2) is the unknown amplitude of the spectral component at 
relaxation time T2, e− tT2 is the decay term, while T2max − T2min is the range of the T2distribution. The 
determination of a(T2) requires eq.(2.51) fitting to the experimental Is data. At this purpose, eq.(2.51) 
integral was discretisized with the criterion suggested by Whittal and MacKay [120]: 
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I(t) = � a(T2)e− tT2dT2T2max
T2
min
≈� ai�T2i�e− tT2iN
i=1
�T2i+1 − T2i� = �Ai(T2iN
i=1
)e− tT2i  (2.52) 
 
where the range of the T2 distribution (T2min − T2max) was logarithmically subdivided into N=200 parts 
(higher N values were unnecessary). To reduce the noise in the signal, data fitting accounted for a 
smoothed version of χ2 (χs2): 
 
χs
2 = ��Is(ti) − I(ti)
σi
�
2N
i=1
+ μ� |Ai+2 − 2Ai+1 + Ai|2N−2
i=1
 (2.53) 
 
where σi is the standard deviation of the ith data point, while µ is the smoothening term proposed by 
Provencher [121]. The value of µ have a bearing on the value of χ as results shown in the plot shown in 
figure 2.22. Therefore, µ was chosen adopting the strategy suggested by Wang and Ni [122]: the value 
chosen for µ (in the example µ=261) was the one corresponding to the slope variation of the plot ln(χ) vs. 
ln(µ). Data fitting of (2.53) was carried out by a Visual Basic ‘‘User Defined Function’’ code embedded in 
Microsoft Excel worksheet and solved by ‘‘Solver” function. 
 
 
Figure 2.22: Bi-logarithmic plot of χ as a 
function of the smoothening term µ. According 
to the criterion of Wang and Ni [122], µ is 
chosen where the plot displays a change of 
slope. 
 
Finally, the determination of the mesh size distribution is determined separately for the evaluations of 
average mesh sizes with rheology and Scherer´s theory. 
For the “rheological” value, the distribution was performed as stated in  a ‘‘two fraction fast exchange 
model’’ [123]. The quantitative relation between the relaxation time (T2i) of the water confined inside a 
mesh of diameter ξi is: 
 1T2i = 1T2,H2O + 1kξi (2.54) 
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where T2,H2O is the free water relaxation time (3007 ± 20 ms at 25°C) and k is an unknown constant, 
depending on temperature, the nature of fluid filling the polymer mesh, the magnetic field strength and the 
chemical characteristics of the polymer. The most important hypothesis at the basis of equation (2.54) is 
that the fraction of bulk water molecules (i.e. those not in contact with the mesh wall) is much bigger than 
the fraction of surface water molecules (i.e. those in contact with the mesh wall). Equation (2.54) holds for 
ξi >8 nm.  
Assuming that k does not depend on mesh size [124], relation (2.54) can be re-written for a system 
composed of meshes of different diameters: 
 1T2a = 1T2,H2O + 1kξa (2.55) 
 
where T2a is the average relaxation time and ξa is the average mesh size. Once T2a (calculated from 
relaxation tests) and ξa (estimated according to rheological experiments) are known, k value is calculated 
from equation (2.55). Equation (2.55) allows to correlate each relaxation time (T2i) with a corresponding 
mesh diameter (ξi), and as a consequence, the conversion of the T2 distribution a(T2) into the normalized 
mesh size distribution: 
 P = a(ξ)
∫ a(ξ)d(ξ)ξmaxξmin     (2.56) 
 
The result is a distribution of mesh sizes centered in the average value ξa.  
The link connecting Scherer´s theory with the interpretation of NMR data, lays in the hydraulic radius of the 
polymer fiber Rh. Chui et al. [125] proposed the following relationship to calculate the average relaxation 
time:  
 
〈
1T2〉 = 1T2,H2O + 2ℳRh  (2.57) 
 
W here T2 is the relaxation time of water in the gel, T2,H2O is the relaxation time of bulk water (3007 ± 20 ms 
at 25°C), and ℳ is an empirical sink parameter at the surface accounting for polymeric chains effect on 
water protons. Rh can be conveniently replaced by ξ  according to a proper combination of equations (2.25) 
and (2.27):  
 Rh
ξ
= �(1 − 0.58 νp)(1 − νp)
νp
C0C1 = 𝑓(νp) or likewise:    Rh = ξ ∙ 𝑓(νp) (2.58) 
 
Therefore, equation (2.57) becomes: 
 
〈
1T2〉 = 1T2,H2O + 2ℳξ ∙ 𝑓(νp) (2.59) 
 
Theory and methods 
44 
 
Similarly to the case of rheology, ℳ estimation allows finding a relation between the relaxation times T2i 
and ξi. It is easy to see that eq.(2.59) gives a physical interpretation of parameter k appearing in eq.(2.55). 
From the achievement of (2.59) it is clear that the main advantage of using the previously obtained 
approximated solution (2.27) over the analytical expression of Scherer (2.24) stays in the possibility of 
establishing a direct correlation between the hydraulic radius Rh (obtained by NMR spectroscopy, [123]) 
and the network mesh size.  
 
2.6.3 Enviromental SEM on gels 
Enviromental scanning electron microscopy (E-SEM) was used for the imaging of gel micropatterns 
obtained by selective crosslinking of polymer. The observation were aimed to visualize microstructure in 
the swollen conditions. All the images were collected by Ramona Valentina Mateiu, at the Centre of 
Electron Nanoscopy (DTU CEN).  
The analysis was done in an FEI Quanta 200 ESEM FEG. The samples were attached to an aluminum stub 
with a double sided carbon tape and the electrical grown was made with copper tape. All samples were 
imaged with the gaseous secondary electron detector at room temperature and 2 mbar partial water vapor 
pressure. The acceleration voltage was set to 15 keV and the spot size to 4 in all cases. The sample was 
tilted to 40 degrees and the working distance was adjusted between 22 and 27 mm as needed. 
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3. Inkjet printing as a drug loading 
method 
 
This chapter investigates the feasibility of inkjet printing as a drug loading method for microcontainers. 
Initially, the investigation focused on printing solutions containing furosemide and lipid based-mixtures, 
principal component of SNEDDS (Self Emulsifying Drug Delivery Systems).  
Then, the drug loading approach was divided into two steps: i) filling microcontainers with a polymer 
matrix, ii) loading the matrix with the drug. Inkjet printing was used to immobilize polymers inside 
microcontainers. This approach was tested with sodium alginate and poly(vinyl pyrrolidone) (PVP).  
Preliminary experiments with PVP were performed in the laboratories at the Naughton Institute (Trinity 
College Dublin, CRANN) and at the Danish Technological Institute (DTI, Taastrup, Denmark).  
Results of furosemide printing were presented in an oral presentation at the 6th Symposium of The 
Pharmaceutical Solid State Research Cluster (PSSRC) (Lisbon 26-28 August 2012). 
The section regarding printing of PVP is based on the paper “Inkjet printing as a technique for filling of 
microwells with biocompatible polymers“(see Appendix 1). Some topics of this work were presented in a 
poster presentation at the 38th International Conference on Micro and Nano Engineering (Toulouse 16-20 
September 2012) 
3.1 Inkjet printing in life sciences and drug delivery 
3.1.1 Application in high throughput screening (HTS) 
In the last decade inkjet printing has become a key technology in life sciences. In fields like genomics, 
molecular biology and drug screening, the typically reduced amounts of biological material available for 
each test, and the need of more rapid and cost effective procedures, have edged more and more on 
computerization and scaling down processes. In high throughput screening (HTS) thousands of small 
quantities of compound are transferred from a master plate to the assay plate. The implementation of 
microdispensing technology for HTS offered the capability of minimizing reagent costs and optimizing the 
quantity of information from each plate run [1]. At the same time all the usually required dilution steps 
were faster [2]. Microarrays become soon a valuable replacement of manual pipetting in microtiter plates, 
allowing simultaneous analysis of several thousands of nanoliter assay spots with high density printing. 
One of the first successful applications of inkjet printing has been the large scale screening of diverse genes 
by immobilization of DNA or synthetic oligonucleotides onto substrates, for the detection of genomic 
material by selective base-pair binding. In 2000, MacBeath and Schreiber [3] developed miniaturized assays 
of nanoliter-volumes, with a spatial density of 1300 dots/cm2, for the simultaneous processing of thousands 
of proteins. In the same year, Goldmann and Gonzalez [4] used a commercial printer to deposit high 
resolution DNA arrays with a high density (300 dpi). 
Microarray spotting has also found a valuable application in the fields of tissue engineering and cellular 
colony patterning. Roth and coworkers [5] used dispensed collagen solution to fabricate cellular scaffolds. 
Barralet et al. [6] created 3D angiogenic implants by spraying calcium phosphates onto hydroxyapatite and 
brushite based-ceramics biomaterials. 
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3.1.2 Application in drug delivery 
Thanks to the improvements obtained in the control of droplets volume and jet direction, as well as the 
accuracy of spot placement, inkjet printing has become an interesting tool also in the field of drug delivery. 
Indeed, one of most important added values, which this technology can offer to drug delivery, is the 
capability of manufacturing personalized medication. Thermal inkjet technology was employed to create 
aerosol inhaler for local and systemic delivery of therapeutic proteins [7]. Goodman and coworkers showed 
that aerosol of insulin and human growth hormone solutions generated particles with a narrow size 
distribution and that the model proteins were not damaged by the inkjet operation. Tarcha et al. [8] has 
employed this technique to deposit 100 μg of drug, on the surface of a small stent, with a very high 
deposition efficiency. 
The implementation of inkjet printing for pharmaceutical oral dosage forms is quite recent, and the 
literature regarding this field is limited. Inkjet printing has been employed by Haushild and collaborators [9] 
as alternative solution for the preparation of unilamellar vesicles for drug delivery. Ethanol solutions, 
containing both polymeric and lipid amphiphiles were printed into water, forming vesicles with diameter 
50-200 nm. In this case the advantages of inkjet printing compared to traditional emulsions, are the narrow 
size distributions of vesicles, and the consequent high control of drug loading.  
Sandler and coworkers have extensively studied the use of inkjet printing for drug formulation purposes 
[10-12] and combined it with flexopraphy [13]. Their work represents the state of the art in the use of 
printing for the manufacture of flexible doses and tailored drug delivery systems. The feasability of drug 
printing has been investigated for several APIs and sprayed droplets were characterized with scanning 
electron microscopy, X-ray diffraction and differential scanning calorimetry. Printed solutions containing 
caffeine and loperamide exhibited limited and no recrystallization events after deposition [10]. The printing 
of piroxicam was optimized for inkjet and impression printing [12] giving accelerated release of the drug. 
The effect of three different substrates on printed riboflavin solution was elucidated [13], demonstrating 
that the substrate composition influences significantly the drug release. 
A deep understanding of the drug distribution in printed droplets of felodipine-poly(vinylpyrrolidone) 
mixtures was provided by Scoutaris et al. [14]; spectroscopic analysis and atomic force spectroscopy 
scanning revealed that the printed formulations remained homogeneous dispersions after printing, and 
that the drug release can be modulated by the drug loading. 
3.2 Equipment description and operation 
3.2.1 Equipment description 
An inkjet printer is schematically represented in figure 3.1. The equipment used in this investigation is 
composed by a XYZ movable inkjet head (Nanoplotter NP 2.1, GeSiM, Germany) equipped with a piezo-
driven micropipette (GeSiM nanotip) with a 70 µm orifice, and a tray where substrates with typical 
dimensions of microscope slides can be mounted. The spotting area can be isolated from the surrounding 
with a moveble glass box. In this way the dispensing tip can spot the liquid in an environment saturated 
with the desired level of humidity by means of a connected vaporizer. The temperature of the slide tray can 
be cooled from room temperature down to 4° C by means of a refrigerant system. The humidity level and 
the stage temperature are important parameters which influence both the surface tension and the 
evaporation time of the dispensed material. The sample is aspired by the pipette through the orifice from a 
well in a titer plate where the sample is stored in microliter volumes at the desired temperature.  
The aspiration of the sample is driven by a pressure unit, through a system liquid (micro filtered deionized 
water) which is generally in contact with the sample during aspiration and dispensing. Eventually, an air gap 
can be interjected between the sample and the system liquid in order to avoid direct contact between the 
two liquids. This is particularly important for samples containing water unsoluble compounds, which would 
precipitate inside the pipette by the contact with water, causing pipette blockage.  
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The system liquid is also used to rinse the pipette, both internally and externally: the head moves to a 
washing station, where the tip is immersed in a water reservoir and system water is flushed through the 
pipette for a desired time period. The outside of the tip is then wiped with filter paper. The washing is 
performed by default before sample aspiration, and at the end of the spotting session. 
The inkjet head is monitored by a control unit connected to a computer. A top microscope camera is 
integrated into the pipette head and allows the alignment of the pipette and the imaging of the spotting 
result, when the printing session is completed. The system is also supplied with a stroboscope camera (side 
view camera) which allows to visualize the jet direction and stability, as well as shape and diameter of the 
generated droplets.  
3.2.2 Spotting operation  
The spotting is performed as a sequence of steps: i)washing, ii)sample aspiration, iii)stroboscopic check of 
the jet, iv)spotting, v)pipette emptying, vi)washing. During the stroboscopic check, the voltage and pulse 
length of the piezo actuators can be changed, and the effects on the jet can be monitored in real time by 
the operator. The general requirements for a good spotting are the following: 
1. vertical jet direction 
2. ejection of a single droplet (or eventually second smaller satellite droplet in vertical position) 
3. spherical droplet shape  
4. jet stability (i.e. position of droplets in the stroboscope frames) 
The fulfillment of these requirements is double-checked by a software interface. The software checks the 
jet quality according to the set of parameters given by the operator and measures the droplet diameter 
fitting a circle on the visualized droplet shade (see figure 3.2). This is particularly useful for overnight 
spotting sessions. If one of the requirements is not satisfied, the software aborts the spotting session, the 
pipette is rinsed, wiped, and a new sample volume is aspired. The total aspired volume of the spotting 
session is calculated by the number of droplets set by the operator and the volume calculated by the 
software. The intensity, duration, and frequency of the voltage applied to the piezoelectric actuator of the 
dispenser were tuned for optimized microcontainer filling and kept constant during the spotting session. 
 
 
 
Figure 3.1: Schematic of the inkjet printer setup. The micropipette is 
mounted on a XYZ movable head. It aspires the liquid sample to be 
dispensed from a microtiter plate. The aspiration is driven by a dilutor 
pump. A functional pipette check takes place in the stroboscope. During 
spotting the pressure of the diluter pump is kept constant by system 
liquid (water). 
Figure 3.2: Stroboscope picture of in-fly 
droplets of buffer solution, ejected by a 
pipette (GeSiM nanotip). The software 
performs droplet recognition and allows 
the dispensing if the jet quality is good. 
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The intensity of the pulsatory voltage is a decisive parameter in the spotting experiment, as it strongly 
influences the droplet volume and shape. In table 3.1, droplet volume at different voltages and ejection 
frequencies are shown.  
 
Ejection 
frequency 
[Hz] 
Droplet volume (nL) 
60 V 70 V 80 V 
100 0.42 ±0.01 0.50 ±0.03 0.59 ±0.03 
200 0.42 ±0.02 0.50 ±0.02 0.59 ±0.02 
500 0.42 ±0.02 0.50 ±0.02 0.60 ±0.02 
1000 0.45 ±0.01 0.52 ±0.06 0.56 ±0.11 
 
 
Figure 3.3: Consecutive stroboscope snapshots taken during ejection of water, at different voltage amplitudes. The 
increase of voltage reduces the delay of onset of droplet breakup. 
 
In general, the pulse frequency does not have a significant effect on the ejected volume. Instead the 
voltage intensity modifies the droplet volume in a sensible way. From table 3.1 it can be observed that the 
ejected volume is proportional to the pulse amplitude. Another effect of voltage lies in the distance of the 
onset of droplet breakup for the tip, as shown in figure 3.3, where the droplet ejection of water at different 
voltage amplitudes is depicted. 
3.2.3 Sample alignment 
The alignment with the substrates on which the sample material is deposited on is another important 
feature of the equipment. The spotter in use offers the possibility of performing a manual alignment or 
implements an automatic recognition of pre-existing substrate patterns. The manual alignment is 
performed by assigning the offset between the pipette and microscope camera. The pipette and the 
camera are positioned upon the same recognizable object on the printing tray, and their (x,y) coordinates 
are annotated. The difference between the coordinates gives the offset. In alternative, the alignment step 
can be performed automatically by means of an object recognition program which finds the spotting target 
by their geometry. Once the alignment is done, the deposition pattern can be defined either manually (by 
positioning crosshairs in the microscope image), or alternatively drawn in a matrix scheme. Both are fast 
and efficient methods, and were preferred for the microcontainer filling, since the wells are arranged in 
squared matrices. Alternatively for complex deposition patterns a customized geometry can be drawn.  
3.2.4 Spotting of liquid 
As mentioned in section 2.2.2, a crucial requirement for inkjet printing of liquids, is that they exhibit a 
Newtonian behavior and a low viscosity. Indeed, the viscosity limit of the equipment used in this study is 5 
Table 3.1: Droplet volume (nL) at different voltages for a pulse width of 50 µs (averages 
on three GeSiM nanotips). Data adapted from manufacturer tests, performed on 
microfiltered water. 
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mPa·s, which is five times larger than the viscosity of water. The droplet travel speed is up to 50 cm/sec. For 
this reason, dynamic viscosity of solutions were measured by means of a rotational rheometer prior to 
dispensing. One possibility to overcome the viscosity limitation, is offered by using heatable pipettes. These 
dispendser tips can be heated up to 120 °C allowing a substantial drop in viscosity for a large number of 
liquids. 
3.3 Materials 
3.3.1 Furosemide 
Furosemide is a loop diuretic used for the treatment of hypertension and edema [15, 16]. It is a weak acid 
with pKa values of 9.9 and 3.5. Its aqueous solubility ranges between 5 and 20 μg/mL at pH 7 combined 
with a low permeability. Furosemide is classified as a class IV drug and thereby as poorly soluble [17]. The 
oral bioavailability is highly variable (20-60%) and the absorption sites are stomach and upper small 
intestine [18]. Furosemide was the first candidate for direct inkjet printing of drug used in this project. 
3.3.2 Poly(vinylpyrrolidone)  
Poly(vinylpyrrolidone) (PVP) having molecular weights from 2500 to about 106 is mainly obtained by radical 
polymerization in solution [19]. The glass transition temperature of PVP is between 100°C (Mw=2500) and 
175°C (Mw=10
6). In table 3.2 the main properties of PVP grades used in this study are summarized. K-values 
are often assigned to PVP commercial names. These values are derived from viscosity measurements by the 
manufacturer and are calculated according to Fikentscher´s formula [20]. PVP is a non-toxic polymer [21, 
22], which is widely used as excipient for oral dosage forms e.g as binder and coating agent for tablets [19], 
as solubility enhancer for water insoluble pharmaceuticals [23], and as solubilizing agent for injections. PVP 
exhibits high solubility both in water and many organic solvents [24]. PVP forms complexes with various 
compounds, particularly with H-donors such as phenols and carboxylic acids. In the pharmaceutical field 
PVP is broadly used, as PVP K30 and K90 can be crosslinked by exposure to UV radiation [25, 26], giving a 
water insoluble compound that swells in water forming hydrogels. The crosslinked version of PVP is also 
used as tablet disintegrant due to its swelling property [27].  
 
 
 
Figure 3.4: Molecular structure of (a) furosemide and (b) poly(vinylpyrrolidone) (PVP) monomer. 
 
 
Table 3.2: Molecular weight and intrinsic viscosities of different grades of PVP [19]. 
K values Molecular weight 
average (Mw) 
Intrinsic viscosity  
(dL/g) [η] 
K17 104 0.09 
K30 4·104 0.22  
K90 106 1 
A B 
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3.3.3 Sodium alginate and calcium chloride 
Sodium alginate is an anionic polysaccharide of natural origin. It derives from alginic acid, which is a linear 
copolymer with homopolymeric blocks of (1-4)-linked β-D-mannuronate (M) and its C-5 epimer α-L-
guluronate (G) residues. 
 
 
 
Figure 3.5: Alginate structure and monomers. (a) structure of β-D-mannuronic acid (M) and α-D-guluronic acid (G). 
(b) Polar coordination with a Ca2+ ion og G-blocks, (c) M-blocks region ,(d) MG-blocks region. (e) examples of blocks 
distributions inside polymer chain (adapted from [28]) 
 
A consequence of the spatial arrangement of G and M monomers is in the ability of the sodium alginates to 
form hydrogels in water solutions in presence of bivalent cations. The gelation is given by an ions exchange 
between the Na+ of the G monomers with bivalent cations, like for instance Ca2+. The bivalent of cation is 
interacts with G-blocks regions of adjacent polymer chains creating a three dimensional polymer network. 
This fact allows to convert alginate solution into hydrogels through reaction with solutions containing 
bivalent ions, like those of calcium chloride (CaCl2) and several other compounds. The ion exchange 
reaction gives physically crosslinked hydrogel matrices, capable of swelling up to 100 times the dry polymer 
weight in water. Crosslinked alginates are broadly used in controlled release systems as well as for 
immobilization of biological agents such as live cells, proteins or active molecules in general.  
3.3.4 Lipid solutions for SNEDDS-based formulations 
SNEDDS (Self Nano-Emulsifying Drug Delivery System) are isotropic mixtures of oil, surfactant and co-
surfactants designed to provide a protection to fragile biological therapeutics, against the harsh 
environment of the GIT.  
When getting in contact with an aqueous environment (i.e.the physiological medium) SNEDDS formulations 
spontaneously form a nanoemulsion with nanomicelles encapsulating the protein therapeutics [29].  
Such a formulation could be loaded inside microcontainers, which should release the therapeutic in the 
form of nanomicelles once they are in contact with the intestinal mucus.  
One of the projects of our collaborators in NAMEC at KU Pharma, was dedicated to the development of a 
SNEDDS for the encapsulation of insulin. The aim of the study was to test the feasibility of inkjet printing for 
filling microcontainers with SNEDDS formulations. An optimized formulation for insulin developed by our 
collaborators [30], was composed by 50% Miglyol 812, 30% Medium-chain partial glycerides (Akoline 
MCMEP), 20% TW80 (a mixture of surfactants). The investigation presented in this thesis, consists of 
experiments which were carried out with samples not including insulin. For a preliminary study, it was 
believed that the contribution of insulin to parameters affecting the printability (e.g. viscosity) could be 
neglected. 
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3.4 Inkjet printing of furosemide solutions 
3.4.1 Preparation of solutions 
Furosemide dissolves in many organic solvents [31]. The equipment manufacturer discourages the use of 
methanol and dichloromethane, which cause the softening and dissolution of the glue used for the pipette 
assembly. Furthermore, the choice of solvent was directed to less toxic chemicals. Ethanol has a low boiling 
point, and preliminary printing tests revealed that ejected droplets evaporated before landing on the 
surface. Therefore, DMSO was added as cosolvent. Solubility of furosemide in ethanol ranges between 2 
and 14 mg/mL [31, 32] and DMSO is over 50 mg/mL [31]. Solutions of furosemide were prepared by 
dissolving the drug (1, 5, 10 mg/mL) in mixtures of ethanol and DMSO at different volume ratio (10:90, 
30:70, 50:50, 70:30, 90:10).  
In a second stage of the investigation, solutions of furosemide in buffer solutions (pH 9.2) at a 5 mg/mL 
(reported solubility value is 10 mg/mL [33]) were printed on microcontainers. This was motivated by the 
intention of studying the effect of surface tension of the solvent on the deposition. 
 
3.4.2 Results of spotting 
3.4.2.1 Inkjet optimization 
Due to the poor aqueous solubility of furosemide, the contact of the aspired solution with water had to be 
avoided to prevent solute precipitation inside the nozzle. As a consequence, a fixed volume of pure ethanol 
was sucked in the nozzle, prior the sample aspiration. With that, the ethanol flushed the internal volume of 
the tip prior to the washing step with system water at the end of the dispensing. Between the sample and 
ethanol, an air gap was used instead to avoid dilution of the solution. 
Despite this procedure, in general the printing of furosemide solutions was barely reproducible, due to 
frequent clogging of the tips, occurring after few seconds, although the sample solution in the vials was 
stable for weeks after their preparation. This problem occured in any test performed, both with new and 
already used tips, and was getting worse at increasing drug concentration. This fact suggested that the tip 
obstruction was related to drug precipitation on the edge of the needle tip. From the stroboscopic imaging, 
it was observed that the progressive occlusion, deflected the jet direction for substantial angles (10-25°) 
with respect to the vertical direction. Printing of solutions containing 0.1-1 mg/mL was also tested, but 
clogging occurred even in this case. Clogged nozzles could in most cases be recovered, by manual flushing 
with pure ethanol, but in some cases tips were permanently damaged. Nevertheless, the stroboscopic 
imaging of the spray jet formation (droplet size and jet direction) allowed to identify a set of ejection 
parameters for a number of solutions (referred as type A, B and C). The optimal parameters for the 
solutions listed in table 3.3.  
 
Table 3.3: Optimized printing setting for various furosemide solutions. 
Sample 
type 
Solution 
(v/v) 
Drug conc. 
(mg/mL) 
Pulse width 
(µs) 
Voltage  
(V) 
Frequency 
(Hz) 
Humidity  
(%) 
A 
EtOH:DMSO 
(50:50) 
1-5 112 64-70 370 42.9 
B 
EtOH:DMSO 
(10:90) 
1-10 50 70-74 200 44.9 
C 
Buffer  
(ph 9.2) 
1-5 90-100 63-90 370 32 
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3.4.2.2 Microcontainer filling 
Directly after the printing, by means of the top view camera, it was possible to visualize the containers 
spotted without spillages, before the progressive obstruction of the orifice caused jet deflections. 
Microcontainers appeared visibly translucent. After the solvent evaporation, containers were inspected 
with an optical microscope. Top view micrographs of containers spotted with sample type A (see table 3.3), 
are shown in figure 3.6a. Optical pictures show one circular ring of particles outside the containers walls. It 
was believed that this outer ring was formed by the drug which crystallized. Apparently the solution flowed 
out of the microcontainer cavity. This flow was probably induced by a surface wetting effect. This 
conclusion was also supported by the translucence of SU-8 after the spotting. Thus, it was believed that, 
making microcontainer surface more hydrophilic would have helped to restrain the solution inside the 
cavity. For this purpose, the microwells were submitted to oxygen plasma (70mL/min O2, 50 W, 0.5 mbar, 8 
min) as suggested for a similar purpose in [34]. Oxygen ions react with the exposed surface generating 
more OH-groups, which renders SU-8 more hydrophilic [35]. Just after plasma activation, microcontainers 
were filled with sample type A. The result of the spotting is shown in the figure 3.6b. In this case, solution 
drying occurred both inside and outside of the wells. The solution spreading was improved, since 
furosemide deposited partially inside the cavities. However, the performance was not satisfactory yet. 
 
 
Figure 3.6: Top view micrograph of two containers (on the 
right) filled with sample type A before surface 
hydrophilization (a), and after surface hydrophilization (b). 
On the left, empty containers are shown as comparison 
(scale bar 200 µm) 
 
A further attempt of inkjet deposition was accomplished with aqueous furosemide solutions (sample type 
C) with no plasma treatment. In figure 3.7 the result of printing is shown. From the stroboscopic check, the 
printing of buffer solutions gave a more stable jet formation, although nozzle clogging still occurred after 
few minutes. The result is a reproducible deposition of furosemide inside the containers. This fact 
confirmed that a water-based solution is more suitable for printing. Figure 3.8 shows the bottom of a 
container where crystalline material (buffer salts and furosemide) is visible at the edges. Nevertheless, the 
deposited drug amounts, even after multiple printing sessions, were still too small to quantify the loading 
or to detect a drug release.  
 
  
Figure 3.7: Optical microscope image of arrays of 
microwells filled with sample type C (scale bar 200 µm). 
Figure 3.8 Optical microscope of a container bottom 
filled with sample type C. 
A B
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3.5 Confined crosslinking of alginate matrices 
The unsatisfactory printing of furosemide demonstrated the need to consider alternative approaches for 
drug loading of containers. Albeit the inkjet printing of water-unsoluble compounds revealed operational 
limitations, it was observed that water based-solution exhibited a more stable dispensation. Therefore, it 
was believed that this technique was a good choice for a precise deposition of minute amounts of materials 
fulfilling the requirements of low viscosity and compatibility with the system liquid of the printer. 
A possible solution was dividing the drug loading into two steps: i) fixing a polymer matrix inside the 
microcontainers and ii) loading the drug by polymer swelling. In principle, the first step can be 
accomplished by inkjet printing as long as the dispensed solutions do not contain water insoluble 
compounds causing pipette clogging. The fixation can be performed by polymer deposition and a 
crosslinking reaction confined inside the microcontainer volume. Once the polymer matrix is fixed inside 
the container cavity, the second step can be carried out by the absorption of the drug solution. For this task 
it is important that the solvent used is both dissolving the API and swelling but not eroding or dissolving the 
matrix.  
3.5.1. Experimental procedure  
The printing of alginate solution could not be performed with the available equipment because of the high 
viscosity of the polymer solution even at low concentrations (3% w/v) [36]. An alternative approach for 
local crosslinking of alginate is schematized in figure 3.9. The procedure consists of printing aqueous 
solutions of the crosslinker (CaCl2, calcium chloride) inside the containers (I), followed by a deposition of 
sodium alginate onto the whole chip. The gelation of the solution is activated inside the microwell. Finally, 
the uncrosslinked portions of the polymer are dissolved by immersion in water. The choice of putting the 
crosslinker injection step before the polymer deposition was motivated by the need to confine the gelation 
inside the cavity by diffusion of Ca2+ ions in the matrix, avoiding the risk of unspecific crosslinking.  
 
 
Figure 3.9: Schematic of confined crosslinking of sodium alginate: (I) inkjet printing of crosslinker (CaCl2 in water), (II) 
deposition of alginate solution and activation of crosslinking reaction inside the microwell, (III) dissolution and 
removal of uncrosslinked polymer. 
 
The crosslinker solution was prepared dissolving the chlorine salt CaCl2 (anhydrous powder >97%, Sigma 
Aldrich) in microfiltered deionized water with the concentration of 0.45 M, under stirring for 1 hour at 
room temperature. The solution was filtered to remove particles which could block the inkjet nozzle. The 
printing resulted in a stable jet with an optimized setting (85 µs, 80 V, 100 Hz), giving droplets of 0.25 nL 
(volume estimated from stroboscopic check of droplet size). Figure 3.10 shows arrays of microcontainers 
filled with CaCl2 crystals (dark halo). In each microwell were spotted 120 droplets, in 6 consecutive sessions 
of 20 droplets. The estimated CaCl2 weight for each container was 1.5 µm. After printing, the chips were 
stored in vacuum at room temperature for 24 hours, to ensure a complete evaporation of the solvent. A 
SEM picture of salt crystals on the container bottom is shown in figure 3.11. Although during the 
stroboscopic check the liquid jet was stable, the amount of dispensed liquid in several cases did not appear 
uniform inside the wells, as also results from the top view image in figure 3.10. 
 
I) II) III)
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Figure 3.10: Microscope picture of arrays 
of 300 µm wide microcontainers filled 
with 120 droplets of crosslinker solution 
(black round halo), dispensed in six 
consecutive spotting sessions of 20 
droplets each. The resulting total mass of 
CaCl2 is 1.5 µg for container. 
  
 
Figure 3.11: SEM picture of 
microcontainer bottom after spotting of 
120 droplets of CaCl2.  
  
 
 
Figure 3.12: Optical microscope image of 
air bubbles inside containers, after 
pouring of 3% alginate solution. Air 
remains trapped because of the slow 
wetting by the solution; the high 
viscosity of the liquid hinders bubble 
release. 
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Sodium alginate was dispersed in deionized water, with the following concentrations: 0.5, 1, 2, 3% (w/v). 
The solution deposition onto microcontainers required a preliminary study to optimize the experimental 
procedure. In a first series of trials, pouring viscous water solutions of sodium alginate on hydrophobic SU-8 
microcontainers resulted in a non homogeneous filling because of the entrapment of air bubbles, as shown 
in figure 3.12. To improve the wetting properties of SU-8, microcontainers were subjected to oxygen 
plasma treatment (70mL/min O2, 50 W, 0.5 mbar, 8 min), as described in section 3.4.2. The subsequent 
immersion of plasma treated chips in alginate solution in an ultrasonic bath was also unsuccessful. As 
alternative to improve bubbles removal, the chip with containers was put inside a vacuum chamber and the 
solution was dosed on top of it by means of a syringe through rubber tubing placed on top of the chip. 
Most of the prepared solutions were too viscous for injection; as a result only 0.5% alginate (w/v) injection 
resulted suitable for the purpose. The standardized procedure, adopted in the experiments, is as follows: 
1. A syringe is filled with 1 mL solution of 0.5% (w/v) alginate in water and approximately 5 mL of air; 
2. the CaCl2 laden-chip is placed in the vacuum chamber, which is then sealed; 
3. the vacuum is applied for 5 minutes, during which the 5 mL of air in the syringe is sucked in; 
4. 1 mL of alginate solution is injected onto the chip through the tubing; 
5. the solution is aspired by the vacuum, and through the tubing, droplet starts to deposit onto the 
silicon surface with the microwells; later the first bubbles are released from the container volume.  
6. After few minutes, when the last bubbles are released, the chamber is opened and the chip 
collected. The exceeding amount of polymer is removed with a spatula. 
3.5.2 Results 
The amounts of printed CaCl2 had a relevant effect on the confinement of alginate gelation. 
Experiments were performed on 18 nL volume containers (inner diameter 300 µm) filled with 30, 60 and 
120 droplets (0.25 nL), of solution of 50 mg/mL (CaCl2). This corresponds to approximately to 0.38, 0.75 and 
1.5 µg of CaCl2 per containers respectively. With a 0.5% (w/v) alginate solution (5 mg/mL), each cavity was 
filled approximately with 0.09 µg of polymer. Thus, in principle the alginate/CaCl2 weight ratios within one 
container, filled with 30, 60 and 120 crosslinker droplets, were approximately equal to 1:4.5, 1:9 and 1:17 
respectively.  
Alginate dispensing, performed with a 1:18 ratio, resulted in the gelatinization of a continuous film of 
polymer, which could even be pealed off the chip surface. An example of continous gel film is shown in 
figure 3.13. In this optical picture the transparent film can be recognized by the halos of round edges of 
containers, imprinted on the film and shifted inrespect to the containers. This phenomenon was explained 
with the spreading of the gelling reaction to the volume outside the containers. Probably, the excess of 
CaCl2 inside the well started to diffuse outward, reacting with external portions of polymer. This 
explanation was supported by a closer inspection of individual containers, as depicted in figure 3.14.  
Deposition of alginate on containers filled with the smallest amounts of crosslinker (1:4.5 Alginate:CaCl2 
weight ratio), resulted in complete salt dissolution and in better confinement of gelation. An example is 
shown in picture 3.15. Thereafter, alginate filled containers were immersed in water to remove the 
uncrosslinked polymer from the surface in between the containers. 
In figure 3.16 the same chip as the one shown in figure 3.15 can be seen after dissolution and removal of 
uncrosslinked alginate. 
The level of alginate filling was measured by means of a visible light interferometer. The heights of well 
filling were very variable even on adjacent containers. This result was attributed to the difficult control of 
polymer deposition which had to occur inside a vacuum chamber, as well as to the issues with removal of 
air bubbles. The containers in the chip centre were covered first by sodium alginate which resulted in 
improved filling and with less residual bubbles than containers at the edges. 
In general, the results of alginate deposition were unsatisfactory due to the complexity of the phenomena 
involved (surface wetting, bubble extraction). 
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Figure 3.13: Optical microscope picture of local 
crosslinking of alginate. A transparent film with round 
halos is visible on top of microwells.  
Figure 3.14: Optical microscope picture of particles 
migration occuring just after polymer deposition. The 
particles are probably CaCl2 crystallites that are not 
fixed in the polymer and diffuse out the container 
cavity. 
 
 
  
Figure 3.15: Optical microscope picture of arrays of 
containers after the crosslinking reaction (1:1 
Alginate:CaCl2). No residual crosslinker is visible. 
Figure 3.16: Optical microscope picture of the same 
group of containers shown in figure 3.15, taken 
after the removal of uncrosslinked alginate. 
 
  
Inkjet printing as a loading method 
63 
 
3.6 Inkjet printing of PVP solutions 
This section contains results published in the paper: “Inkjet Printing as a technique for filling of microwells 
with biocompatible polymer”. Preliminary tests of printing of PVP solutions were performed at the 
Naughton Institute (Trinity College Dublin, CRANN) in the laboratories of Martin Hegner´s research group. 
3.6.1 Printability of PVP solutions  
Based on previous experiences printing of aqueous solutions was feasible with the equipment in use and 
resulted in a good reproducibility. As an alternative procedure for filling the containers in the dispensing a 
diluted aqueous solution of polymer into the microwells was identified. Poly(vinyl pyrrolidone) (PVP) was 
chosen because it is highly soluble in water and because the viscosity of solutions can be tuned to be 
compatible with the printer limitations. To reduce the risk of jet instability and shorten process time, an 
increase of polymer concentration would have limited the number of consecutive depositions. On the other 
hand, viscosity also increases with concentration. Furthermore higher concentration can induce the 
occurrence of non-Newtoninan behaviors, which is not suitable for printing. Therefore, a compromise 
between polymer concentration and printing feasibility was searched. Sadeghi et al. [37] reported the 
viscosity of aqueous solutions of PVP (Mw 10
4 Da) at different concentrations and temperatures. According 
to this work, PVP up to 17% (wt) has a viscosity below the operation limit of 5 mPa·s at room temperature. 
At T= 55°C, PVP solution with 25% wt can potentially be spotted. PVP was dissolved in different 
concentrations of 5, 10 and 20% wt and viscosity measurements were performed with a rotational 
rheometer to ensure that the solutions exhibit a Newtonian behavior and a viscosity value below 5 mPa·s. 
To investigate the effect of surface tension of spotted solutions on wetting of SU-8, solutions of PVP in 
isopropanol (2% wt) were also printed. These last tests were performed with another inkjet printer 
(Microdrop Dispenser Head, MD-K-130, Germany) at the Danish Technological Institute (DTI, Taastrup, 
Denmark). 
3.6.2 Inkjet printing of PVP solutions 
The intensity, duration, and frequency of the voltage applied to the piezoelectric actuator of the dispenser 
have been tuned for optimized microwell filling. The optimum set of parameters is a pulsing voltage of 90 
V, a pulse width of 90 µs and a frequency of 175 Hz for all the solutions. The diameter of the droplets was 
measured with the stroboscope imaging to 47 µm for 20 % wt PVP and 53 µm for 5 and 10 % wt PVP. 
3.6.3 Microcontainer filling 
PVP solutions are dispensed by DOD inkjet printing into containers of different sizes. The number of 
droplets to dispense in each container is estimated dividing the cavity volume by the droplet volume. An 
overview of the spotting plan is shown in table 3.4. The typical time needed for spotting an array of 625 
containers is around 12 minutes. To increase the polymer content inside the microcontainers, the spotting 
process is repeated up to three times on the same array in subsequent printing sessions, where during each 
session a solution volume equal to the cavity volume is dispensed into each microcontainer. Between the 
sessions, a waiting time for solvent evaporation is introduced in order to avoid spillover. The evaporation of 
the drops is observed with the top view camera and the time is measured. The typical drying times for 
isopropanol and water based-solutions were 1 and 2 minutes respectively. The polymer concentration did 
not sensitively affect the evaporation time of dispensed solutions. To measure the filling level of the 
microcontainers, the chips are coated with an Aluminum layer (15 nm, Alcatel SCM 600). The PVP thickness 
was then measured by means of an optical profiler (PLu Neox Optical Profiler, Sensofar), equipped with 50x 
(cavity diameter 300 and 200 µm) and 20x (100 and 50 µm) objective to measure. The profiler is set in 
confocal mode, with a monochromatic blue light (460 nm). Each microcontainer is scanned along a cross 
section passing through the container center within a scanning range of 400 µm with a resolution of 1 µm. 
Figure 3.17a shows a SEM image of a microcontainer, where the cross section is highlighted in red. In figure 
3.17b the two dimensional profile of a polymer-filled container is plotted. 
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Table 3.4: Dispensed volumes of polymer solution for different well sizes for one inkjet session. 
Cavity diameter 
(µm) 
Cavity volume 
(nL) 
Dispensed volume for one inkjet session 
5%, 10% wt.  
number of 
droplets 
20% wt. 
number of 
droplets 
300 18 18 60 18 75 
200 8 7.5 25 7.7 32 
100 2 1.8 6 1.9 8 
50 0.5 0.3 1 0.5 2 
 
 
 
 
 
Figure 3.17: (a) SEM picture of a polymer filled microcontainer with outlined cross section, (b) 2D profiles of an 
empty (dotted line) and filled microcontainer (solid line) with 64 droplets of PVP 10% wt in water scanned with the 
optical profiler. 
 
 
 
Figure 3.18: (a) Microscope image of three arrays of microcontainers filled with 10 wt % PVP. SEM images of (b) an 
empty (bottom right) and a filled well with diameter 50 µm (top left), (c) 300 µm inner diameter wells filled  with 5 % 
wt PVP, 60 droplets. 
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3.6.4 Level of microcontainer filling  
Arrays of containers with cavity diameter of 50, 100, 200 and 300 µm are filled with aqueous solutions of 
PVP at different concentrations. In figure 3.18a a microscope picture of three arrays of filled containers is 
shown. In figure 3.18b a SEM picture of an empty well (bottom right) and a filled one (top left) are shown. 
SEM pictures of microcontainers after filling revealed that large arrays of microwells can be filled with high 
precision. A quasi-no-waste deposition (see figure 3.18c) can be achieved when subsequent printing steps 
are performed on the same wells and a waiting time for solvent evaporation is included. According to the 
viscosity limit of the dispensing system, a concentration of polymer up to 20 % wt is successfully spotted. It 
is observed that water solutions can be spotted with a higher volume than the microcontainer cavity, 
because the high contact angle of water on SU-8 and the high surface tension of water confine the solution 
in a cap on the top of the microstructures (see figure 3.19). Upon drying of the liquid, the liquid cap shrinks, 
and the polymer is deposited in the cavity. After water evaporation the microcontainers were analyzed 
with scanning electron microscopy and the polymer deposition looked similar to figure 3.18c. The change of 
jet frequency was also investigated but it did not affect the coating performance. Thus the content of 
polymer in each microwell can be controlled by varying its original concentration in the solution and 
repeating several printing sessions. The level of polymer filling is measured with an optical profiler. An array 
of 25 microwells was scanned for each container dimension, for the three different level of filling (i.e. inkjet 
sessions), along their cross section passing through the centre. In table 3.5 the height of the polymer layer 
in the center of the microcontainers is shown. The reported values are the difference of the height of the 
polymer layer and the container bottom thickness (35 µm). By comparing the filling level with the 
corresponding number of droplets it can be noticed that the increase is non-linear. This is due to the fact 
that the polymer tends to be distributed also on the walls of the containers, and this coating layer gets 
gradually thicker with the level of filling. The roughness of the surface due to cracks induced by the polymer 
shrinking does not allow a more accurate computation of the polymer volume by numerical integration. 
 
Table 3.5: Filling level of polymer for different container sizes after one, two and three inkjet sessions with solutions 
of PVP 20% wt. in water. Each value is the average of 25 microcontainers.  
Cavity 
diameter 
(µm) 
Polymer height after subsequent inkjet sessions 
number of 
droplets 
polymer 
height (µm) 
number of 
droplets 
polymer 
height (µm) 
number of 
droplets 
polymer 
height (µm) 
300 75 8±2 150 20±1 225 24±1 
200 32 88±7 64 132±9 96 155±2 
100 8 102±3 16 223±7 24 246±5 
50 2 125±5 4 182±4 6 282±8 
 
 
Figure 3.19: Microscope picture 
from the side of one microwell 
spotted with 4000 droplets of 
PVP in deionized water (2% wt) 
with a drop ejection frequency of 
100 Hz. 
Picture taken with a custom-made 
side view microscope, mounted on 
an inkjet spotter (Microdrop 
technologies, GmbH, Germany) at 
Martin Hegner´s laboratory 
(CRANN, Trinity College Dublin). 
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Figure 3.20: SEM pictures of microcontainers spotted with PVP in isopropanol solution (2% wt). The same solution 
volume was dispensed with a drop ejection frequency of 100 Hz (a), 200 Hz (b) and 500 Hz (c). 
 
Figure 3.21: SEM images of microcontainers filled with an increasing number of droplets: 1000 (a), 2000 (b) and 
6000 (c). 
3.6.5 Effect of surface tension on deposition 
The effect of surface tension of different solvents on the SU-8 surface is investigated by dispensing 
solutions of PVP in isopropanol. It was also believed that spotting of PVP in isopropanol could be compared 
with the results obtained with furosemide in DMSO and ethanol (described in section 3.4.2). For this 
purpose, solution of 2% wt PVP (Mw 10
6 Da) is dispensed into wells with a diameter of 200 µm. The 
substrate temperature is kept at 50˚C in order to shorten the solvent evaporation time. The droplet volume 
was 0.3 nL. Figure 3.20 shows SEM images of containers filled with 1000 droplets at different frequencies: 
100 Hz (figure 3.20a), 200 Hz (figure 3.20b) and 500 Hz (figure 3.20c). For all three cases, the same volume 
of solution was dispensed, with equal droplet size (not depending on the jet frequency), but with different 
dispensing rates. In any case the solution did not fill the cavity, but tended to wet the surface of the 
container covering it with a uniform coating. However, at higher frequency, not only the container was 
coated but also an increasing part of the substrate in between the containers. In the SEM pictures in figure 
3.21 the effect of droplet number on the coating is shown: 1000 (figure 3.21a), 2000 (figure 3.21b) and 
6000 droplets (figure 3.21c) were dispensed at a constant frequency of 100 Hz. PVP layer thickness 
increases with the droplet number. 1000 droplets were dispensed without spillage. These results are 
explained by the low contact angle of isopropanol on SU-8. Before evaporation, the solvent wets the 
container distributing the polymer uniformly on its surface. The result is a conformal coating of the three 
dimensional structure. The effect of frequency could be explained by the different time it takes for the 
droplets of solution to dry once they land on the microcontainer bottom. The higher the spotting 
frequency, the longer was the time the solution remained wet. The droplets coalesced and formed a liquid 
volume that symmetrically flowed onto the surrounding available surface until the solvent dries.  
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3.7 Inkjet printing of lipid based formulations for insulin delivery 
One of the formulations developed for microcontainers was a lipid based solutions and was composed of a 
mixture of oils and surfactants (see section 3.3.4), resulting in a viscous liquid. The shear viscosity of the 
solution was measured with a rotational rheometer, and was at room temperature approximately equal to 
55 mPa·s. As a consequence, the liquid needed to be heated in order to be printed. A feasibility study 
performed by the equipment manufacturer revealed that the lipid formulation needed to be heated to 
50°C in order to overcome the viscosity limit of the equipment. 
The optimum set of parameters was a pulsing voltage of 100 V, a pulse width of 12 µs and a frequency of 
50 Hz. The estimated droplets volume was 0.15 nL. SEM pictures of oil filled containers are shown in figures 
3.22 and 3.23. 
Spotting was successfully performed on microcontainers of different sizes, showing that it is possible to 
dose precisely picoliter amounts of SNEDDS formulation which potentially can incorporate bioactive 
ingredients. 
However, the need to decrease viscosity with heat, represents a non negligible disadvantage for insulin. To 
study the effect of heat on the active ingredient, volumes of insulin-loaded formulation (with composition 
mentioned in section 3.3.4) were kept in an oven at different temperatures for a time period equal to the 
expected printing time (12-15 minutes). Thereafter, defined aliquots of the solution were analyzed with 
HPLC to measure if the concentration of insulin was equal to the one of the untreated insulin solution. At 
50°C, the amount of active protein was measured to be between 70 and 80% (tests performed by our 
collaborators at KU Pharma). 
The optimized SNEDDS formulation includes an insulin concentration of 2.5-10 mg/mg OIL. 
An estimate of the total number of microdevices needed for an oral therapeutic dose of insulin can be 
calculated taking in account the following facts: i) the volume available for loading of a typical microdevice 
is 18 nL (300 µm containers), ii) the total daily average insulin dose for humans is 0.5-1 units per kg of body 
weight with injection for patients without a severe insulin resistance [38]. Assuming an absorption in the 
blood stream through the GIT of 10% of the one via injection,  the dose needed daily becomes equal to 5-
10 unit/kg that is, for a 70 kg human, 12.5-25 mg. The number of microcontainer needed for a therapeutic 
dose, considering the most favorable conditions (lowest dose, highest loading), is given by: 
 #microdevices = insuline doseinsulin loaded per container = 12.5 (mg)18 ∙ 10−6(ml) ∗ 0.95 �g OILml � ∗ 10 � mgg OIL� ≅ 73100 
 
assuming that the density of the formulation is equal to the one of its most abundant component (Miglyol 
812). Such a number of microdevices, with the current microfabrication design, correspond approximately 
to 4 wafers. Furthermore, considering that one pipette takes approximately 12 minutes to fill 625 
microdevices, with a printer like the one in use, equipped with 16 pipettes, the total printing time needed 
for one dose of insulin would be approximately 88 minutes. And considering the additional loss of activity 
of insulin due to the heating, the total time for one dose becomes 110 minutes. 
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Figure 3.22: SEM image of containers filled with 
100 droplets of lipid formulation (left) and empty 
containers (right). 
Figure 3.23: SEM image of 0.5 
nL container willed with 4 
droplets of lipid formulation. 
3.8 Conclusion on inkjet printing 
The use of DOD inkjet printing as a filling technique for furosemide demonstrated in general substantial 
limitations of the available equipment. The precipitation of the drug within the pipette was the main cause 
of irreproducible results. In certain cases, nozzle clogging compromised permanently the pipette operation. 
The need of dispensing diluted solutions limited the drug loading. The deposited amounts were too small to 
quantify drug loading or to be close to a therapeutic dose. A search in the literature confirmed that the 
same obstructions occurred in the printing experiments of felodipine solutions (another water unsoluble 
substance) with micropipettes of the same manufacturer [1]. Buffer solutions of furosemide exhibited a 
more stable jet formation, although pipette blocking could not be avoided. This fact suggested that water-
based solutions can be suitable for printing. Controlled volumes of aqueous solutions of PVP were 
dispensed inside the microcontainers, with a good reproducibility in terms of alignment and dispensed 
volume. Polymer concentrations up to 20% (wt) were successfully dispensed. Water-based solutions 
completely fill the cavity volume and the polymer content is controlled by repeated spotting sessions. The 
deposition of both PVP in isopropanol and furosemide in DMSO-ethanol showed instead that organic 
solvents tend to wet SU-8 surface and that it is easier to coat containers rather than filling their cavities. 
However, the spotting of organic solvent based solutions on SU-8 could be an interesting method for the 
deposition of selective conformal coating on individual microstructures. The deposition of a hydrophilic 
polymer like PVP can be used to permanently change surface properties of SU-8. Viscous solutions like 
chemicals used for SNEDDS can be successfully printed, but in that case a heating dispensing system is 
required in order to decrease the viscosity to below 5 mPa·s. 
Inkjet printing could be employed as a tool for filling microcontainers with drug formulations, as long as no 
water insoluble compounds precipitate within the pipette.  
In conclusion, an innovative loading technique of microcontainers with poorly water soluble drugs could be 
divided into two steps: the DOD deposition of a polymer matrix (PVP, but potentially any water soluble 
filler), followed by an additional step fulfilling the drug loading. This second step will be discussed in the 
next chapter. 
  
Inkjet printing as a loading method 
69 
 
Bibliography 
[1] N. Scoutaris, Home based formulation of personalised medicines by means of inkjet printing technique, 
in, University of Nottingham, 2011. 
[2] P.O. Brown, T.D. Shalon, Methods for fabricating microarrays of biological samples, in, Google Patents, 
1998. 
[3] G. MacBeath, S.L. Schreiber, Printing Proteins as Microarrays for High-Throughput Function 
Determination, Science, 289 (2000) 1760-1763. 
[4] T. Goldmann, J.S. Gonzalez, DNA-printing: utilization of a standard inkjet printer for the transfer of 
nucleic acids to solid supports, Journal of Biochemical and Biophysical Methods, 42 (2000) 105-110. 
[5] E.A. Roth, T. Xu, M. Das, C. Gregory, J.J. Hickman, T. Boland, Inkjet printing for high-throughput cell 
patterning, Biomaterials, 25 (2004) 3707-3715. 
[6] U. Gbureck, T. Hölzel, C.J. Doillon, F.A. Müller, J.E. Barralet, Direct Printing of Bioceramic Implants with 
Spatially Localized Angiogenic Factors, Advanced Materials, 19 (2007) 795-800. 
[7] S. Goodall, N. Chew, K. Chan, D. Auriac, M.J. Waters, Aerosolization of protein solutions using thermal 
inkjet technology, Journal of aerosol medicine, 15 (2002) 351-357. 
[8] P. Tarcha, D. Verlee, H. Hui, J. Setesak, B. Antohe, D. Radulescu, D. Wallace, The Application of Ink-Jet 
Technology for the Coating and Loading of Drug-Eluting Stents, Annals of Biomedical Engineering, 35 (2007) 
1791-1799. 
[9] S. Hauschild, U. Lipprandt, A. Rumplecker, U. Borchert, A. Rank, R. Schubert, S. Förster, Direct 
Preparation and Loading of Lipid and Polymer Vesicles Using Inkjets, Small, 1 (2005) 1177-1180. 
[10] N. Genina, D. Fors, M. Palo, J. Peltonen, N. Sandler, Behavior of printable formulations of loperamide 
and caffeine on different substrates–effect of print density in inkjet printing, International Journal of 
Pharmaceutics, (2013). 
[11] R. Kolakovic, T. Viitala, P. Ihalainen, N. Genina, J. Peltonen, N. Sandler, Printing technologies in 
fabrication of drug delivery systems, Expert Opinion on Drug Delivery, 10 (2013) 1711-1723. 
[12] D. Raijada, N. Genina, D. Fors, E. Wisaeus, J. Peltonen, J. Rantanen, N. Sandler, A step toward 
development of printable dosage forms for poorly soluble drugs, Journal of Pharmaceutical Sciences, 102 
(2013) 3694-3704. 
[13] N. Genina, D. Fors, H. Vakili, P. Ihalainen, L. Pohjala, H. Ehlers, I. Kassamakov, E. Haeggström, P. 
Vuorela, J. Peltonen, N. Sandler, Tailoring controlled-release oral dosage forms by combining inkjet and 
flexographic printing techniques, European Journal of Pharmaceutical Sciences, 47 (2012) 615-623. 
[14] N. Scoutaris, M.R. Alexander, P.R. Gellert, C.J. Roberts, Inkjet printing as a novel medicine formulation 
technique, Journal of Controlled Release, 156 (2011) 179-185. 
[15] P.J. Marsac, H. Konno, L.S. Taylor, A comparison of the physical stability of amorphous felodipine and 
nifedipine systems, Pharmaceutical research, 23 (2006) 2306-2316. 
[16] Y. Matsuda, E. Tatsumi, Physicochemical characterization of furosemide modifications, International 
Journal of Pharmaceutics, 60 (1990) 11-26. 
[17] M. Lindenberg, S. Kopp, J.B. Dressman, Classification of orally administered drugs on the World Health 
Organization Model list of Essential Medicines according to the biopharmaceutics classification system, 
European Journal of Pharmaceutics and Biopharmaceutics, 58 (2004) 265-278. 
[18] V. Iannuccelli, G. Coppi, E. Leo, F. Fontana, M.T. Bernabei, PVP solid dispersions for the controlled 
release of furosemide from a floating multiple-unit system, Drug Development and Industrial Pharmacy, 26 
(2000) 595-603. 
[19] F. Haaf, A. Sanner, F. Straub, Polymers of N-vinylpyrrolidone: synthesis, characterization and uses, 
Polymer Journal, 17 (1985) 143-152. 
[20] M.L. Huggins, The viscosity of dilute solutions of long-chain molecules. IV. Dependence on 
concentration, Journal of the American Chemical Society, 64 (1942) 2716-2718. 
[21] C. Leuner, J. Dressman, Improving drug solubility for oral delivery using solid dispersions, European 
Journal of Pharmaceutics and Biopharmaceutics, 50 (2000) 47-60. 
Inkjet printing as a loading method 
70 
 
[22] P. Caliceti, O. Schiavon, F.M. Veronese, Biopharmaceutical properties of uricase conjugated to neutral 
and amphiphilic polymers, Bioconjugate chemistry, 10 (1999) 638-646. 
[23] V. Iyer, S. Katageri, R. Radhakrishnan, N.B. Gaddipati, Pharmaceutical formulation in a drug delivery 
system and process for preparing the same, in, Google Patents, 2002. 
[24] V.P. Torchilin, T.S. Levchenko, K.R. Whiteman, A.A. Yaroslavov, A.M. Tsatsakis, A.K. Rizos, E.V. 
Michailova, M.I. Shtilman, Amphiphilic poly-N-vinylpyrrolidones:: synthesis, properties and liposome 
surface modification, Biomaterials, 22 (2001) 3035-3044. 
[25] G.J.M. Fechine, J.A.G. Barros, L.H. Catalani, Poly (< i> N</i>-vinyl-2-pyrrolidone) hydrogel production by 
ultraviolet radiation: new methodologies to accelerate crosslinking, Polymer, 45 (2004) 4705-4709. 
[26] L.C. Lopérgolo, A.B. Lugão, L.H. Catalani, Direct UV photocrosslinking of poly (< i> N</i>-vinyl-2-
pyrrolidone)(PVP) to produce hydrogels, Polymer, 44 (2003) 6217-6222. 
[27] E. Rudnic, J. Lausier, R. Chilamkurti, C. Rhodes, Studies of the Utility of Cross Linked 
Polyvinlpolypyrrolidine as a Tablet Disintegrant, Drug Development and Industrial Pharmacy, 6 (1980) 291-
309. 
[28] D. Perin, Biomaterials for biotechnological applications: synthesis and activity evaluations, (2010). 
[29] C.W. Pouton, Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 
‘self-microemulsifying’drug delivery systems, European Journal of Pharmaceutical Sciences, 11 (2000) S93-
S98. 
[30] P. Li, H.M. Nielsen, A. Müllertz, Oral delivery of peptides and proteins using lipid-based drug delivery 
systems, Expert Opinion on Drug Delivery, 9 (2012) 1289-1304. 
[31] F.L. Mota, A.P. Carneiro, A.J. Queimada, S.P. Pinho, E.A. Macedo, Temperature and solvent effects in 
the solubility of some pharmaceutical compounds: Measurements and modeling, European Journal of 
Pharmaceutical Sciences, 37 (2009) 499-507. 
[32] A. Jouyban, Handbook of Solubility Data for Pharmaceuticals, Taylor & Francis, 2010. 
[33] Ullmann's Encyclopedia of Industrial Chemistry, John Wiley & Sons, 2003. 
[34] F. Walther, T. Drobek, A.M. Gigler, M. Hennemeyer, M. Kaiser, H. Herberg, T. Shimitsu, G.E. Morfill, 
R.W. Stark, Surface hydrophilization of SU-8 by plasma and wet chemical processes, Surface and Interface 
Analysis, 42 (2010) 1735-1744. 
[35] F. Walther, T. Drobek, A.M. Gigler, M. Hennemeyer, M. Kaiser, H. Herberg, T. Shimitsu, G.E. Morfill, 
R.W. Stark, Surface hydrophilization of SU-8 by plasma and wet chemical processes, Surface and Interface 
Analysis, 42 (2010) 1735-1744. 
[36] G. Turco, I. Donati, M. Grassi, G. Marchioli, R. Lapasin, S. Paoletti, Mechanical spectroscopy and 
relaxometry on alginate hydrogels: a comparative analysis for structural characterization and network mesh 
size determination, Biomacromolecules, 12 (2011) 1272-1282. 
[37] R. Sadeghi, M. Taghi Zafarani-Moattar, Thermodynamics of aqueous solutions of polyvinylpyrrolidone, 
The Journal of Chemical Thermodynamics, 36 (2004) 665-670. 
[38] J. Conget, E. Esmatjes, J. Ferrer, J. Vendrell, E. Moscoso, R. Gomis, Human insulin dosage and 
distribution at the onset of type 1 diabetes mellitus, Diabetes research and clinical practice, 9 (1990) 251-
255. 
 
 
Supercritical impregnation 
71 
 
4. Supercritical impregnation 
The work presented in this chapter resulted in the scientific article “Polymer-filled microcontainers for oral 
delivery loaded using supercritical impregnation”, published in the Journal of Controlled Release (see 
Appendix 2). Some topics and results of this work were also shown in an oral presentation at the 7th Annual 
Symposium of the Pharmaceutical Solid State Research Cluster (PSSRC Lille, July 3-6, 2013) and in a podium 
presentation at the 40th Annual Meeting and Exhibition of Controlled Release Society (CRS Honolulu, July 
21-24, 2013). The experiments were partially performed in the lab facilities of Chempilots A/S (Farum, 
Denmark). The study described in section 4.3.6 was conducted at the Univesity of Trieste (Italy), in a co-
supervised master project. 
4.1 Concepts of drug loading by polymer swelling 
In chapter 3, the deposition of aqueous PVP solutions by inkjet printing was described. Once precise 
amounts of polymer were deposited inside the microcontainers, the loading of poorly soluble drugs could 
be performed on large arrays of devices by swelling the polymer matrix with a solution containing the drug, 
followed by a short washing step. The steps of drug loading by swelling are schematically depicted in figure 
4.1. 
In such a loading process the chemical nature of the swelling solvent plays a crucial role. The solvent must 
act as drug carrier. The solvent should dissolve the drug of interest but not the polymer matrix, which just 
has to be swelled and loaded with drug. At the same time, the affinity between polymer and API must 
prevail over the one between API and solvent in order to make the loading efficient. Furthermore, it is 
important that the solvent is easily removed from the polymer matrix once the loading has taken place with 
minimal unspecific deposition of API. In the optical case, the solvent evaporation would be fast to avoid 
drug recrystallization within the polymer matrix.   
 
 
Figure 4.1: Drug loading via polymer swelling: (a) inkjet printing of polymer solution; (b) swelling with drug solution; 
(c) polymer deswelling by solvent removal. 
a b c
Supercritical impregnation 
72 
 
As a preliminary experiment, swelling was performed on a chip with microcontainers filled with alginate 
prepared with the procedure described in section 3.5. The array was immersed in DI water for 30 minutes 
at room temperature to investigate the behaviour of confined volumes of alginate in a liquid solvent. 
Pictures of gel-laden microcontainers were collected with a scanning electron microscope (FEI Quanta 200 
ESEM FEG) at room temperature and 2 mbar partial water vapor pressure with the gaseous secondary 
electron detector (acceleration voltage 15 eV). An array of polymer filled-containers are shown in figure 4.2 
before (figure 4.2a) and after swelling (figure 4.2b). It can be observed that the solvent absorption in the 
polymer matrix is so pronounced that the swelling induces a “pop corn” effect. This is probably also 
enhanced by the hydrophobicity of SU-8 container surfaces, which might expell the polymer out of the 
containers. 
 
  
Figure 4.2: E-SEM pictures of arrays of alginate –filled microcontainers, (a) before swelling and (b) after swelling for 
30 min in DI water (from R. Mateiu). 
 
Although the extent of polymer swelling might be modulated by varying for instance solvent and time of 
immersion, it was believed that in general the loading by immersion in a liquid drug solution would have 
been difficult to control. Therefore, this strategy was not further explored for the loading of 
microcontainers with poorly soluble drugs.  
An optimal solution for controlled swelling would be represented by a solvent, whose diffusivity and 
solvent power can be modulated during the different steps of the loading process. A high diffusivity, or 
more precisely a proper combination of viscosity and diffusion coefficient, enables the drug carrier to 
penetrate the polymer matrix more in depth, and to leave it more rapidly and with minimum residuals. A 
tunable solvent power would permit to dissolve a proper quantity of API, but at the same time to change its 
affinity in order to promote the API partition between solvent and polymer in favour of the latter. 
The need of such properties is not new for the preparation of solid dispersions of pharmaceutical interest. 
The choice of volatile solvents is always preferred, but often implicates the use of synthetic organic 
compounds. The presence of traces of potentially toxic organic solvents in pharmaceutical products entails 
a substantial risk for safety as well as to the stability of the formulation [1].  
In the last decade, research in pharmaceutical technology found in supercritical carbon dioxide (scCO2) a 
valuable alternative to organic solvents. As discussed in section 2.3, CO2 above its critical point acquires a 
density (i.e. solvent power) similar to a liquid, and a viscosity of a gas, which makes it particularly suitable 
for tuning impregnation of polymers. In this work, scCO2 was used to load a poorly soluble drug into 
microcontainers previously filled with PVP by inkjet printing. To prove the feasibility of the supercritical 
technology with respect to microcontainers, the drug of choice was ketoprofen, a well known poorly 
soluble compound whose dissolution in scCO2 already had been studied in several research works [2-4]. 
A B 
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4.2 Materials and methods 
4.2.1 Solubility of ketoprofen in supercritical CO2 
Ketoprofen is a non steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties, 
used to treat rheumatoid arthritis osteoarthritis, dysmenorrheal and in general prescribed as a pain-killer 
[6]. In figure 4.3a, the molecular structure ketoprofen is shown. The ketoprofen molecule has one 
asymmetric carbon atom which gives rise to two enantiomers, both showing biological activity [7]. In this 
thesis experiments were carried out with the racemic mixture. Ketoprofen is considered in different 
pharmacopeias as practically insoluble in water. Its solubility in pure water at ambient temperature (22-
24°C) was reported to be 0.010 mg/mL [8]. As for many drugs, the preferred site of absorption in the oral 
route is the small intestine [9]. After oral administration, the dose fraction absorbed was reported to be 
90%, and thus ketoprofen is considered as a “highly permeable” drug [6]. Thus, ketoprofen is classified as a 
class II in the BCS standard, mentioned in figure 1.1.  
From a chemical perspective, ketoprofen is a weak acid with reported pKa values of 4.39 at 25°C [10]. 
Ketoprofen side effects are similar to other anti-inflammatory agents. However, it is one of the most 
ulcerogenic [6]. The solubility of NSAIDs in supercritical scCO2 has been extensively studied [2-4, 11, 12]. 
The solubility of ketoprofen follows a profile similar to the one shown in figure 4.4 [5]. In general solubility 
is a monotonic function of pressure, as a result of the increasing volatility and CO2 density [13]. As 
discussed in section 2.3.2, the plots of solubility versus pressure at different temperatures (solubility 
isotherms) exhibit two crossover points, at defined values of pressure PL
* (lower value) and PU
* (upper 
value). The upper crossover pressure PU
* of solubility isotherms was reported between 160 and 180 bar. 
Several authors confirmed this discovery [2, 3]. In light of its solubility issues in water, its suitability for the 
supercritical operation, as well as the existing need to reduce side effects, ketoprofen was considered an 
eligible model API for impregnation in microcontainers.  
 
 
 
Figure 4.3: Chemical structure of (a) 
ketoprofen, (b) monomer of poly 
(vinyl pyrrolidone) (PVP).  
Figure 4.4: Solubility isotherms of ketoprofen in scCO2 as a 
function of pressure at 40, 50 and 60 °C (adapted from [5]). 
The lines are guides for the eyes. 
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4.2.2 Swellability of PVP by supercritical CO2 
The chemical structure of poly(vinylpyrrolidone) (PVP) is depicted in figure 4.3b. PVP is a polymer with 
many functions as discussed in section 3.3.2. The effects of CO2 on PVP was studied by Kikic and coworkers 
[14]. Gaseous CO2 sorption in PVP matrices (K25 Mw 2.9·10
4 Da and K90 106 Da) generates a plasticization of 
the polymer, resulting in a decrease of the Tg. This fact caused the so called retrograde vitrification where 
at a constant pressure an increase of the temperature invokes a liquid to glass transition, opposite to the 
typical behavior. In the same research group, Alessi et al. [15] showed how the molecular weight influences 
the CO2 sorption in PVP swelling ratio. 
 
  
Figure 4.5: Absorbed CO2 (weight fraction) in PVP at 
different fluid pressures for two molecular weights 
(adapted from [15]; courtesy of Alessi et al.). 
Figure 4.6: Absorbed CO2 (weight fraction) in linear and 
chemically and physically crosslinked PVP as a function of 
pressure at 47°C (from [16]; courtesy of Kikic et al.). 
 
In figure 4.5 the CO2 sorption in PVP is shown as a function of the fluid pressure for polymer grades K90 
(white dots) and K25 (black dots). Both curves follow a monotonic trend, and it appears that at a given 
pressure, the CO2 uptake is higher for lower the polymer molecular weight. This difference in polymer 
penetration becomes more pronounced with increasing pressure because of the concomitant increase of 
fluid density. As a reasonable assumption, a K17 grade (Mw 10
4) of the polymer as it was used in this work is 
expected to have an even higher absorption than K25. Finally, Kikic et al. [16] compared the CO2 sorption in 
linear PVP and in its crosslinked versions, observing  that polymer permeability depends on the level and 
the strength of entanglement between polymer chains (see figure 4.6). At low pressures, the linear PVP is 
permeated more easily by CO2 than the crosslinked versions. However, above a pressure of around 40 bar 
the chain stiffness and the entanglement due to the physical crosslinks is reduced by the CO2 pressure and 
the swelling is enhanced [16]. The impregnation of PVP with ketoprofen has also previously been 
investigated. Manna et al. [17] prepared solid dispersions of ketoprofen and PVP K30 via supercritical 
carbon dioxide in a continuous operation. The drug was put in excess amounts (according to a previous 
solubility study) in a chamber (dissolution vessel) and dissolved in pressurized CO2 under stirring together 
with glass beads. The API concentration was measured and when it reached saturation at the chosen 
conditions of P and T, the drug enriched scCO2 was conveyed in a second vessel (impregnation vessel). 
There, the PVP powder had previously been mixed with glass beads and swollen with pure supercritical CO2 
for 1 hour in advance. This operation aimed to ensure complete polymer swelling prior to impregnation. 
The impregnation was carried out in dynamic conditions where the CO2-ketoprofen flow is recycled to the 
dissolution vessel. With this procedure, the impregnation is carried out in saturation conditions during the 
whole operation. The drug partition equilibrium between CO2 and polymer was attained by monitoring the 
drug concentration in the flow leaving the impregnation vessel. The experiment was stopped when the 
drug concentration in the flow returned to be equal to the solubility value. Certain experiments required 
long times to reach equilibrium (up to 5 days), attaining drug loading of 58% wt of ketoprofen in PVP. 
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4.2.3 Deposition of PVP solution in the microcontainers and preparation of PVP films 
The microwells with diameter 200 µm were filled with PVP by means of an inkjet printer as described 
previously in section 3.6.3. PVP K17 was chosen for the feasibility for inkjet printing (discussed in section 
3.6) and for the expected high degree of swelling in scCO2 (as mentioned in section 4.2.2). The polymer was 
dissolved in DI water (10% wt) and the solution was stirred for 3 h. The chips were weighed before and 
after the polymer deposition and the polymer weight per chip was estimated. Characterization of polymer 
filled microcontainers was done with a Plu Neox 3D Optical Profiler (Sensofar) in the confocal mode. 
Polymer films were prepared with the same solution used for the inkjet printing (10% wt in DI water). These 
samples were intended for spectroscopic characterization studies. The films were cast in a cylindrical cavity 
of a teflon mold (diameter 5 mm, height 0.255 mm) with a volume equal to the sum of the cavity volumes 
of 625 microcontainers. A volume of 5 μl of solution was dispended in the mold and left on a hotplate at 50 
°C for 1 h to remove the solvent. 
 
4.2.4. High pressure equipment and experimental procedure 
In this work the impregnations were performed in batch conditions: The chips with polymer filled 
containers and the solid drug were placed in the reactor chamber, which was sealed and filled with scCO2.  
The implant used in this research work is schematically represented by the flow diagram in figure 4.7. 
Weighed amounts of crystalline ketoprofen powder were poured on the bottom of a 100 mL high pressure 
reactor with sapphire windows (Thar SFC). Different weights of drug, 4.7 and 14.1 mg for 100 and 200 bar 
batched respectively, were dissolved in order to reach saturation conditions according to the data shown 
by Macnaughton et al. [2]. One chip with the microcontainers was placed on a steel grid fitting the chamber 
cross section.  
Then, the valve V5 was closed, and desired temperature was set. The apparatus was pressurized through 
valves V2 (on/off valve) and V4 (needle valve) by the pump with a controlled ramp. The pressure was 
monitored through pressure gauge PI3: The CO2 filled the chamber slowly to avoid fluid hammers of the 
pipes and to prevent the need of excessive mass of fluid to fill the chamber. The CO2 inlet stream was 
generally colder than the operating T. If the feed flow was too high, the CO2 cooled down the chamber and 
once the chamber was again heated up to correct set point T, the fluid pressure overshoots the desired 
value. It is therefore important that the filling step is performed at constant T and that the chamber is 
slowly filled with CO2. The volumes of residual air in the chamber at 40°C at 100 and 200 bar were 
estimated to be 1 and 0.5 mL respectively which was considered negligible because this was lower than the 
available surplus chamber volume (4 mL). Once the set point pressure was reached, V4 was closed and 
impregnation started by activating the stirring. The experiments were carried out at constant T, P and 
stirring speed. At the end of the experiment, the reactor was depressurized at a controlled rate during 2 
and 3 hours when the operating pressures were 100 and 200 bar respectively. For this purpose, the valve 
V5 (needle valve) was gradually opened and the fluid pressure was slowly released. The depressurization 
step was performed at a controlled rate of 1.1 bar/min. At V5 level, where the major CO2 pressure drop 
occurs, higher rates caused pipe freezing and frequent occlusions due to fluid densification. The drug rich-
CO2 outlet stream was bubbled through ethanol (99.5 %) and ketoprofen concentration was measured with 
a UV spectrophotometer to cross check the drug mass balance of the operation.  
The main differences compared to the previously mentioned work of Manna et al. [17], is that the polymer 
inside the microcontainers was grade K17 (i.e. lower molecular weight) in our case, which might be 
dissolved or excessively swollen by CO2. No related data in the literature were found. Furthermore, polymer 
and drug might not be mixed because of the confinement in the microwells.  
It was expected that the impregnation of microcontainers was controlled by the dissolution of the drug in 
the fluid, and by its diffusion in the polymer matrix. After depressurization, the chip with impregnated 
containers was weighed and stored in a desiccator until further study. The morphology of the impregnated 
microcontainers was examined using SEM. The investigations were carried out using a Nova600 NanoSEM 
from FEI (Eindhoven, the Netherlands). 
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Imaging was performed in low-vacuum-mode at a pressure of 0.6 mbar and an operation voltage of 5 kV. 
Prior to examination, the samples were mounted onto metal stubs and were tilted by 30 degrees. 
 
 
Figure 4.7: Process flow diagram of the supercritical implant utilized in the experiments. V3 and V6 are purge valves, 
used to empty the pipes after the experiments. V1, V4 and V5 are needle valves, V2, V3, V6 are on/off valves. TC is a 
temperature controller, PI1-3 are pressure gauges, RPM a magnetic stirring system. 
 
4.2.5 Preparation of micro-tablets 
For comparison with impregnated samples, microcontainers were filled with PVP-ketoprofen physical 
mixtures, and the drug dissolution curves were measured. Physical mixtures were prepared by gently 
mixing the two powders with a mortar (1:9 drug: polymer weight ratio). The dispersions were compacted 
into empty microcontainers following a procedure developed by our collaborators at KU Pharma [18], 
resulting in an array of micro-tablets. The residual material in between adjacent containers was removed 
using pressurized air. The chips were weighed before and after the filling. Micro-tablets with amorphous 
drug were obtained by heating containers filled with the physical mixture at 120 °C for 3 minutes on a 
hotplate and quenching in liquid nitrogen for 1 minute. This sequence was repeated thrice. In the 
preparation of micro-tablets a relevant amount of chemicals was wasted and the procedure was quite 
laborious and time consuming.  
 
4.2.6 Spectroscopic characterization and X-ray diffraction  
Raman and ATR–IR spectroscopy measurements were performed on microcontainers and films to 
investigate the drug–polymer interactions after supercritical treatment. Raman spectra from the 
impregnated microcontainers 24 h after the CO2 treatment were collected with a DXR Raman microscope 
(Thermo Scientific, Germany) equipped with a frequency-stabilized single mode diode laser (780 nm). The 
laser power was set to 10 mW at the sample position (center of the container cavity) and the estimated 
resolution was 2.4–4.4 cm−1. An exposure time of 1 s and the average/integration of 40 scans were used. 
Because of the strong auto-fluorescence of SU-8, a dedicated correction was applied to the spectra during 
the collection. A Spectrum 100 spectrometer (Perkin Elmer, Germany) with an MIR source and a TGS 
detector was used to measure the ATR–IR spectra of the impregnated PVP films 24 h after preparation. The 
resolution was set to 4 cm−1 and 16 accumulations with a scan speed of 0.2 were collected.  The X-ray 
powder diffraction (XRPD) study was carried out to characterize the physical state of the drug in the 
impregnated microcontainers and micro-tablets. The basic principles of this technique were introduced in 
section 2.5.1. All XRPD analyses were performed using an X'Pert PRO X-ray diffractometer (PANalytical, λ = 
1.541 Å; 45 kV; 40 mA). A starting angle of 5° (2θ) and an end angle of 45° (2θ) were employed for the 
scans. A scan speed of 0.6565° 2θ/min and a step size of 0.01313° (2θ) were employed. Data were collected 
using the X'Pert Data Collector software (PANalytical B.V.). 
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4.2.7 In vitro drug dissolution studies 
Dissolution of PVP and ketoprofen from loaded microcontainers was measured in 10 mL DI sonicated water 
at 37 °C using a μDISS profiler (Pion) as described in section 2.4.2. Individual chips were glued with carbon 
pads on teflon-coated magnetic stirrers. For the detection of ketoprofen release, the UV probe wavelength 
was set at 259 nm. After dissolution, the microcontainers were analyzed with an optical microscope to 
confirm complete emptying. The amount of drug loaded per chip was estimated from the final 
concentration value in the dissolution profiles obtained after 16 h. Solubility of ketoprofen at 37 °C in 
aqueous solutions changes significantly with pH between 1 and 7 [6]. The dissolution tests were performed 
at pH 7 where ketoprofen solubility is >1.4 mg/mL. With ketoprofen being a weak acid (pKa = 4.5) the pH of 
the dissolution medium did not change sensitively during the dissolution tests. According to solubility data 
reported in [6], in can be assumed that dissolution tests were performed in sink conditions, meaning at 
conditions sufficiently far from saturation conditions where solubility is not limiting drug dissolution.  
4.3 Result and discussion 
4.3.1 Inkjet printing of PVP solutions into microcontainer 
The number of droplets to dispense in each container is estimated dividing the cavity volume by the droplet 
volume. Three subsequent printing sessions have been performed on the same array and a waiting time 
between the sessions has been included in order to enable solvent evaporation and to avoid spillover. After 
drying, the level of container filling has been measured with an optical profilometer. The measured average 
thickness is 141 ± 9 µm. The weight of polymer dispensed onto one chip (625 microcontainers) is 1.6 ± 0.04 
mg. The high accuracy of polymer deposition shows that inkjet printing can be used to dispense precise 
quantities of polymer with a quasi-no-waste performance. The precise control of the dispensed polymer 
mass is important to control the drug loaded in each microreservoir.  
 
4.3.2 Loading of ketoprofen into polymer-filled microreservoirs 
Figure 4.8 shows SEM images of microcontainers subjected to sc impregnation. The fluid pressure during 
the impregnation has a relevant influence on the volume of the polymer which increases with increasing 
CO2 pressure, as appears clearly by the comparison of figures 4.8a and 4.8b. This is likely explained by an 
increase of CO2 uptake in the PVP matrix with pressure, as shown by Kikic and Vecchione [19]. As scCO2 acts 
as a plasticizer for polymers, the viscosity of the CO2 saturated matrix decreases during the impregnation, 
causing in some cases spillages from the containers. This aspect is more pronounced for longer experiments 
(see figures 4.8c and 4.8d). Polymer softening and swelling play an essential role with respect to the desired 
quasi no-waste performance. For an optimal combination of inkjet printing and sc impregnation, the PVP 
must remain confined in the cylindrical cavity of the micro-well. During impregnations at 200 bar, several 
droplets were deposited in the space in between adjacent microcontainers (see figure 4.8d). This effect was 
observed when the depressurization rate at the CO2 critical pressure was higher than 1.1 bar/min. 
Compared to that, there was a negligible polymer spillage with a slower pressure decay. The holes in the 
de-swelling matrix, also shown in figure 4.8d, are probably due to the formation of micropores during CO2 
release. All the SEM images show no effect of the supercritical fluid on SU-8 at the micro-scale. 
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Figure 4.8: Scanning electron microscopy images of the polymer-filled 
microcontainers impregnated with ketoprofen using scCO2 at different conditions: 
(a) 100 bar 1 hour; (b) 200 bar 1 hour; (c) 100 bar 4 hours; (d) 200 bar 4 hours. 
 
 
 
Figure 4.9: Controlled release of the model drug from polymer-filled 
microcontainers loaded at different pressures and times as compared to empty 
microcontainers (control; without polymer). Release test on individual chips 
with 625 microcontainers in 10 mL DI water (N=3). 
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4.3.3 Controlled in vitro drug release from impregnated microdevices and Raman characterization 
To measure the ketoprofen release from the microcontainers, dissolution measurements were carried out 
with individual chips. Figure 4.9 shows the in vitro dissolution profiles of microcontainers loaded via scCO2 
impregnation at different conditions.  
As a control experiment, microcontainers without PVP were submitted to ketoprofen impregnation at 200 
bar 40 °C for 4 h. The different amounts of drug released show that both the sc fluid pressure and the 
impregnation time significantly influence the loading. As shown in the release profiles in figure 4.9, the drug 
uptake increases with an increase in the fluid pressure and with a larger duration of the impregnation. This 
suggests that the polymer swelling and the drug diffusion play a relevant role in the loading. In table 4.1 the 
weights of loaded drug per chip in terms of absolute value, drug/polymer weight ratio and weight fraction 
are shown. The effect of the pressure may be attributed to the fact that both the drug solubility and the 
CO2 uptake in the polymer increase with the sc fluid pressure. At 200 bar a higher number of drug 
molecules can interact with the polymer chains, and this results in an enhanced loading. The effect of time 
can be explained supposing that the impregnation follows a diffusion-limited mechanism. A previous work 
shows that SU-8 microstructures treated with scCO2 undergo only small mechanical changes [20], which is 
also confirmed by our SEM micrographs. Therefore it may reasonably be assumed that SU-8 containers 
undergo a negligible swelling by the CO2 if compared with the one of PVP. As a consequence, we assume 
that container walls provide a spatial shielding to the loading and that the drug is mainly conveyed across 
the interface PVP/sc fluid.  
Finally, the combination of these two effects can give an explanation of the different loading gains for 
impregnation time which can be obtained at the two considered pressures. At 100 bar the CO2 moderately 
swells the polymer chains, the drug diffuses with difficulty and the gain over time is poor. At 200 bar the 
CO2 uptake is higher and swollen polymer offers a larger interfacial area and a reduced resistance to drug 
diffusion, resulting in an enhanced loading gain from 1 to 4 hours. As shown in table 4.1, at the hardest 
conditions of 200 bar and 4 hours the drug deposited in the microcontainers without PVP is less than 8% of 
the drug loaded into polymer filled containers at the same conditions. The control experiment shows that a 
negligible amount of drug is observed in the SU-8 container and that the preliminary deposition of the PVP 
is required to achieve drug loading. From a technological perspective, the possibility of tuning the drug 
loading with a change in fluid pressure and time of impregnation represents a relevant advantage. The 
times of 90% of drug dissolution (t90%) are also shown in table 4.1. The samples impregnated at 100 bar 
show similar t90% around 270 minutes, while the samples at 200 bar exhibit a markedly faster drug 
dissolution:  For containers impregnated for 1 hour t90% is equal to 60 minutes, for those impregnated for 4 
hours t90% is approximately 180 minutes. All dissolution profiles show a burst effect, which might be 
explained by the presence of a fast dissolving drug coating on the microcontainer surface after the 
treatment with the carbon dioxide. To clarify this aspect, a Raman mapping of containers was carried out 
just after the experiments. The Raman spectra are shown in figure 4.10: Pattern (a) and (b) are the spectral 
fingerprints of crystalline pure ketoprofen and PVP respectively. The vibrational patterns of all impregnated 
samples exhibit characteristic peaks of the drug where PVP does not show any signal. In particular the band 
at 1657 cm-1, attributed to the stretching vibration of the ketoprofen carbonyl  ν(C=O) and the band at 
1198 cm-1, regarding the ring CH in plane bending, seem to have an intensity which is proportional to the 
impregnation pressure and in particular for 200 bar increases with time. This fact seems to confirm the 
results of the dissolution tests. In [21] De Carvalho et al. attribute these two peaks to the amorphization of 
the drug in the presence of the excipient.  
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Figure 4.10: Raman spectra for (a) solid ketoprofen, (b) 
PVP and (c) polymer filled microcontainers impregnated 
at 100 bar 1 h, (d) 100 bar 4 h, (e) 200 bar 1 h, (f) 200 
bar 4 h. 
Figure 4.11: X-ray diffraction patterns of (a) empty 
microcontainers, containers filled with (b) crystalline 
ketoprofen, (c) 1:9 (wt) keto:PVP physical mixture with 
crystalline drug (crystalline micro-tablets), (d) 1:9 (wt) 
keto:PVP physical mixture with amorphous drug 
(amorphous micro-tablets). 
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Table 4.1: Drug loading of impregnated samples and of physical mix-laden micro-tablets. The drug weight 
refers to total loaded mass on individual chips with 625 microcontainers and is normalized with respect to the 
polymer mass in the micro-wells (N=3). 
Samples 
Loaded drug 
per chip (mg) 
Resulted 
drug/polymer 
weight ratio 
Drug weight fraction 
after dissolution  
keto / (PVP+keto) 
Time at 90% 
dissolution 
t90% (hours) 
100 bar 40°C 1 hour 0.33±0.03 0.22±0.04 0.16±0.03 4.46 
100 bar 40°C 4 hour 0.41±0.02 0.28±0.02 0.22±0.02 4.63 
200 bar 40°C 1 hour 0.61±0.05 0.37±0.05 0.27±0.03 1.0 
200 bar 40°C 4 hour 0.82±0.02 0.52±0.03 0.32±0.01 3.3 
Empty containers (200 
bar 40°C 4 hour)  
0.07±0.02 - - 6.0 
Physical mix laden 
micro-tablets (1:9 
keto:PVP, 10%wt) 
0.22±0.06 0.18±0.10 0.15±0.07 6.32 
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Figure 4.12: The enhanced dissolution kinetics of the model drug from impregnated microdevices (a) 100 bar 1 hr and 
(b) 200 bar 1 h as compared to drug-polymer physical mixtures laden micro-tablets with similar loaded drug masses. 
The concentration was normalized with respect to the total drug loaded in each chip (625 microcontainers) released 
in 10 mL DI water (N= 3). 
 
4.3.4 Comparison with physical mixtures and XRPD characterization 
After preparation, the samples called micro-tablets (see section 4.2.5) were examined with X-ray diffraction 
to check out the solid state of the drug. 
The diffractograms of crystalline and amorphous micro-tablets, are shown in figure 4.11. The silicon chip 
with empty containers (Figure 4.11a) exhibits a broad scattered band meaning that the SU-8 is an 
amorphous material with one single peak at 2θ= 33.3° belonging to the Silicon substrate. The chip filled 
with pure fresh crystalline ketoprofen (Figure 4.11b) shows defined peaks emerging from the scattered 
background signal of the containers. The containers filled with a physical mixture containing crystalline 
drug show a diffractogram with some peaks of the drug (Figure 4.11c) but with a lower intensity than for 
the pure crystalline ketoprofen. The samples submitted to melt and quench cooling (d) do not show 
distinguishable peaks of ketoprofen. The drug content and the drug/polymer weight ratios in these samples 
were cross-checked by dissolution tests afterwards. XRPD measurements were also performed on all 
impregnated microcontainers and all the samples showed scattered patterns. In table 4.1 the drug loading 
data in terms of drug/polymer weight ratio are shown. In micro-tablets the average relative drug content 
(15% wt) differs from the original physical mixture (1:9, i.e. 10% wt) which demonstrates that the drug and 
the polymer are demixed during the preparation. The large variation of 50% associated to the data shows 
that the micro-tablets filling method has a lower accuracy than the sc impregnation where variations are 
below 18%. Figure 4.12 shows the in vitro cumulative drug release from impregnated microcontainers and 
the crystalline and amorphous micro-tablets with a similar drug content. Due to the high standard deviation 
of micro-tablets (see in table 4.1), additional experiments were done and only those with the drug/polymer 
weight ratio numerically close to the one for impregnated containers were considered for the comparison. 
The dissolution curve of microcontainers treated at 100 bar (figure 4.12a) overlaps the amorphous micro-
tablets profile. Samples loaded at 200 bar (figure 4.12b) show instead a slightly faster dissolution than both 
amorphous and crystalline micro-tablets.  
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The similarity factor f2 of the cumulative dissolution profiles of impregnated microcontainers and micro-
tablets was estimated. The results of the comparison are shown in the table 4.2. In all the comparisons the 
similarity factor is greater than 50 and the profiles is considered similar according to the FDA regulations. Di 
Martino and coworkers [22] showed that already in physical mixtures of crystalline ketoprofen and PVP K30 
(1:1 wt), the drug undergoes a significant decrease of crystallinity just after preparation. That can explain 
why in general the profiles of amorphous and crystalline drug are quite similar. Nonetheless, impregnated 
containers show at both pressures faster dissolution compared to the corresponding crystalline and 
amorphous mixture laden containers. In the system loaded at 200 bar this enhancement is more 
pronounced and 87% of the drug is dissolved in the medium after only 30 minutes.  
 
Table 4.2: Similarity factors f2 of cumulative dissolution profiles shown in figure 
4.12 of impregnated microcontainers and corresponding micro-tablets. 
Impregnation 
conditions 
 
Similarity factor f2 
Crystalline micro-
tablets 
Amorphous micro-
tablets 
100 bar 40˚C 1 hour 50.8 51 
200 bar 40˚C 1 hour 50.7 50.8 
 
 
A possible mathematical model for the dissolution kinetics of these systems would have to consider the 
Fick´s law, the drug-polymer interactions and the particular geometry of the microdevice. For what 
concerns the material aspects, for a similar impregnated system of PVP K30 and ketoprofen, Manna and 
coworkers [17] observed a behaviour based on two dissolution mechanisms: At low drug concentration the 
release rate is fast and is governed by the PVP dissolution, at higher concentrations a stagnant drug-rich 
layer is formed, and the drug dissolution rate is mainly constant. From a qualitative perspective this trend 
was also noticed in our experiments. The fast drug dissolution observed for the sample loaded at 200 bar 
might be explained by the presence of intimate interaction between drug and polymer in the scCO2 aided-
loading and the dissolution rate seems to be controlled by the polymer dissolution. 
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4.3.5 Spectroscopic characterization of impregnated PVP films  
The impregnated PVP films were studied via ATR-IR spectroscopy in order to investigate the physical state 
of the drug in the formulation and eventual presence of interactions with the polymer. The spectra are 
reported in the ν (C=O) stretching regions in figure 4.13. Pure crystalline ketoprofen (figure 4.13a) is 
characterized by two well defined peaks at 1697 cm-1 and 1655 cm-1, which represent the stretching 
vibration of the carbonyl group in the carboxylic and in the ketonic groups respectively. The former peak 
indicates the presence of a dimer of ketoprofen molecules as reported in [17]. In the impregnated films 
(figure 4.13c and d) this peak is shifted to a higher wavenumber (1723 cm-1) which indicates, as suggested 
in [17], the breakage of ketoprofen-ketoprofen interactions. The intensity of this shifted peak is stronger 
for the 200 bar impregnated films (see figure 4.13d). This observation indicates that ketoprofen is 
molecularly dispersed in the polymer. 
A closer analysis of the PVP ν(C=O) region shows that in the impregnated films the ν(C=O) band of PVP at 
1625 cm-1 is shifted to lower wavenumbers compared to the ν(C=O) band of pure PVP (1652 cm-1) (figure 
4.13b). This fact is again more evident in the impregnation at 200 bar. This shift might be assigned to the 
formation of H-bonds between the carbonyl group of PVP and the hydroxilic group of ketoprofen as 
suggested for the supercritical impregnation of PVP films with ibuprofen in [23]. On the other hand, the 
peak of virgin PVP is still strong in the films, which suggests that a considerable portion of the C=O bonds in 
the polymer does not interact with the drug. 
 
 
Figure 4.13: ATR-IR spectra in the ν(C=O) spectral region: 
(a) pure solid ketoprofen, (b) pure PVP film, (c) 
impregnated PVP film at 100 bar for 1 hour, (d) 
impregnated PVP film at 200 bar for 1 hour. 
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4.3.6 Effect of temperature on impregnation yield 
An important parameter influencing supercritical impregnation is temperature. At constant pressure, an 
increase in T produces a decrease of density in the supercritical fluid. As discussed in section 2.3.2, the 
effect of T on the solvent power depends on the pressure value: Solubility of a drug in scCO2 increases with 
T if the increase of solute volatility prevails over the decrease of the density of the sc phase. As shown by 
the solubility profiles in figure 4.4, this occurs for pressures above the upper crossover value of 170 bar in 
the case of ketoprofen. In the attempt of investigating the effect of temperature on the loading of 
microcontainers, further tests were conducted at different T (40, 50 and 60°C) and times (1 and 4 hours), at 
a fixed pressure of 200 bar and dissolving a drug amount corresponding to the saturation conditions at 
40°C. In these tests, the only effect of T was investigated. These experiments were carried out in 
collaboration with the Department of Industrial Engineering at the University of Trieste in the MSc-project 
of Laura Pontoni. Microcontainers were filled with PVP powder following a procedure previously used in 
the preparation of micro-tablets (see section 4.2.5): The polymer powder was compacted in the microwells 
and the residual amount was blown away with a pressured air gun. The chip was weighed before and after 
the filling and the PVP weight was in average 1.78 mg per chip with 625 microcontainers. The filling was 
homogeneous and with minimal residues in between microwells, as representatively illustrated in figures 
4.14a and b. A fixed weighed amount of drug (14.1 mg) and the chip were placed in two separate 
compartments of a sample carrier in the bottom of a 100 mL high pressure unit. The impregnation 
experiment was performed with the same procedure as described in section 4.2.4. After the CO2 treatment 
the chips were left in a desiccator until submission to dissolution in 10 mL DI water at 37°C and a stirring 
rate of 100 rpm. Dissolution was monitored for approximately 17 hours and at the end all the 
concentration profiles were approaching a stable concentration. An observation at microscope confirmed 
that the material in the wells was completely dissolved. The drug loading was calculated by the 
concentration values at the end of the dissolution. The results of the impregnation are shown in figure 4.15. 
The drug loading is strongly influenced by T: After 1 hour, the drug loading increases from 0.55 mg to 0.75 
mg passing form 40°C to 60°C, which corresponds to an increase by 39%. For longer impregnations of 4 
hours, the gain is even more remarkable from 0.62 mg to 1.05 mg, corresponding to a 68% increase. This 
might be explained by the following considerations: At higher temperatures the density of CO2 decreases, 
that is there is a lower mass of fluid per unit volume. The amount of drug dissolved was set constant for all 
the experiments. Therefore, the mass fraction of the drug in the supercritical solution is higher at higher T. 
In figure 4.16, the drug loading is represented as a function of CO2 density (density data extracted from 
[24]). Moreover, the solution diffusivity also increases with T and, despite a weaker tendency for the drug 
to leave the supercritical phase due to a higher solubility, the final combination of these competing factors 
results in a higher drug loading. The higher increase in drug concentration for 4 h experiments compared to 
1 h also supports the hypothesis that the increased loading at 60°C is related to a higher diffusivity which 
has a time-dependent effect. 
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Figure 4.14: Containers filled with PVP powder by manual compaction: (a) detail of the chip corner, (b) arrays in the 
middle of the chip. 
 
  
Figure 4.15: Impregnated drug per chip (625 microwells) 
at 200 bar for different T and times.(N=3). 
Figure 4.16: Loaded drug as a function  of CO2 density ( in 
different impregnation conditions (N=3). 
0
0.2
0.4
0.6
0.8
1
1.2
40°C 200 bar 50°C 200bar 60°C 200 bar
Lo
ad
ed
 d
ru
g 
(m
g)
1 h 4 h
0.4
0.6
0.8
1
1.2
0.70 0.75 0.80 0.85
Lo
ad
ed
 d
ru
g 
(m
g)
CO2 density (g/mL)
1h
4h
Supercritical impregnation 
86 
 
4.4 Conclusions 
This chapter describes a technological solution for the drug loading of reservoir-based microdevice with a 
poorly soluble model drug. The microcontainers were filled with precisely controlled amounts of aqueous 
PVP solutions by means of inkjet printing. The sc CO2 impregnation was shown to be a compatible loading 
method which allows to tune the drug loading by varying fluid pressure, temperature and impregnation 
time. At 200 bar 40°C 4 hours a ketoprofen concentration of 32 % wt was obtained, corresponding to a 
drug:polymer ratio of 1:2. Further experiments showed that temperature has also a significant effect on 
drug loading: a change in temperature of 20°C corresponded to an increase of drug content of 39% in 1 h 
and 68% in 4 h. Spectroscopic characterizations like Raman and ATR-IR were performed. Raman 
spectroscopy shows that there is amorphous drug-rich phase on the containers surface and a chemical 
interaction between the components. ATR-IR spectroscopy of PVP films confirms these evidences, showing 
also the presence of H bonds in samples treated at 200 bar. Impregnated containers exhibit an enhanced 
dissolution rate compared to reservoirs laden with solid dispersions of crystalline and amorphous drug. Up 
to 87% of the drug can be released within 30 minutes demonstrating that microcontainers can deliver the 
active ingredient in compatibility with average tablets transit time in the GI tract. The combination of inkjet 
printing and scCO2 impregnation allows microcontainers to be filled with precise doses of drug. The 
combination of these two technologies enables to load CO2-soluble hydrophobic drugs without the use of 
organic solvents and with a minimum waste of chemicals in a potentially up scalable process. The use of 
inkjet printing and sc impregnation shows significant improvements and promising perspective in the 
framework of the microfabricated devices for oral therapeutics. 
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5. Photocrosslinking of PVP hydrogels 
5.1 Hydrogels in drug delivery 
5.1.1 Introduction  
Hydrogels are hydrophilic three dimensional polymer networks, where molecular chains are entangled or 
connected along limited lengths or at punctual sites (crosslinks) of the polymer backbone by physical 
junctions or chemical bonds. Hydrogels can absorb and retain large amounts of aqueous media, swelling to 
up to dozens of times their dry volume. The high water content, together with a low cytotoxicity and 
biocompatible features place them among the most suitable materials to resemble natural living tissues [1, 
2], as well as to serve as binders for several biomedical and pharmaceutical purposes [3, 4]. Polymeric 
hydrogels are a very important class of materials, which in recent years has attracted an increasing interest 
for a large number of applications in the biomedical and pharmaceutical research areas including 
transdermal drug delivery and wound dressing [5, 6], drug delivery systems [7-9], injectable formulations 
[10, 11], dental medications [12, 13], implants [14, 15], and ophthalmic systems [16, 17]. 
Since the discovery of crosslinked poly(2-hydroxyethyl methacrylate) (pHEMA) [18] by Wichterle and Lim in 
1960, the synthesis and applications of hydrogels have been widely investigated.  
Hydrogels can be prepared by crosslinking of both natural and fully synthetic hydrophilic polymers. The 
crosslinking reaction converts the solution, where polymer chains are free to diffuse in the solvent, in a 
semi-ordered three dimensional network, where the chains are connected to each other. From a 
rheological viewpoint, the transition from solution to gel (also called sol-gel) in most cases corresponds to a 
change from a purely viscous to a viscoelastic behaviour. Additionally, dramatic loss of solubility in water 
occurs.  
A great variety of methods have been developed for hydrogel preparation. Hydrogels can be divided into 
the two main groups of physical and chemical hydrogels according to the nature of the crosslinks [19]. In 
the first group we find examples of crosslinking by ionic interactions (like alginate [20], whose application 
was discussed also in this thesis in section 3.5), by polymer freeze-thawing (like PVA [21]), by hydrogen 
bonding (like complexes of poly(acrylic acid) (PAA), poly(methacrylic acid) and poly(ethylene glycol) (PEG) 
[22]) or, in more recent discoveries, by protein interactions. Examples for the latter are genetically 
engineered proteins, which by coil-coil interactions serve as crosslinkers for synthetic polymers [23] and 
crosslinks by antigen-antiboby interactions, like in the case of an antigen-selective hydrogel for binding with 
antibodies [24]. Among the chemically crosslinked hydrogels, the main classification criterion is the 
chemical mechanism: There are hydrogels prepared by radical polymerization of low molecular weight 
monomers (like for instance the above cited pioneering work of Wichterle and Lim [18]), reaction of 
complementary groups (like NHx- COOH) [25, 26], addition and condensation reactions [27], or enzymatic 
reactions (like for PEG functionalized with glutaminyl groups) [28]. Finally, also the exposure to high energy 
irradiation (gamma ray and electron beam) and UV light can induce crosslinking. This technique was 
investigated for polymers like poly(vinyl alcohol) (PVA) [29], PEG [30] and PAA [31]. The use of gamma 
radiation has been explored for PEG, PVP and agar based hydrogels [32] and for polymers such as 
biodegradable PCL [33] and polyurethanes (PCL-PEO)[34].  
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The crosslinking and polymerization upon exposure to UV radiation was investigated for several 
compounds of biomedical interest and in particular for oral drug delivery. Casadei et al. prepared 
photocrosslinked dextran methacrylate (DM) [35] and loaded it with lipid nanosuspension of ibuprofen 
resulting in a delayed release of the drug. In the same group, Pitarresi and coworkers [36] crosslinked 
modified DM by UV exposure in the presence of a polyaminoacid derivative, such as α,β-poly(N-2-
hydroxyethyl)-DL-aspartamide methacrylate (PHM). The resulting hydrogel was specifically modified to 
survive degradation in the GI tract and reach the colon, where a medicine against inflammatory bowel 
diseases was delivered while the hydrogel was degraded by dextranase enzymes. A similar modification 
was previously performed for the natural polysaccharide inulin (INU) derivatized with methacrylic 
anhydride (MA) and succinic anhydride (SA) [37] which conferred a stronger resistance to gastric hydrolysis.  
In case of hydrogels, the UV radiation induces crosslinking by radical polymerization [38]. Generally, the 
reaction is activated by a photoinitiator. Photoinitiators can be grouped into two main types [39]. 
Type I initiators are splitted into free radicals when exposed to UV light. These radicals attack the polymer 
backbone generating macroradicals [29], which themselves react with other chains. This reaction 
propagates, resulting in the formation of a polymer network. Examples of this type of photoinitiator are 
acetophenone derivatives and α-hydroxyalkyl phenones. Type II photoinitiators react with a compounds 
called co-initiator (generally a tertiary amine) prior to creating active radicals. The process continues with 
an electron and a hydrogen transfer resulting in the radical formation.  
The chemical reactivity of the photoinitiator determines the reaction rate, the spectral sensitivity 
(wavelength of absorption), the light resistance and the stability of the materials under storage conditions 
[39]. Sometimes macroradicals can also be activated by homolytic scission of C–H bonds in the polymer 
backbone. In that case, the presence of a photoinitiator is not needed. Since the generated macroradicals 
can react with oxygen, radiation is normally performed in an inert atmosphere saturated by nitrogen or 
argon. Biocompatibility of photoinitiators used for crosslinking of biomaterials is a critical issue as many of 
them in fact are cytotoxic [40].  
From a microfabrication perspective, UV photocrosslinkable hydrogels represent an extremely interesting 
class of materials for the design of drug delivery microdevices. These materials allow to use of 
photolithography for patterning, which is a key technique in the field of micro- and nanofabrication. This 
fact entails the possibility of using radiation to create a hydrogel-laden microdevice.  
 
5.1.2 UV Photocrosslinking of PVP hydrogels  
Photocrosslinking of poly(vinylpyrrolidone) (PVP) was investigated by several researchers. Rosiak and 
coworkers [41, 42] developed a successful methodology for the preparation of PVP hydrogel wound 
dressings based on the use of high energy irradiation (electron beam or gamma radiation). However, the 
use of energetic radiation usually entails the availability of expensive equipment. More important, the 
exposure to high energy radiation produced a non negligible degradation of the polymer chains which often 
turned out to be more prominent than the crosslinking reaction. More recently, the use of ultraviolet 
radiation (UV) was proposed by Lopérlogo et al. [43] for the crosslinking of aqueous solutions of PVP as an 
alternative to high energy radiation. In that study, no photoinitiator was used and the first radicals were 
generated by radiolysis of water molecules. A good degree of crosslinking was only achieved by long 
exposures, i.e. high radiation doses, which again entailed a consistent photodegradation of the polymer 
and a consequent low reticulation yield. As a solution to this drawback, the addition of hydrogen peroxide 
(H2O2) as photoinitiator was suggested [44]. In that case, the gelification yields were sensitively increased 
and a gel fraction of 90% could be obtained for reduced UV doses compared to without H2O2 as initiator. 
The chemical mechanism of PVP photocrosslinking reaction was also elucidated through spectroscopic 
techniques [45]. H2O2 is a type I photoinitiators, being splitted into radical which attack the polymer 
backbone. The structural and mechanical properties of crosslinked hydrogels were recently studied by 
D´Errico and coworkers [46].  
  
Photocrosslinking of PVP hydrogel 
91 
 
5.1.3 Hydrogel matrices in microcontainers  
In section 3.5.1, first attempts to immobilize polymer matrices inside microcontainerswere tried with 
alginate as polymer. Here, selective UV crosslinking of PVP was considered an interesting technique to 
define polymer matrices inside microcontainers as alternative to inkjet printing presented in section 3.6.2. 
A schematic of this approach is depicted in figure 5.1. 
 
 
Figure 5.1: Schematic of selective crosslinking of a polymer film (negative photolithography): (a) spin coating of 
polymer solution on microcontainers, (b) selective exposure of polymer film through a photolithographic mask, (c) 
development in solvent. 
 
PVP is used as a photoresist in a process of negative photolithography similar to the fabrication of 
microcontainers with SU-8 (see section 2.1.1). A PVP solution is spin coated onto the empty 
microstructures (Figure 5.1a). Then a mask is aligned on top of the microcontainers and only the cavities 
are exposed to UV light and crosslinked (Figure 5.1b). Finally, the uncrosslinked portions of the polymer 
are dissolved and removed in a solvent (Figure 5.1c). Subsequently, the defined polymer micro volumes 
could be loaded with the desired drug. The choice of PVP represents a valuable advantage, since it can 
be successfully loaded with hydrophobic drugs by supercritical impregnation, as described in chapter 4. 
Alternatively, the swelling properties of PVP hydrogels could also be exploited to load bioactive 
macromolecules of pharmaceutical interest. 
 
5.1.4 Microgels 
Previous attempts of loading SU-8 microcontainers with polymer solutions resulted in an uneven cavity 
filling because of air bubbles (as sketched in figure 3.12 in section 3.5.1). The definition of patterns by UV 
photolithography, permits to conceive a new fabrication concept of microcapsules for oral delivery that 
we will call microgels. In the microgel fabrication process the first step consists of the definition of a drug 
loaded matrix. As a second step, the container shell is deposited on top. This approach is represented in 
the schematic of figure 5.2: (a) a film is spin coated on a substrate and the pattern is defined by exposure 
to UV light without need of alignment, (b) the film is developed, and (c) the deposition of a shell is 
performed by spray coating through an aligned shadow mask. The focus of this thesis was to elucidate 
the properties of drug-loadable microfabricated structures. Therefore, the deposition of the shell by 
spray coating was not investigated and should be part of eventual future development of this concept.  
 
 
a b c
UV
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5.2 Fabrication of PVP microgels 
5.2.1 Overview of the process 
As discussed in the previous section, photocrosslinking of bulk PVP hydrogels has been demonstrated. 
However, the use of radiation to transfer patterns on PVP films was barely investigated. Burkert et al. [47] 
used electron-beam lithography to define structures in films of solutions of PVP in ethane, while no work 
was found regarding the definition of patterns in films of aqueous solutions. A first step consisted in the 
fabrication of masks used for the selective exposure to UV light. The fabrication process was previously 
explained in section 2.1.3. The masks consisted of glass wafers with a patterned metal coating (chromium 
or aluminum) on one side, representing the negative image of the pattern which is supposed to be 
transferred to the PVP film. The masks were fabricated with the same pattern design as the SU-8 
microcontainer bottom, with circles of different diameters and center-to-center distances. The typical mask 
had arrays of transparent spots ranging from 100-500 µm in diameter with a centre-to-centre pitch of 450-
600 µm. The glass masks were diced into squares (called mask chips) containing 625 spots aligned in a 
25×25 matrix as previously shown in figure 2.4. For the study of the swelling properties of individual 
microgels (see section 5.3), additional mask chips were fabricated with a design including only 4 
transparent spots of variable diameter of 100-500 µm and a centre-to centre pitch of 5 mm.  
In an optimal pattern transfer, the crosslinking should be confined to the exposed areas. Furthermore, the 
reaction should propagate anisotropically through the whole thickness of the irradiated film. The most 
important parameter is the gap between the mask and the layer where the pattern is replicated. In general, 
if the gap is too wide, the irradiated areas are larger than the actual mask pattern, i.e. there is a loss of 
resolution in the pattern dimensions. This phenomenon is due to light diffraction effects, and is more 
pronounced if the radiation is not collimated as in the case of this study. Therefore, the polymer was spin 
coated directly onto the glass mask and the exposure to UV light was performed from the mask back side. 
In this way, the film was physically in contact with the mask and the gap between mask and polymer layer 
was reduced to zero. Moreover, to reduce light diffraction within the glass, the polymer was deposited on 
the metal coated-side of the mask, while the glass side faced the UV light.  
In figure 5.3, the fabrication process of PVP microgels through backside exposure is schematized. A solution 
of PLLA is spin coated (Figure 5.3a). A layer of PVP solution is spin coated on PLLA (Figure 5.3b). The mask is 
flipped and exposed to UV light form the back side (Figure 5.3c). Finally, the chip is immersed in a solvent to 
dissolve the uncrosslinked polymer and the PVP microgels are developed (Figure 5.3d). The PLLA film serves 
as substrate layer for the microgels. PLLA is biodegradable and can be peeled off the mask chip after PVP 
development. Eventually, it could be rolled and put in a capsule ready for oral ingestion. Also, the 
hydrophobicity of PLLA facilitated the removal of uncrosslinked material. In the following sections the 
single operation steps schematized in figure 5.3 will be described in detail.  
 
 
Figure 5.2: Schematic of microgel fabrication process: (a) spin coating of polymer film on a substrate and selective 
UV irradiation, (b) development of uncrosslinked portions, (c) deposition of a protective shell by spray coating 
through a shadow mask. 
a
UV
b c
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Figure 5.3: Fabrication steps of PVP microgels: (a) spin coating of PLLA substrate layer, (b) spin coating of PVP layer, 
(c) mask flipping and UV exposure form the back side, (d) development in water. 
CromiumGlass
(a)
MASK
PLA
(d)
UV
(c)
MASK
PVP
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5.2.2 Materials and methods  
Poly(L-lactic-acid) (PLLA) was purchased from Natureworks (Mw=126000 Da, determined by size exclusion 
chromatography measurements). Poly(vinylpyrrolidone) (PVP K90, Mw=360000 Da), hydrogen peroxide 
(H2O2) aqueous solution (30% wt) and dichloromethane (DCM) (anhydrous >99.8%) were supplied by Sigma 
Aldrich. PLLA pellets were dissolved in DCM (20% wt) under stirring at room temperature for 24 h. PVP 
solutions were prepared dissolving powder in mixtures of DI water (99.1% v/v) and H2O2 solution (0.9% 
v/v), with polymer concentration of 10, 20 and 30% wt under stirring (250 rpm) at 50°C for 36 h. PVP has a 
very high solubility in water [48]. Even at the highest concentration, PVP was perfectly dissolved, resulting 
in very viscous and transparent solutions. The polymer solutions were poured into syringes and stored 
overnight in vertical position for air bubbles removal. PLLA solution was kept in a fridge at 4°C. Spin coating 
steps were performed on single mask chips mounted on a custom made Teflon chip holder (WS-650Mz-
23NPP Spin processor, Laurell, USA). The use of the holder was beneficial for uniform PVP deposition 
reducing film thickening at the edges (edge bead) due to surface tension effects. After spin coating, the 
mask chips were flipped over and mounted into squared slots milled in a Teflon rod, which was then 
transferred into the UV chamber. The slots had dimensions perfectly fitting the mask chips and included 
small pools previously filled with water-imbibed cotton which kept the film humid during irradiation. 
Irradiation was carried out in a UV chamber (BS-02, Dr. Gröbel UV Elektronik, Germany) equipped with 8 
tubes: 4 lamps emitting in the UVC range (emission spectrum with a single peak at 253.4 nm) and 4 lamps 
emitting UVB range (broad band in the region 265-400 nm). The samples were placed at a distance of 15 
cm from the light source, where the total radiant flux was measured with a radiometer ranging from 29-32 
mW/cm2. After exposure, the mask chips were immersed in DI water, rinsed with moderate stirring for 10 
minutes and left drying overnight at room temperature. The thickness of dry films and microgels was 
measured with a contact profiler (KLA Tencor Alpha-Step IQ, stylus force 8.33 mg) with a scanning length of 
4-6 mm, a scan speed of 100 µm/s and a data acquisition frequency of 50 Hz.  
 
5.2.3 Spin coating  
The spin coating of the PLLA was performed dispensing 0.5 mL of solution and spinning at 2400 rpm for 30 
sec with an acceleration of 200 rpm/s. The layer was left drying for 3 min at room temperature. The PLLA 
film was transparent and absorbed a limited amount of UV radiation (lower than UV sensor resolution, 0.1 
mW/cm2). The spin coating of PVP was studied in more detail. An important aspect in the spin coating of 
films is the viscosity of the polymer solution. In figure 5.4 the viscosity of PVP solutions with different solid 
polymer concentrations are shown as a function of applied stress.  
 
  
Figure 5.4: Viscosity curves of aqueous solutions of PVP 
K90 at different concentrations. 
Figure 5.5: Thickness of dried uncrosslinked? PVP films 
prepared at different spinning rates with 30% wt 
solution (N=4). 
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The solutions exhibit a Newtonian behaviour with a weak shear thinning tendency within the range of 20-
80 Pa. The viscosity plateau values increase by approximately one order of magnitude with an increase of 
the concentration by 10%. 
Preliminary tests on spin coating of PVP solutions revealed that only the concentration of 30% PVP was 
giving uniform films, while more diluted solutions coated the chips only partially even at low spin rates. 
Therefore, it was decided to proceed only with 30% PVP solutions. Moreover the photoreticulation of 30% 
solutions gives a maximum gelification yield according to a previous work [46].  
Fixed amounts of polymer solution (approx. 34 mg) were dispensed on mask chips with one of corners 
covered by tape. The chip was spinned for 60 sec with a ramp of 100 rpm/s at various spin speeds ranging 
from 1000-2500 rpm. The obtained films were left drying at room temperature overnight. For thickness 
measurements, a scratch was made with a scalpel in the film next to the corner covered by tape before the 
spin coating. By removing the tape with the layer on, a step was obtained in the film along the scratch. A 
stylus profile was recorded across the step. The results of the scanning are shown in figure 5.5. Each data 
point corresponds to 4 samples. As expected, the film thickness becomes lower for increasing spinning 
speed. For the fabrication of microgels, the procedure with a spin speed of 2500 rpm was preferred 
because it resulted in a more homogeneous film.  
The thickness of the polymer film in the wet state (i.e. just after spin coating, before drying) could not be 
directly measured because of the softness of the material. However, an estimation can be made by 
knowing the polymer concentration and the weight of the films. For the spin coating at 2500 rpm, the mass 
of the polymer film on the chips was 16.5±0.7 mg. For a solution 30% wt having a density of 1.08 g/mL 
(value extrapolated from [48]), the film thickness after spin coating z is calculated as follows: 
 z = �ilm mass 
solution density ∙ chip surface area = 16.5(mg)1.08 � mg
mm3
� ∙ 163.84(mm2) ≅ 94 µm (5.1) 
 
5.2.4 UV exposure of PVP films 
After the spin coating, PVP films were exposed to UV light for different irradiation times: 5.5, 11, 22, 33, 44 
min. In table 5.1, the energy received by an individual microgel volume is reported as a function of 
dimension and irradiation time assuming a mean exposure density of 29 mW/cm2 (UVB+UVC radiation). 
After irradiation, samples were washed in DI water for 5 min under moderate stirring (100 rpm, higher 
rates caused delamination). The developed microgels were then left drying at room temperature in a 
desiccator overnight. Figures 5.6 and 5.7 show images of microgels after development and drying.  
Thereafter, size and shape of dried microgels were analyzed by means of the contact profilometer with the 
same recipe as the one used for films. The profiles of microgels with different diameters and irradiation 
times are shown in figure 5.8. Each profile is the average of 15 measurements. For all the gel sizes, the 
thickness is proportional to the exposure time. Moreover, the height of gels irradiated for 22 min (32.1 µm) 
was similar to the film thickness after spin coating (32.4 µm), and exposures longer than 22 min resulted in 
microgels with the same height. Therefore it was concluded that there is a radiation dose, above which the 
whole thickness of the exposed polymer layer is crosslinked. The volume of the microgels can easily be 
modulated according to the design specifications of the drug delivery system.  
 
Table 5.1: Irradiation energies for each exposed microgel. 
Microgel 
diameter 
Exposed area  
(10-3 µm2) 
Irradiation power  
(µW) 
Irradiation energy at different exposure times (mJ) 
22 min 33 min 44 min 
100 µm 7.85 20.5 3 4.5 6 
200 µm 31.41 9.1 12 18 24 
300 µm 70.68 2.3 27 40.5 54 
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Figure 5.6: Arrays of PVP microgels (300 µm in diameter) 
on PLLA film. 
Figure 5.7: Film of PLLA with arrays of PVP microgels 
after being peeled off the mask chip. 
 
 
Figure 5.8: Microgel Profiles of microgels with different nominal diameters (300, 200, 100 µm), UV irradiated for 5.5 
min (dotted line), 11 min (dashed line), 22 min (solid line). The axes have different scales. 
 
If we approximate the microgels as spherical caps, we can calculate their volume with the following 
equation: 
 V = πh6 (3a2 + h2)  (5.2) 
 
Where a is the radius of the base of the cap (microgel base), and h is the height of the cap (central height). 
According to equation (5.2), the volumes of microgels fabricated with different irradiation times can be 
computed from the values of a and h measured by contact profiling. The results are listed in table 5.2. 
 
Table 5.2: Estimated microgel volume for different sizes and irradiation times. 
Microgel 
diameter 
(µm) 
Cap radius 
(a) (µm) 
Cap height (h) (µm) Volumes of microgels (nL) 
Irradiation time (min) Irradiation time (min) 
5.5 11 22 5.5 11 22 
100 µm 50 14.59 22.29 32.08 0.06 0.09 0.14 
200 µm 100 10.52 21.62 30.45 0.27 0.34 0.49 
300 µm 150 12.98 23.68 32.04 0.46 0.84 1.15 
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5.3 Loading of microgels 
The loading of hydrogels was performed after the crosslinking step, in order to avoid the well known 
photolysis reactions induced by UV irradiation on both small active ingredient [49] and biomacromolecules 
[50]. Indeed, these reactions are often sensitively enhanced by the presence of H2O2 [51]. Loading of 
hydrogels can be performed by swelling with several solvents. Besides in water based solutions, 
photocrosslinked PVP also swells in ethanol and DMSO. As an example, PVP hydrogel swelled in ethanol 
(>99.5%) in 24 h, reaching up to 14 times its dry weight. As a consequence, a large number of hydrophobic 
APIs, dissolvable in ethanol or DMSO, could potentially be loaded into PVP hydrogels (or microgels).  
 
5.3.1 Confocal microscopy 
Confocal microscopy was used to investigate the swelling properties of the gels and the loading of model 
macromolecules. Confocal micrograph stacks were acquired with a Zeiss LSM 5 microscope (Carl Zeiss, 
Oberkochen, Germany). For the detection of Rhodamin, a 20x objective with 0,5 numerical aperture (NA) 
with excitation light at 543 nm (HeNe laser) and collecting emitted light at 560 nm was used. 
For the detection of FITC-avidin imaging was performed with a 40x objectve, 1.2 NA, using excitation light 
at 488 nm (argon laser) and collecting emitted light from 505-530 nm. The recorded stacks were processed 
using the software ImageJ. 
 
5.3.2 Loading of small molecules 
To study the dimensions of swollen microgels, the uptake of fluorescent dye (Rhodamin B, Sigma Aldrich) 
was visualized by confocal microscopy. For this purpose, mask chips with only 4 well separated microgels 
were utilized. Individual microgels were wetted by manual pipetting with fixed aliquots of the aqueous 
fluorophore solution (8 µl, 20 µg/mL) and left swelling for defined times. Confocal images where acquired 
while microgels were in a swollen state (see figure 5.9a) and in a dry state after having whiped the excess 
solution surrounding the gel with cotton buds (figure 5.9b). Comparing the swollen and the dry states, a 
significant increase of volume can be noticed. By analyzing the white zone heights in figure 5.9a and b 
(where the luminescent dye reaches fluorescent saturation) the gel thickness increases from 28 to 128 µm 
during immersion for 8 min. From a qualitative viewpoint, the confocal images show that small molecules 
like Rhodamin can easily be incorporated into PVP microgels by a short immersion in a liquid solution.  
 
 
Figure 5.9: Fluorescent micrographs 
showing the XZ sections of a confocal 
scanning through a 300 µm wide microgel, 
swollen for 8 minutes with fluorescent dye. 
(a) Microgel in the swollen state (immersed 
in the Rhodamin solution) and (b) in the dry 
state. The color palette and the scale bar 
are referred to both (a) and (b) images. 
Colors are referred to fluorescent intensity.  
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To test the compatibility of this new polymer structures with the supercritical loading technique discussed 
in chapter 4, photocrosslinked PVP films were submitted to CO2 impregnation with ketoprofen. To test the 
effect of crosslinking on impregnation, two polymer films were prepared as described previously (section 
5.2.3). One film was crosslinked by UV radiation for 22 min, and the other one not. After solvent 
evaporation in a desiccator overnight, the dried films were weighed. The weight of the deposited polymer 
estimated by subtraction of the chip weight is shown in table 5.3. Both samples were impregnated in the 
same experiment with ketoprofen at a CO2 pressure of 200 bar at 40°C for 1 hour. The drug amount 
dissolved in the batch corresponded to saturation condition, as indicated by Macnaughton et al. [52]). The 
dissolution was measured with a similar procedure as described in section 4.2.7. Impregnated films were 
immersed in 10 mL of sonicated DI water, at 37°C and a stirring rate of 100 rpm.  
The loaded drug amounts were estimated from the final concentrations in the dissolution media and the 
loading yields from the ratio of drug to the polymer weight. In table 5.3 the results of impregnation are 
shown. The loading yields in the two films seem to be almost the same. The presence of crosslinking does 
not have an effect on the loading for such low film thicknesses. However, during the dissolution 
experiments the polymer films behaved quite differently: The uncrosslinked film gradually detached from 
the chip and dissolved in the medium and the drug dissolved together with the film. Compared to that, the 
gel film swelled in the dissolution medium and was still bonded to the substrate at the end of the test. In 
this case the drug diffused out of the swollen matrix. The dissolution curves are represented in figure 5.10. 
Although the drug release mechanisms from the two samples were different, unexpectedly the cumulative 
release profiles appear quite similar. This can be explained by the high diffusivity of the drug in the polymer 
network due to the low size of ketoprofen. 
 
Table 5.3: Results of impregnation of PVP films with ketoprofen: Polymer and drug weight at the different 
fabrication steps. 
Sample PVP after spinning 
(mg) 
PVP after (washing*)  
and drying (mg) 
Loaded drug 
weight (mg) 
Drug mass 
fraction  
uncrosslinked  17.9 9.32 1.66 0.15 
crosslinked  17.9 7.73 1.22 0.14 
*only for the crosslinked films. 
 
 
Figure 5.10: Cumulative release profiles of ketoprofen from PVP 
films with and without crosslinking  
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5.3.3 Loading of macromolecules 
Microgels can be potentially used to deliver bioactive macromolecules like proteins and nucleic acid based- 
therapeutics in the GIT. To test the feasibility of the system to this purpose, the loading of a model 
macromolecule was performed. The microgels were swollen with solutions containing a labelled protein 
with a similar procedure as the one explained previously in section 5.3.1. A FITC Avidin stock solution 
(phosphate-buffered saline 2.5 mg/mL, 66 kDa, Invitrogen) was diluted to 20 µg/mL concentration. Aliquots 
of 4 µl of the solution were manually dispensed onto single microgels and thereafter a sequence of 
confocal microscope scannings of the gel volume were taken at defined times. In figure 5.11 the fluorescent 
micrograph of a gel incubated for 25 minutes is represented from different viewpoints: (a) shows the top 
view, with focus on the microgel upper surface. Here, precipitated particles of avidine can be recognized. 
Figures 5.11b and 5.11c show orthogonal cross sections of the gel. Apparently, a thin layer of tagged-
protein has deposited on the surface whereas no protein has been incorporated within the gel volume. 
Other tests were performed increasing dispensed solution volumes (8 and 16 µl) and the immersion time 
(up to 1 h), but no significant protein uptake could be detected in the microgels. This fact suggested that 
most likely longer times were needed for the absorption of large molecules like proteins. To further 
elucidate the feasibility of protein encapsulation in microgels for, PLLA films with 625 PVP microgels 
irradiated for 33 min were incubated in a 0.5 mL droplet of buffer solution with higher concentrations of 
FITC avidin (0.1 mg/mL). The microgel film was placed on top of the droplet dispensed inside a parafilm-
coated box which was then closed and protected from light. In this way, solvent evaporation was delayed 
and protein precipitation on top of microstructures was minimized. The incubation was carried out for 24 h 
and 48 h. After 24 h gels were still wet, and a confocal scan revealed that protein absorption was uniform 
but the fluorescence signal was still weak. After 48 h, the solution was completed sucked up by the gels, 
which looked yellowish and were completely dry. After solution drying, no traces of solute precipitation 
were found, which suggested that the whole 0.5 mL incubation volume had been absorbed by the 
microgels. A total of four incubated microgels, chosen from different points on the film, were visualized by 
confocal microscopy. A representative example of the microgel z scanning is shown in figure 5.12. These 
experiments quantitatively show that the loading of macromolecules into microgels is possible but that 
protein diffusion is significantly hindered in the polymer network.  
 
  
Figure 5.11: Fluorescence micrograph of a 300 µm 
wide microgel irradiated for 33 min after 
immersion in FITC Avidin solution for 25 min and 
drying. (a) Top view of the gel showing 
precipitated dye particles; (b) YZ section and (c) 
XZ section of confocal scan. The top view image is 
taken at height shown by the red arrows in (c). 
Figure 5.12: Fluorescence micrograph of a 300 µm 
wide microgel irradiated for 33 min after immersion 
in FITC Avidin solution for 48 h. (a) Top view of the 
gel; (b) YZ section and (c) XZ section of confocal scan. 
The protein seems to be encapsulated uniformly 
inside the microgel. The top view image is taken at 
height shown by the red arrows in (c). 
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5.4 Structural properties of PVP hydrogels 
From the perspective of a drug delivery system, the control of the release is a crucial feature. The 
experiments on the loading of PVP hydrogels with avidin presented in the previous section, showed that a 
non negligible hindrance of the protein diffusion exists. It is reasonable to assume that a macromolecule 
encounters a similar hindrance when it diffuses out of the gel. Generally the slow diffusion can be explained 
either by protein-polymer interactions, or by steric hindrance. Considered that PVP is a neutral polymer and 
no evidence of PVP interactions with proteins was reported in the literature, this resistance to diffusion is 
most likely related to the mesh dimensions of the polymer network. The polymer mesh size might be 
comparable to the molecular dimensions of avidin (6×5.5×4 nm3 [53]). In the attempts of elucidating this 
phenomenon, a more in-depth characterization of UV-crosslinked PVP hydrogels networks was carried out 
by means of rheological techniques and nuclear magnetic resonance spectroscopy.  
 
5.4.1 Gel preparation  
For the rheological and the NMR investigations, macroscopic specimens of the hydrogel were prepared. 
From a short sequence of preliminary crosslinking tests performed on solution layers of different thickness, 
it was concluded that samples thicker than 1 mm exhibit a macroscopically inhomogeneous structure with 
a softer texture in the bottom and a more rigid one on the top. On the other hand, membranes thinner 
than 1 mm were very fragile and unpractical to handle. As a consequence a fixed thickness of 1 mm was 
used.  
PVP hydrogels were prepared as follows: Solutions of PVP K90 were prepared with various concentrations 
of polymer (10, 20, 30% wt) as described in section 5.2.2. To investigate the influence of the crosslinker 
concentration on the structural properties, additional 30% PVP solutions were prepared with double and 
triple amounts of H2O2 (later referred as 30%+2H and 30%+3H). The mixtures were cast into cylindrical 
moulds (1 mm in depth, 15 mm in diameter) composed of an Aluminum sheet with circular holes clamped 
to a parafilm-coated plastic disc. The solutions were poured into the cavities and leveled with a spatula. 
Finally, the same kind of glass wafer as the ones used for the mask fabrication was clamped onto the mold. 
The placement of glass on the samples was necessary to reproduce experimental conditions as close as 
possible to the ones during microgel fabrication. Most importantly, the glass prevented water evaporation 
during the exposure.  It was measured that the glass absorbs a negligible amount of the radiation emitted 
by the UV lamps  of approx. 5 mW/cm2. Considering a power density of 29 mW/cm2, each sample was 
exposed to 67 J, 100 J, 134 J corresponding to irradiations of 22, 33 and 44 min respectively. After 
photoreticulation and prior to any analysis, all the considered gels were separated from the moulds with a 
spatula and dipped in DI water for 24 h under stirring to extract eventually unreacted polymer and 
crosslinker. During this operation, gel disks underwent a macroscopic swelling. Figure 5.13 shows an 
example of gel before (left) and after 24 h of swelling (right).  
After the swelling, gels were dried and weighed. The water/polymer weight ratios were calculated as 
follows: 
 
mH2O(t)
mdry
= m(t) −mdry
mdry
 (5.3) 
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Figure 5.13: PVP hydrogel before (left) and after (right) 
the swelling.  
Figure 5.14: Plots of the water/polymer ratio in the gels 
as a function of time for different polymer and crosslinker 
concentrations.  
 
In figure 5.14 the ratio is plotted as a function of swelling time for the considered concentrations. All the 
systems share a common trend described by a rapid swelling within the first 5 hours followed by a slower 
water uptake. From the slope of the curve at 24 h it seems that the systems have not yet reached 
equilibrium. However, a phenomenon of overswelling was observed for immersion for longer than 24 h 
characterized by the breakage of the membranes in smaller fragments. The values at the beginning of the 
experiment (t = 0) recorded before the swelling started, correspond to a water content very close to the 
water fraction in the solution. In fact, it was observed that the dry polymer weight was equal to the 
polymer concentration of the corresponding solution. Thus, it was deducted that most of the polymer was 
involved in the reticulation and a minimal portion of polymer is degraded or not bound to the gel lattice. 
This is reasonable, since polymer degradation is strictly connected to UV irradiation dose [54]. In these 
experiments a very limited UV dose was utilized, compared to other works where gels were submitted to 
energies in the range of kJ  [43, 45] or prolonged irradiations of 2-6 h [46]. 
 
5.4.2 Rheological characterization of gels 
Each gel was left swelling for 24 h and cut into a disc of 20 mm diameter fitting the rotating probe of the 
rheometer. The analyses were performed as previously explained in section 2.6.1.1. The results of the small 
oscillatory shear experiments (i.e. frequency sweep tests, FS, aimed at the determination of the mechanical 
spectrum), also called mechanical spectra, reveal different viscoelastic behaviours for the considered 
systems. The tests were performed on samples treated with UV light for 22, 33 and 44 minutes in three 
replica. To simplify the illustration only profiles 22 and 44 minutes are presented in the following, as those 
at 33 min were always placed in between (as can be seen in table 5.3). In figure 5.15 the mechanical spectra 
of samples at 10% are depicted. The sample irradiated for 22 min cannot strictly be defined as a gel, as the 
moduli G´ and G´´ almost are overlapping. The sample irradiated for 44 min exhibits a stronger elastic 
response and can be considered as an incipient gel as G’ and G” have a slight dependence on the shear 
frequency but G’ is close to G’’ (the viscous component is still important). 
The mechanical spectra of 20% wt PVP systems are shown in figure 5.16. The sample with shorter 
irradiation is already a structured gel, with a stronger elastic component than for the 10% PVP films in 
figure 5.15. There is a residual dependency of the moduli on ω as it occurs in weak gels. The gel with 20% 
wt irradiated for 44 min is what is commonly called a strong gel, with an important elastic modulus, 
independent from oscillation frequency and dominant with respect to the viscous modulus (G’ > 10*G’’).  
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Figure 5.15: Mechanical spectra of hydrogels prepared 
from 10% wt solution at different irradiation times.  
Figure 5.16: Mechanical spectra of hydrogels prepared 
from 20% wt solution at different irradiation times. 
 
In figure 5.17 the comparison of gels prepared with different crosslinker concentration in solutions with 
30% PVP is shown. All the samples exhibit the typical features of strong gels. This is an evidence that UV 
radiation has induced the formation of chemical crosslinks between polymer chains. Elastic moduli differ 
from respective viscous moduli with more than one order of magnitude and in case of 2H even two. A 
double concentration of H2O2 in the solution has a clear effect on the value of G’(ω) which increases from 
around 400 Pa to 1400 Pa. In the sample 3H this effect seems to be smaller.  
Finally, figure 5.18 shows the moduli of gels at a fixed UV dose (67 J) and for different initial polymer 
concentrations. With the increase of concentration there is a clear transition from solutions close to gel 
point (sample 10% wt) to more structured materials (20 and 30%). There is a significant increase of the 
elastic response from 10% to 20% and this is another typical feature of chemically crosslinked gels [55, 56]. 
The increase of G’ plateau values is less pronounced from 20% to 30%. The influence of polymer content on 
viscoelastic properties is certainly less important than the one of the UV irradiation dose/time. The 
rheological characterization provides important informations about the structural properties of 
photocrosslinked films: The strong nature of the gels indicates that the polymer chains are connected by 
punctual crosslinks, most likely by chemical bonds. This fact permits the use of Flory´s model to calculate 
the average mesh size of the network. 
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Figure 5.17: Mechanical spectra of hydrogels prepared 
from 30% wt solution (white), with double (grey) and 
triple (black) crosslinker concentrations, irradiated for 
44 min. 
Figure 5.18: Comparison between elastic and viscous 
moduli for gels of different concentrations irradiated for 
22 min. 
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5.4.3 Average mesh size estimations 
5.4.3.1 Estimation according to the theory of Flory 
The mechanical spectra of the systems were fitted with the generalized Maxwell model proposed in section 
2.6.1.4: 
 G′(ω) = � gk(λkω)21 + (λkω)2nk=1  gk(ω) = ηkλk (5.4) G"(ω) = � gkλkω1 + (λkω)2nk=1  gk(ω) = ηkλk (5.5) 
 
where n is the number of considered Maxwell elements, gk, ηk, λk represent  the spring constant, the 
dashpot viscosity and the relaxation time of the ith Maxwell element, respectively. The data fitting was 
performed assuming that the relaxation times are scaled by a factor of 10. Thus GE, gk and λ1 are the n+2 
fitting parameters. The number of Maxwell elements was selected according to the statistical criterion of 
the minimization of the product χ2Np , where χ2 is given by the sum of the squared errors while Np is the 
number of fitting parameters equal to n+1. The data fitting procedure was written in a Visual basic “user 
defined” program and executed by Microsoft Excel “Solver” function. With the fitted values of GE and gi, 
and λk, the crosslink density ρx and the mesh size ξa were estimated using the equations showed in section 
2.6.1.5. In table 5.3 the results are summarized. 
From table 5.3 it can be noticed that the mesh size ξa is strictly related to ∑gi+GE that is the contribution of 
elastic elements to G’. Indeed, there is a direct correlation between these two parameters in the theory of 
Flory. The mesh sizes at different UV exposures are plotted in figure 5.19 comparing different PVP 
concentrations. All the profiles show a decrease of the crosslink-to-crosslink distance upon longer exposure 
to UV radiation. 
 
Table 5.3: Results of the fitting of mechanical spectra with Maxwell´s generalized model. 
Sample UV time 
(min) 
G’ (Pa) (from 
FS) 
∑gi+GE 
(Pa) 
ρx 
(10-9 mol/cm3) 
ξa (Flory) 
(nm) 
10% 
22 5.74 4.61 1.54 127.3 ±6.10 
33 24.06 41.77 6.29 79.58±2.54 
44 75.76 134.96 20.8 53.39 ±2.24 
20% 
22 37.29 52.52 7.61 74.70 ±1.79 
33 170.00 113.05 28.8 47.94±1.82 
44 284.10 290.67 38.3 43.58 ±0.59 
30% 
22 47.03 71.04 11.9 64.39 ±2.22 
33 97.33 119.75 48.4 40.33 ±1.41 
44 426.2 457.98 62 37.11 ±1.03 
30%+2H 
22 10.12 15.05 1.74 122.15 ±6.26 
33 161.90 181.84 25.7 49.81 ±1.08 
44 1404.00 1435.10 194 25.36 ±0.08 
30%+3H 
22 4.75 4.19 0.98 147.80 ±3.69 
33 208.8 274.77 31.1 46.71 ±0.92 
44 620.70 742.65 0.96 32.06 ±0.53 
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In the sample with 10% PVP the radiation dose significantly influences the gel structure. The estimated 
mesh size is more than halved when passing from 22 to 44 min exposures, which can explain the transition 
from a solution to a gel behaviour shown in the mechanical spectra in figure 5.15. Networks generated by 
the photocrosslinking of 10% solutions exhibit meshes larger than the ones obtained from more 
concentrated solutions for all the tested exposures. Membranes prepared with 20% and 30% PVP show a 
very similar structure for all of the studied cases. This fact could also be predicted from the comparison of 
elastic moduli in figure 5.18. The density of crosslinks for these systems is less dependent on the UV dose 
than for 10% PVP. Passing from 10% to 20-30% there is in fact a reduced decrease in the mesh size with 
irradiation time. The plots depicted in figure 5.20 represent the mean mesh size for 30% PVP hydrogels 
crosslinked with different H2O2 amounts. These systems exhibit a more complex behaviour. At the lowest 
UV dose, higher concentrations of the photoinitiator seem to create larger meshes with dimension 
comparable to the system with 10% PVP irradiated for 22 min. This fact might be explained by a 
recombination of OH radicals back to H2O2 with a termination of the reaction. This might be more 
prominent for higher concentrations of crosslinker. For a longer irradiation there is a drastic thickening of 
the networks. For 30+3H at 33 min the estimated ξa value is reduced to one third, for 30+2H to one half of 
the value for 22 min. After 33 min of crosslinking, the structure of the gels seems to be very similar 
independent of the H2O2 concentration. For 44 min, there is a reduction in ξa for higher concentrations of 
photoinitiator, primarily due to a substantial increase of G’ moduli (see table 5.3). 
In conclusion, there is no clear advantage in having higher concentration of the photoinitiator, at least for 
the system at 30% and the irradiation times considered. The irradiation dose is more suitable parameters 
for tuning of the structural properties of the hydrogel. We can show that longer irradiations yield in general 
denser networks, but the values obtained by the theory of Flory cannot explain yet the hindrance 
encountered during the protein loading. The loading experiments would be explained by tighter networks. 
However, it is not excluded that for longer or more energetic irradiation, the polymer network can be 
thickened (i.e. with smaller values of ξa) and designed for controlling the release of small molecules with 
dimensions comparable to the mesh size. Other works about photoreticulation of PVP hydrogels [43,44] 
reported smaller values for ξa , but in those cases the irradiation energies were significantly higher (300-
4000 J) than those used in this study. 
 
  
Figure 5.19: Average mesh size, according to the theory 
of Flory, as a function of UV exposure times for different 
PVP concentrations. The lines are guides for the eyes. 
Figure 5.20: Average mesh size, according to the theory 
of Flory, as a function of UV exposure times for different 
H2O2 concentrations in 30% PVP gels. The lines are 
guides for the eyes. 
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5.4.3.2 Estimation according to the theory of Scherer and its approximation 
An alternative method based on the theory of Scherer about polymer networks was used for the estimation 
of the mean mesh size, as described in section 2.6.1.6. The method provides an analytical solution of mean 
crosslink-to-crosslink distance that will be called ξa analytical [57] by assuming that the gel structure is a 
lattice divided into regular and identical domains. In addition, an approximated expression (called ξa 
approx, see equation 2.28) based on Scherer´s solution, was developed. As discussed in 2.6.1.6, this 
approximation has the advantage of establishing a direct (linear) relationship between ξa and hydraulic 
radius of polymer fiber Rf. The validity of the proposed approximation is clearly presented in the plots in 
figure 5.21, where analytical and approximated versions are compared for the range of interest of νp in this 
study. In table 5.4 the results are shown for the considered gel systems. The relative error between the 
analytical and the approximated values for the mesh size are in average below 6.5% which corresponds to a 
dimensional error lower than 0.8 nm. All the values of ξa provided by this method are significantly lower 
than those obtained with the theory of Flory. Furthermore, there is no clear trend for ξa: Scherer´s model 
does not provide any evidence of the presence of denser networks in the case of longer UV exposures or 
more concentrated solutions. All the mesh diameters seem to fall in a range between 8 and 20 nm.  
A possible explanation for these results can be found looking at Scherer´s equation (2.28). ξa depends 
mainly on the polymer volume fraction in the swollen state (νp), or likewise on the swelling capability of the 
gel. It was experimentally observed by weight measurements that the quantity of water absorbed by the 
membranes in 24 h (to which νp is directly linked), only differs slightly with polymer and crosslinker 
concentration. This fact was also observed in figure 5.14, in terms of water/polymer ratios. Scherer´s 
approach gave reliable estimations of the mesh size for hydrogels formed by Alginate and Pluronics [57]. 
However, in the case of photocrosslinked PVP, this method cannot explain the structural difference 
between the considered systems, which instead are observed in the rheological study and coherently 
described by the theory of Flory. 
Finally, to discuss the different results obtained by the rheology and the theory of Scherer, we can give the 
following interpretation: The photoreticulation leads to the formation of relatively few and sparse junction 
points in the PVP solutions. An elastically-active network is formed which can be detected by rheology and 
large values of ξa  are obtained with the Flory model. Conversely, the theory of Scherer is based on purely 
geometrical assumptions and considers all the polymer chains involved in the network, both those that are 
elastically-active and non-active. The non-active portions of the network can be imaged as “loose” polymer 
chains topologically anchored to the elastic network. A similar situation was recently observed for a 
polysaccharide-based gel [58], where rheology and release test of a probe molecule gave different 
estimations of the network mesh size. In that case, it was supposed that the network was composed of a 
“mesoscopic” network responsible for the elastic response and polymer chains entangled in the network 
contributing only to the viscous response. Furthermore, the presence of a non homogeneous network in 
photocrosslinked PVP is consistent with results shown by D´Errico et al. [46]. In that work, the existence of 
polymer rich-portions surrounded by water rich-regions in the network was detected by means of Small 
angle neutron scattering (SANS). The average distance between polymer rich domains was reported to be 
52 nm, a value very close to the mesh sizes estimated for most of the gel systems. 
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Figure 5.21: Comparison between the approximated 
average mesh size ξa (circles) and the Scherer´s analytical 
solution (solid line) as a function of the polymer volume 
fraction νp. 
 
 
 
Table 5.4: Estimation of average mesh sizes in the considered hydrogels, according to 
Scherer´s method (ξa analytical) and the proposed approximation(ξa approx). 
Sample 
UV time 
(min) 
∆w νp ξa analytical ξa approx 
% Relative  
error 
10% 
22 0.02 0.067 10.18 10.93 7.42 
33 20.07 0.020 18.98 19.63 3.45 
44 20.80 0.021 18.62 19.28 3.53 
20% 
22 0.03 0.038 13.63 14.33 5.13 
33 16.14 0.090 8.676 9.47 9.17 
44 16.89 0.033 14.68 15.37 4.69 
30% 
22 0.05 0.072 9.81 10.57 7.79 
33 13.83 0.079 9.32 10.10 8.33 
44 14.61 0.054 11.34 12.08 6.46 
30%+ 2H 
22 0.06 0.041 13.16 13.86 5.36 
33 12.27 0.056 11.14 11.87 6.61 
44 13.08 0.052 11.60 12.33 6.28 
30%+ 3H 
22 0.07 0.119 7.45 8.29 11.30 
33 11.08 0.041 13.27 13.98 5.31 
44 11.91 0.049 12.02 12.75 6.00 
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5.4.4 NMR spectroscopy of gels 
As discussed in section 2.6.2, the purpose of the NMR analysis is to describe more properly the nanoscopic 
structure of polymer networks. In particular NMR is used to determine the distribution for the mesh sizes, 
whose values were in the previous sections calculated as an average, assuming that the gel lattices are 
composed of identical cells with spherical (Flory) or cubic (Scherer) geometry. The crosslink distribution is 
computed by measuring the relaxation times T2 of the magnetic spins of protons in the water trapped in 
the hydrogel. The response of 1H spins upon a magnetic excitation is strictly connected to their degree of 
interaction with the polymer chains, i.e. from the size of the nanoscopic domains where water molecules 
are confined. The T2 measurement consists of a sequence of magnetic excitations and measurement 
intervals: First a 90° magnetic pulse, a time measurement interval τ, a series of 180° pulses applied at 2τ 
intervals are forwarded by the last 180° pulse after a τ interval. The sequence is repeated 8 times every 5 
seconds. In table 5.5, the measured values of T2 for the considered gel systems are listed. All the measured 
values are below the relaxation time of bulk water (T2, H2O = 3007 ms), but there is no significant change in T2 
with respect to the reticulation levels observed in the rheological tests. This fact confirms that polymer 
meshes are considerably larger than water molecules and that most of the water is not perturbated by the 
presence of the polymer macromolecules. 
 
Table 5.5: Relaxation time values T2 measured for the considered PVP hydrogel systems at 
25°C, with an interval of τ=0.25 ms between excitations. 
Sample 
Relaxation times T2 (ms) for each irradiation energy  
22 min 33 min 44 min 
10% 2104 2380 2291 
20% 2447 2328 2393 
30% 2631 2412 2489 
30% + 2H 2329 2480 2692 
30% + 3H 2209 2201 2228 
 
The method used for the data analysis, discussed more in details in section 2.6.2.5, consists briefly in the 
fitting of the magnetization decay of hydrogen nuclei recorded in the NMR experiment with a multi-
exponential function. An example of fitting for the gel with 20% PVP irradiated for 22 min is shown in figure 
5.22. In all the systems under study, the decay of magnetization intensity Is(t) could be fitted satisfactorily 
by a single exponential function I(t). After this result, it was suspected that not only the relaxation of water 
but also the relaxation of 1H of the polymer backbone were measured. This could cause distortions of the 
signal. To clarify this aspect, a gel was prepared irradiating a solution of PVP 30% in heavy water (D2O, 
Deuterium oxide, 99.9% atoms purity, Sigma Aldrich) for 44 min.  
The crosslinked sample was then left for swelling in a large volume of D2O overnight. The viscoelastic 
properties where measured by rotational rheometry and were very close to the corresponding gels in 
normal water previously tested. In these samples, only the presence of polymer of protons could have 
been, in principle, detected, as D2O is not affected by the magnetic field. Since the NMR measurements on 
D2O-gels did not show any signal, we could conclude that polymer protons relaxation was too fast to be 
detected by our equipment. This proved that the NMR relaxation spectra of the hydrogel in water were not 
affected by PVP protons relaxation. 
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This fact proved that the relaxation spectra of the hydrogel in water were not affected by any distortion 
due to polymer hydrogens. From the fitting of Is(t), the distribution a(T2) (also shown in figure 5.22) is 
calculated. All the gel studied a relaxation spectrum a(T2) similar to the one in figure 5.22.  
The parameters obtained from the fitting of the T2 relaxation decays were used in a second fitting step 
leading to a continuous distribution of T2.  
Finally, from the average value of T2 (T2a) and the mesh dimension ξa (Flory or Scherer values), the 
parameter k is calculated with the following relation:  
  1T2,a = 1T2,H2O + 2ℳRh  (5.6) 
 
By knowing M, a direct relationship between T2 and ξ is established, and the T2 distribution can be 
translated in a distribution of ξ. 
In figure 5.23, an example of mesh size distributions in the gel network is shown. In the plot mesh 
distributions computed from T2 curves fitted by one exponential function (grey profile) and by a continuous 
weighted T2 function (black profile) are compared in the plot. The two distributions are overlapping, which 
confirms that one single exponential function is sufficient to describe the hydrogel nanostructure. For all 
the gels studied, ξ distributions were characterized by one single peak, broadening towards larger values of 
mesh size. The peak is centered in the value of ξa  provided either by the rheological studies or by the 
theory of Scherer. In figure 5.23 we chose to show a distribution based on a value provided by Scherer´s 
model, from which in general estimations were smaller than the ones provided by the theory of Flory. This 
was to demonstrate that, for any gel considered, mesh distributions do not cover sizes which can interfere 
with the spatial arrangement of water molecules and proton spin orientation, and this fact is also 
confirmed by the values of T2 comparable to the bulk water (see table 5.5).  
Comparing the relaxation spectrum obtained for all the PVP gels (representatively characterized by figure 
5.22) with a typical relaxation spectrum a(T2) of a hydrogel (depicted in figure 2.21 in section 2.6.2.5), there 
is a remarkable difference. In general hydrogels are characterized by several peaks, meaning that water 
molecules are confined in meshes of quite different sizes. Instead, all the considered PVP hydrogels are 
characterized by one single peak, meaning that the network is quite regular. 
 
  
Figure 5.22: Fitting curve I(t) of the magnetization decay 
curve Is(t) of water inside the gel meshes (sample 20%, 
22 min). The distribution a(T2) results from the fitting 
operation. 
Figure 5.23: Mesh size distribution for the system 20% 
22 min irradiation assuming an average value ξa of 
14.33 nm (sample 20%, 22 min, Scherer´s estimation). 
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5.5 Integration in microcontainers 
The patterning of hydrogels can also be integrated with embossed microcontainers, in a scheme previously 
mentioned in figure 5.1 (section 5.1.2). As a proof of concept, a preliminary experiment was carried out on 
PLLA containers: 0.5 mL of aqueous solution of PVP K90 30% wt were spin coated on the microwells. In 
figure 5.24a an optical micrograph of the result is shown. The limited depth of the microcontainers (65 µm) 
allowed a uniform coating with a limited number of air bubbles. Thereafter, a mask chip with a single 
circular opening was manually aligned on top of a selected container by means of a microscope and the 
sample was subsequently exposed to UV light. Only one container cavity was exposed to UV radiation, to 
test the feasibility of crosslinking and to have an immediate comparison with unexposed areas. Finally the 
whole chip was dipped in water solution, under stirring for 5 min. In figure 5.24b the halo of an exposed 
and crosslinked microgel can be recognized on the container (upper center). This experiments shows that 
the photocrosslinking technique can easily be transferred to the prototype of microcontainers fabricated 
with biodegradable polymers. 
 
 
 
Figure 5.24: (a) PLLA microcontainers filled with aqueous solution of PVP K90 30% wt by spin coating (air bubbles are 
small spots in the upper left edge of containers). (b) Containers after selective crosslinking. The halo on the upper 
centred container is the microgel almost centered in the container cavity. 
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5.6 Conclusions  
The use of selective photocrosslinking proved a successful technique to fabricate large arrays of polymer 
microgels. This method represents a valuable replacement of inkjet printing for the loading of 
microcontainers. The developed process is very simple and cost effective, compared to a drop-on-demand 
deposition. Although photocrosslinking entails an unavoidable loss of material, it offers a faster polymer 
deposition and an improved reproducibility. The characterization studies on PVP hydrogels revealed that 
both the dimensional and the structural properties of microgels can be modulated changing the UV 
exposure according to the specific needs of the drug delivery device. The combination of rheological and 
NMR analysis showed the existence of a three dimensional network. The diffusive properties will be 
particularly interesting for controlled delivery of macromolecules of pharmaceutical interest. The study of 
the mesh size requires still a deeper understanding, maybe supported by the estimation of the diffusion 
coefficient upon the release of a model macromolecule. The amphiphilic properties of PVP, make microgels 
a versatile carrier to encapsulate both small hydrophobic APIs, and bioactive macromolecules. 
Photocrosslinked microgels can be successfully loaded by supercritical impregnation. The combination of 
these two methods is at the moment the loading technique for microfabricated drug delivery devices which 
represents the smallest waste of active ingredient while preserving the therapeutic activity of the drug. 
Finally, all the different techniques explored can be potentially integrated with the biopolymer 
microcontainers concept. 
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6. Conclusions and perspectives 
The goal of this project has been to develop techniques for the loading of poorly soluble drugs and fragile 
biological macromolecules into microcontainers for oral drug delivery. The research study was focused on 
simple and cost effective methods, using technologies compatible with the operation limits imposed by the 
materials in use. Techniques were developed both for the largest group of APIs with poor oral 
bioavailability and for oral formulations already existing. Moreover, attention was paid to the perspective 
of industrial applications. Therefore, the research was directed towards the use of automated equipments 
and to solutions allowing control of the design and performance of the device. 
At the beginning of the project, the state of the art in the loading of reservoir based-microdevices entailed 
a large waste of API and worked only for flat microcontainers with low capacity volumes.  
6.1 Conclusions 
The use of direct DOD inkjet printing of furosemide solutions with the available equipment demonstrated in 
general substantial limitations. The spotting of solutions based on organic solvent showed low 
reproducibility and drug precipitation caused frequent nozzle clogging. The spotting of SNEDDS 
formulations for insulin was instead performed with success by means of heating the dispensing system to 
50°C with an efficiency of 80%.  
Inkjet printing was successfully employed for the deposition of controlled volumes of aqueous solutions of 
PVP. Polymer concentrations up to 20% wt were successfully dispensed into microcontainers with a quasi-
no-waste performance and with high reproducibility in terms of alignment and dispensed volume. The 
method allowed a high control of the level of filling by means of repeated spotting sessions.  
The achievement in the spotting of polymer solutions allowed to develop a loading technique divided into 
two steps: The DOD deposition of PVP aqueous solutions, followed by a step of drug loading, which was 
performed by supercritical impregnation.  
Supercritical impregnation of ketoprofen was shown to be an effective method, allowing the simultaneous 
loading of large arrays of microcontainers in a single batch. The impregnation of confined nanoliter volumes 
of polymer defined by microfabrication represents an important achievement for the loading of 
microdevices, which no one has shown before. The control of drug loading was demonstrated by tuning 
fluid pressure, temperature and time of impregnation. At 200 bar, 40°C and 4 hours a drug concentration 
of 32 % wt was obtained. The effect of temperature on impregnation was also elucidated. The increase 
from 40°C to 60°C resulted in a substantial increase of drug content. For longer impregnation times, at 200 
bar the increase in temperature corresponded to an increase from 0.6 to 1 mg of drug per chip. Raman 
spectroscopy analyses of impregnated containers demonstrated the presence of amorphous drug and ATR-
IR spectroscopy showed strong chemical interactions between the PVP and the drug. In vitro drug release 
tests showed an enhanced dissolution rate for impregnated containers compared to solid dispersion laden 
microdevices. Here, 87% of the total drug was released within 30 minutes.  
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The combination of inkjet printing and scCO2 impregnation demonstrated good reproducibility and 
accuracy of the final drug dose. Furthermore, the loading was performed without the use of organic 
solvents and with a minimum waste of chemicals, which makes the process potentially suitable for up 
scaling.  
The use of selective photocrosslinking was investigated to fabricate large arrays of PVP microgels. UV 
crosslinking allowed to define micropatterns of the polymer with diameter in the range of 100-300 µm, and 
height within 10-30 µm. The volume of microgel ranges from 0.06-1.15 nL and can be controlled with high 
accuracy and reproducibility by modifying the exposure dose during UV radiation. This method was proved 
to be a successful technique which can be used as alternative of inkjet printing for the definition of PVP 
volumes inside the microcontainers. The swelling properties of microgels were studied by means of 
confocal fluorescence microscopy. Microgels can swell significantly in both aqueous and organic solvent 
based solutions. After few minutes of swelling in water, microgel height increased from 28 to 128 µm.  
The hydrogel obtained by photocrosslinking was loaded with ketoprofen by supercritical impregnation. In 
vitro dissolution studies showed that crosslinked and uncrosslinked films release the drug very similarly. 
Furthermore, the loading of microgels with protein was accomplished. The loading of gels was carried out 
by swelling with defined volumes of protein solution. Confocal microscopy showed that the loading of 
macromolecules required longer times compared to small molecules.  
The nanoscopic structure of photocrosslinked hydrogels was investigated by means of rheological 
techniques and NMR spectroscopy. Theoretical models based on Flory´s and Scherer´s theories were 
developed to analyze experimental data and to calculate the average mesh size of the hydrogel network as 
well as the mesh size distribution. The study confirmed the existence of regular three dimensional 
networks. The application of the theory of Flory showed the presence of relatively large mesh dimensions 
between 25-150 nm. The application of this model for the analysis of rheological measurements showed 
that the degree of reticulation depends both on the initial polymer concentration and on the irradiation 
energy. Compared to that, the influence of the crosslinker concentration on the mesh dimensions is smaller 
for the investigated range. Instead, the mesh size estimations derived from the theory of Scherer resulted 
in much smaller mesh dimensions of 8-19 nm. However, this theory could not explain the influence of 
concentration and UV exposure observed in the experiments. The NMR data analysis confirmed the 
presence of large meshes, showing that the polymer chains do not interfere with the magnetic relaxation of 
water hydrogens. In the swollen gels water molecules behave like in bulk liquid phase.  
From gel structure characterization studies it emerges that PVP hydrogels are suitable systems for the 
controlled release of bioactive macromolecules of pharmaceutical interest. 
In conclusion, the loading techniques developed in this thesis represent a novelty in the field of 
microfabricated drug delivery devices. Compared to the other techniques used in this field, the 
combination of inkjet printing and supercritical impregnation allows to minimize the waste of possibly 
expensive active ingredients, preserving the drug therapeutic activity. Also, the use of UV light to 
micropattern polymer films offers a valuable alternative to inkjet deposition of polymer solutions. The 
methods utilized in this research work can potentially be integrated in the fabrication process of 
biopolymer microcontainers developed in NAMEC.  
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6.2 Outlook  
The loading techniques discussed in this thesis present substantial progress towards the goals described in 
section 1.6. However, further improvements are possible by combining the different techniques and by 
optimizing the methods to improve understanding and yields. Developments can be directed towards new 
applications (new drugs and polymers) and to an integration with the overall NAMEC vision, i.e. the loading 
of biopolymer containers, the application of lids, and all the activities mentioned in section 1.4.  
With respect to the optimization of fabrication processes, improvements are possible in each technique. 
Inkjet printing of concentrated PVP solutions can be accomplished and microcontainers can be filled by 
polymer by multiple spotting sessions. However, the process could be speeded up by increasing the 
polymer concentration and thereby reducing the spotting time. At present, the high viscosity of 
concentrated solutions is a substantial limit. A way to overcome this limitation is to use heatable pipettes 
or special nozzles designed for highly viscous liquids. Both these kinds of nozzles are currently available for 
the equipment used in the project. The selective exposure to UV light requires a setup for mask alignment. 
Several UV-aligners are available in DTU Nanotech, but none of them were suitable to the purpose because 
of the low light power and the clamping system. 
From the structural characterization of PVP hydrogels it emerged that mesh size estimations strongly 
depend on the model chosen for the data treatment. An experimental validation of this aspect is therefore 
necessary. Several techniques can be used for this purpose. Small Angle Neutron Scattering (SANS) [1] and 
Transmission Electron Microscopy (TEM) [2] can be useful techniques to obtain a direct measurement of 
mesh size. The mesh size of polymer networks was also estimated by Pescosolido and coworkers by means 
of cryoporometry [3]. From the loading aspect of the study, it would be interesting to elucidate the 
biological activity of macromolecules after the loading in the gel.  
The methods developed can find further applications with other challenging drugs and polymers. The 
supercritical impregnation process developed for ketoprofen potentially works for all CO2 soluble drugs. 
Unfortunately, the majority of class II and IV drugs do not dissolve in supercritical CO2. As mentioned in 
section 2.3.2, a possible solution would be to add surfactants or co-solvent to the supercritical phase, and 
increase the solubility of the drug in the fluid phase.  
Microgels fabricated on mask chips by backside exposure to UV (see section 5.2.1) could be coated with a 
biodegradable container shell by spray coating through a shadow mask. 
Regarding the possibility of integration in NAMEC, further developments are possible in several directions. 
With the perspective of transferring the developed loading methods to biodegradable microcontainers, the 
effect of supercritical impregnation on PCL and PLLA should be tested. Similar to PVP, these polymers also 
absorb CO2 in supercritical conditions. Therefore, their Tg might also decrease with the uptake of CO2 and 
potentially induce deformation of the microstructure shaped in the hot embossing process. In that case, 
the use of biopolymers with higher molecular weight could avoid deformation. Alternatively, impregnations 
could be performed at lower pressure and temperature and eventually conducted for longer times. 
Some possible improvements concern fabrication aspects: UV micropatterning can be used to define 
microgels inside PLLA microcontainers. A preliminary result was already shown in section 5.5 (figure 5.24). 
The spin coating of PVP layers on PLLA microcontainers was already successfully accomplished. Further 
developments are linked to the design of a custom made alignment system for UV exposure. 
Subsequently, the hydrogel laden-microcontainers could be impregnated with scCO2.  
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From a more general viewpoint, the microdevices must be able to compete with established drug delivery 
systems like tablets and pills. To advance the concept of microdevices for oral drug delivery, the in vitro 
tests must be followed by in vivo tests in animals where the efficacy of the different features (drug 
protection, mucoadhesion, unidirectional release) must be verified. Finally, the research on microdevices 
should be focused on the treatment of a specific disease, and all the steps (device fabrication, drug loading, 
coating applications, etc) should be optimized for the development of a prototype designed for that 
purpose. 
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We present an innovative technique to dispense precise amounts of polymer solutions into large arrays of
microscopic wells. An inkjet printer (NP 2.1 GeSim, Germany) is used to ﬁll micro-wells with poly (vinyl
pyrrolidone) (PVP K10). The micro-wells are fabricated with cavity diameters of 300 lm down to 50 lm
with SU-8 with two steps of negative photolithography. Inkjet printing is shown to be a suitable tech-
nique to dispense deﬁned volumes of solution (down to 0.3 nL) in a highly reproducible way. The ﬁlling
with polymer can be controlled varying the concentration of the solution and the number of dispensed
droplets. Solutions of up to 20 wt.% PVP in water are successfully spotted.
 2013 Elsevier B.V. All rights reserved.
1. Introduction
Inkjet printing is a familiar technologywhich has been originally
conceived to transfer electronic data onto ﬂexible substrates like
paper and overhead transparencies. Recently, a variety of new
applications of this technology have been investigated. Versatile
tools have been developed to dispense minute amounts of a broad
range of materials for various industrial manufacturing processes.
Inkjet has been employed for high precision dispensing of polymer
intoMEMS switches [1], metallic solders inmicro-electronic solder-
ing [2], and UV curable epoxy resins for micro-optical applications
[3], representing a valuable mold-free manufacturing technique to
fabricate large arrays of 3D micro-objects [4]. In more recent years
inkjet printing has been introduced in the ﬁelds of biotechnology
and nanomedicine for large-scale screening of genomic material
[5], for cell culturing [6,7], for functionalization of Bio MEMS [8]
and for drug delivery applications [9,10]. This technique in so-
called drop-on-demand mode (DOD) allows dispensing precise vol-
umes of liquid solutions with a quasi-no-waste performance. For
this reason it has received increasing attention in the biotechnolog-
ical and pharmaceutical ﬁelds since it enables performing complex
analysis on small amounts of material, which are often expensive or
in limited supply. A frequent issue in dispensing biological solu-
tions onto ﬂat substrates deals with control of size, shape and rela-
tive distance of dots as well as alignment and regularity of realized
micro-arrays which occurs when spots are formed with a large
number of droplets [11]. As a solution, preliminary micro-pattern-
ing of the substrate has been proposed [12]. As alternative approach
for spatial conﬁnement of liquid volumes in nano and pico-liter
scale we here present microfabricated SU-8 wells.
SU-8 is a commonly used negative photoresist, well suited for
low-cost prototyping of high aspect ratio structures by standard
photolithography. Furthermore SU-8 has been shown to exhibit
biocompatible properties [13] which makes it a suitable support
for cells and biomolecules [14].
Previously, ﬁlling of microfabricated wells with discontinuous
de-wetting has been demonstrated [15]. The use of inkjet printing
for ﬁlling of micro-wells having cavity diameter from 50 to 300 lm
allows to conﬁne liquid volumes of pico up to nanoliter range on
precisely arranged positions, preserving the circular shape and
the size of dots. To accomplish that we use a commercial system
designed to spot on glass slides which prints large arrays of dots
with high speed. We dispense micro-arrays of various solutions
of PVP. Poly(vinyl pyrrolidone) (PVP) is a biocompatible polymer
[16] widely used as excipient for drugs for oral dosage forms [17]
as well as promoter of cell growth and differentiation. PVP exhibits
high solubility in water and many organic solvents [18], giving low
viscous polymer solutions [19].
Additionally, the effect of surface tension on the process of ﬁlling
the micro-wells is studied by dispensing PVP solutions with differ-
ent solvents (isopropanol and water). This has shown very different
results revealing that the surface tension of the solvent plays a key
role in the ﬁlling process of three dimensional micro-structures.
2. Materials and methods
2.1. Fabrication of micro-wells
The fabrication of the micro-wells is a process divided into two
main steps. (I) Anisotropic etching is used to deﬁne trenches in a
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silicon substrate in order to obtain easy-breakable rectangular sub-
strates ﬁtting into the slots of the inkjet printer tray, (II) negative
photolithography is used for the deﬁnition of the micro-wells. In
Fig. 1 the fabrication steps of the overall process are presented.
On a silicon wafer an oxide layer (2 lm) is deposited by LPCVD
(Fig. 1a). A positive photoresist (AZ 5214e) is spin coated on the
front side and patterned by photolithography (Fig. 1b). Afterwards,
the same resist is spin coated on the back side. In this way the re-
sist pattern on the front side and the back side layer act as protec-
tive mask for the etching of the silicon oxide layer (BHF for 30 min)
(Fig. 1c). The resist is then stripped and an anisotropic etching in
KOH (4 h, 80 C) deﬁnes the trenches for the aligned cleavage of
the wafer after micro-well fabrication (Fig. 1d). The remaining
oxide layer is then removed in BHF (4 min) to improve SU-8 adhe-
sion in the next fabrication step. For the well fabrication, a ﬁrst
layer of SU-8 2075 (thickness 35 lm) is spin coated and selectively
exposed to deﬁne the bottom of the micro-wells (Fig. 1e). A second
layer (255 lm) of the same resist is spin coated and patterned
(Fig. 1f). Finally, the uncrosslinked resist is developed in propylene
glycol methyl ether acetate (PGMEA) (Fig. 1g). Fig. 2a shows a wa-
fer after microfabrication. The silicon chips are cleaved (Fig. 1h)
along the trenches (red lines shown in Fig. 2a) deﬁning a rectangle
which ﬁts into the slide slots of the inkjet printer tray (Fig. 2b).
Each slide contains ten squares (outlined in green in Fig. 2(a) which
contains 625 micro-wells each. The micro-wells are aligned into a
25  25 matrix. Micro-wells are fabricated with cavity diameters
of 50 lm, 100 lm, 200 lm, 300 lm corresponding to volumes
going from 0.5 to 18 nL. The width of the well walls is 50 lm
and the center-to-center spacing is 450 lm for all wells.
2.2. Inkjet printing of PVP solutions
Solution of poly (vinyl pyrrolidone) PVP K10 (Mw 105 Da) is
dissolved in deionized water and isopropanol in different concen-
trations (5, 10 and 20% wt). For the more concentrated solutions,
viscosity measurements are performed to ensure that the liquid
exhibits a Newtonian behavior and a viscosity value below 5 mPa s.
This is the minimum viscosity value for dispensable liquids
according to the speciﬁcations of the equipment used. All the
chemicals are purchased from Sigma–Aldrich.
The inkjet printer used in this work is schematically repre-
sented in Fig. 3. It is mainly composed of a XYZ movable inkjet
head (Nanoplotter NP 2.1 GeSim, Germany) equipped with a piezo
driven dispenser with 70 lm oriﬁce (GeSim nanotip) and a slide
tray where the substrate is mounted. The solution is aspired by
the pipette from a well in a titer plate where the sample is stored
at the desired temperature. The inkjet head is monitored by a con-
trol unit connected to a computer. A top microscope camera is
integrated into the pipette head and allows the alignment of the
pipette. The system is supplied with a stroboscope camera (side
view camera) to visualize and tune the jet direction and stability,
as well as shape and diameter of the generated droplets. The inten-
sity, duration, and frequency of the voltage applied to the piezo-
electric actuator of the dispenser are tuned for optimized micro-
well ﬁlling. The optimum set of parameters is a pulsing voltage
of 90 V, a pulse width of 90 ls and a frequency of 175 Hz for all
the solutions. The diameter of the droplets is measured with the
stroboscope imaging, and is 47 lm for 20 wt.% PVP and 53 lm
for 5 and 10 wt.% PVP.
2.3. Micro-well ﬁlling
PVP solutions are dispensed by DOD inkjet printing into wells of
different sizes. The number of droplets to dispense in each well is
estimated dividing the cavity volume by the droplet volume. An
overview of the spotting plan is shown in Table 1. The typical time
needed for spotting an array of 625 wells is around 12 min. To in-
crease the polymer content inside the micro-wells, the spotting
process is repeated up to three times on the same arrays in subse-
quent printing sessions, where during each session a solution vol-
ume equal to the cavity volume is dispensed into each micro-well.
Between the sessions, a waiting time for solvent evaporation is
introduced in order to avoid spillover. The evaporation of the drops
is observed with the top view camera and the time is measured.
The typical drying times for isopropanol and water based-solutions
are 1 and 2 min respectively. The polymer concentration dose not
Fig. 1. Process ﬂow for the fabrication of micro-well on Si microscope slides: (a) LPCVD (2 lm) on silicon wafer; (b) photolithography with positive resist on the front side
(2.2 lm), spin coating of the resist (2.2 lm) on the back side; (c) wet etching of oxide in BHF; (d) resist stripping and wet etching in KOH of Si; (e) SU-8 spin coating (34 lm)
and selective UV exposure; (f) spin coating of second layer of SU-8 (255 lm) and masked exposure; (g) SU-8 development; (h) Chips are cleaved in microscope slides.
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sensitively affect the evaporation time of dispensed solutions. To
measure the ﬁlling level of the micro-wells, the chips are coated
with an Aluminum layer (15 nm, Alcatel SCM 600). The PVP
thickness is then measured by means of an optical proﬁler (PLu
Neox Optical Proﬁler, Sensofar), equipped with 50 objective to
measure cavity diameter (300 and 200 lm) and 20 (100 and
50 lm). The proﬁler is set in confocal mode, with a monochromatic
blue light (460 nm). Each micro-well is scanned along a cross sec-
tion passing through the well center within a scanning range of
400 lm with a resolution of 1 lm.
3. Results and discussion
3.1. Level of micro-well ﬁlling
Arrays of wells with cavity diameter of 50, 100, 200 and 300 lm
are ﬁlled with aqueous solutions of PVP at different concentrations.
In Fig. 4a a microscope picture of three arrays of ﬁlled wells is
shown. In Fig. 4b a SEM picture of an empty well (bottom right)
and a ﬁlled one (top left) is shown. SEM pictures of micro-wells
after ﬁlling reveal that large arrays of micro-wells can be ﬁlled
with high precision and a quasi-no-waste deposition (see Fig. 4c)
can be achieved when subsequent printing steps are performed
on the same wells and a waiting time for solvent evaporation is in-
cluded. According to the viscosity limit of the dispensing system, a
concentration of polymer up to 20 wt.% is successfully spotted. It is
observed that water solutions can be spotted with a higher volume
than the micro-well cavity, because the high surface tension of
water on SU-8 conﬁnes the solution in a cap on the top of the mi-
cro-structures (see Fig. 5). Upon drying of the liquid, the liquid cap
shrinks, and the polymer is deposited in the cavity. After water
evaporation the micro-wells are analyzed with scanning electron
microscopy and the polymer deposition looks similar to Fig. 4c.
The change of jet frequency is also investigated but it did not affect
the coating performance. Thus the content of polymer in each mi-
cro-well can be controlled by varying its original concentration in
the solution and repeating several printing sessions. The level of
polymer ﬁlling is measured with an optical proﬁler. An array of
25 micro-wells is scanned for each micro-well dimension, for the
three different level of ﬁlling (i.e. inkjet sessions), along their cross
section passing through the center. In Table 2 the thickness of the
polymer layer in the center of the micro-wells is shown. The re-
ported values are given by the difference of the height of the poly-
mer layer and the well bottom thickness (35 lm). By comparing
Fig. 2. Wafer after the fabrication process: (a) red rectangle outlines the Si microscope slide composed by 10 square chips (green). Each square contains a 25  25 matrix of
micro-wells. (b) Si slide placed on the nano-plotter tray. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
Fig. 3. Scheme of the inkjet printer setup. The micro-pipette is mounted on a XYZ
movable head. It aspires the liquid sample to be dispensed from a microtiter plate.
The aspiration is driven by a dilutor pump. A functional pipette check takes place in
the stroboscope, and if it is successful, the spotting on the substrate begins. During
spotting the pressure of the diluter pump is kept constant by system liquid (water).
Table 1
Dispensed volumes of polymer solution for different well sizes for one inkjet session.
Cavity
diameter
(lm)
Cavity
volume
(nL)
Dispensed volume for one inkjet session
5%, 10%
wt PVP
Number of
droplets
20%
wt
PVP
Number of
droplets
300 18 18 60 18 75
200 8 7.5 25 7.7 32
100 2 1.8 6 1.9 8
50 0.5 0.3 1 0.5 2
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the ﬁlling level with the corresponding number of droplets it can
be noticed that the increase is non-linear. This is due to the fact
that the polymer tends to be distributed also on the walls of the
wells, and this coating layer gets gradually thicker with the level
of ﬁlling. The roughness of the surface due to cracks induced by
the polymer shrinking does not allow a more accurate computation
of the polymer volume by numerical integration.
3.2. Effect of surface tension on deposition
The effect of surface tension is investigated by dispensing solu-
tions of PVP in isopropanol. This is motivated by the intention of
testing a selective conformal coating of three dimensional micro-
structures. The deposition of a hydrophilic polymer like PVP can
be used to permanently change surface properties of SU-8. For this
purpose, solution of 2 wt.% PVP K10 is dispensed into wells with
cavity diameter of 200 lm. The substrate temperature is kept at
50 C in order to shorten the solvent evaporation time. The droplet
volume is 0.3 nL. Fig. 6 shows SEM images of wells ﬁlled with 1000
droplets at different frequencies: 100 Hz (Fig. 6a), 200 Hz (Fig. 6b)
Fig. 4. (a) Microscope image of three arrays of micro-wells ﬁlled with 10 wt.% PVP. SEM images of (b) an empty (bottom right) and a ﬁlled well with diameter 50 lm (top left),
(c) 300 lm inner diameter wells ﬁlled with 5 wt.% PVP.
Fig. 5. Microscope picture from the side of one micro-well spotted with 4000
droplets of PVP in deionized water (2 wt%) with a drop ejection frequency of
100 Hz.
Table 2
Filling level of polymer for different well sizes after one, two and three inkjet sessions with solutions of PVP 20wt% in water. Each value is the average of 25 micro-wells.
Cavity diameter (lm) Polymer thickness after subsequent inkjet sessions
Number of droplets Polymer height (lm) Number of droplets Polymer height (lm) Number of droplets Polymer height (lm)
300 75 8 ± 2 150 20 ± 1 225 24 ± 1
200 32 88 ± 7 64 132 ± 9 96 155 ± 2
100 8 102 ± 3 16 223 ± 7 24 246 ± 5
50 2 125 ± 5 4 182 ± 4 6 282 ± 8
Fig. 6. SEM pictures of micro-wells spotted with PVP in isopropanol solution (2 wt.%). The same solution volume is dispensed with a drop ejection frequency of 100 Hz (a),
200 Hz (b) and 500 Hz (c).
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and 500 Hz (Fig. 6c). For all three cases, the same volume of solu-
tion is dispensed, with equal droplet size (not depending on the jet
frequency), but with different dispensing rates. In any case the
solution does not ﬁll the cavity, but tends to wet the surface of
the well and covers it with a homogeneous coating. However, at
higher frequency, not only the well is coated but also an increasing
part of the substrate in between the wells.
In the SEM pictures in Fig. 7 the effect of droplet number on the
coating is shown: 1000 (7a), 2000 (7b) and 6000 droplets (7c) are
dispensed at a constant frequency of 100 Hz. PVP layer thickness
increases with the droplet number. 1000 droplets are dispensed
without spillage. These results are explained by the low contact an-
gle of isopropanol on SU-8. Before evaporation, the solvent wets
the well distributing the polymer uniformly on its surface. The re-
sult is a conformal coating of the three dimensional structure. The
effect of frequency can be explained by the different time it takes
for the droplets of solution, to dry once they land on the micro-well
bottom. The higher the spotting frequency, the longer is the time
the solution remains wet. The droplets coalesce and form a liquid
mass that symmetrically ﬂows onto the surrounding available sur-
face until the solvent dries.
4. Conclusions
In this work we show the fabrication of polymer-ﬁlled micro-
wells using DOD inkjet printing technology. By means of wet etch-
ing, silicon microscope slides are obtained. On top of them SU-8
micro-wells with cavity volumes down to 0.5 nL are fabricated
with a two step photolithography process. Controlled volumes of
PVP in aqueous solutions are dispensed inside the micro-wells,
with a good reproducibility in terms of alignment and dispensed
volume. Polymer concentrations up to 20% (wt) are successfully
dispensed. Water-based solutions completely ﬁll the cavity volume
and the polymer content is controlled by repeated spotting
sessions.
Other deposition types are investigated by changing the solvent
of the PVP solution. Inkjet printing of isopropanol solutions results
in a conformal coating as an effect of the lower contact angle on
SU-8. Thus, according to the purpose of the deposition, it is possi-
ble to obtain either a conformal coating of the exposed surface or a
ﬁlling with the same polymer just by changing the solvent of the
dispensed solution. The conformal coating with PVP can allow to
selectively modify the surface tension of three dimensional
micro-structures. This potentially avoids the limitations of other
methods, like plasma activation and wet chemical functionaliza-
tion, which usually change surface properties on wafer scale. In
conclusion, we demonstrate a very versatile ﬁlling technique for
three dimensional micro-structures that can be tuned for several
purposes, including promising applications in the ﬁeld of micro-
devices for drug delivery and biomedical research.
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In the last years a large variety of drug delivery systems have been developed to improve bioavailability of ther-
apeutics in oral administration. An increasing interest has arisen in reservoir-basedmicrodevices designed for ac-
tive ingredients like water insoluble compounds and fragile biomolecules. Such microdevices are designed to
protect the active ingredient against degradation and deactivation, and to allow cytoadhesion and unidirectional
drug release. There are few works which optimize the drug loading step and often therapeutics are dosed in the
microdevices through laborious and time consuming procedures. This work proposes an effective loading
technique for a poorly soluble model drug in microcontainers, by combining inkjet printing and supercritical
ﬂuid impregnation. Well deﬁned quantities of poly(vinyl pyrrolidone) (PVP) solutions are dispensed into
microcontainers by inkjet printing with a quasi-no-waste performance. Then ketoprofen is impregnated in the
polymermatrix by using supercritical carbon dioxide (scCO2) as loadingmedium. The amount of polymer is con-
trolled by the volume and the number of droplets of dispensed polymer and drug loading is tuned by varying the
impregnation parameters. Compared to solid dispersions of the same drug and polymer, scCO2-impregnated
microcontainers exhibit a more reproducible drug loading and a faster dissolution rate of the active compound
which allows drug release to be modulated. The combination of these loading techniques potentially allows
the high throughput fabrication of microdevices for oral drug delivery with a safe and solvent-free
solution.
© 2013 Published by Elsevier B.V.
1. Introduction
In these last years one of the most challenging tasks in the pharma-
ceutical research is ﬁnding effective and safe solutions to administrate
active principles through the oral delivery that still represents the
preferred administration route, being less invasive, simple and usually
requiring no assistance. However between the oral ingestion and the
therapeutic effect there is a sequence of barriers which limits the bio-
availability of amolecule in the oral delivery [1]. Traditional pharmaceu-
tical dosage forms deliver the active ingredient in an omni-directional
release, through a limited interfacial area in the physiological ﬂuids. As
a consequence, frequent administrations are needed in order to main-
tain an efﬁcient therapeutic action. Therefore high drug doses are
swallowed, which is the cause of serious side effects for the GI tract of
patients [2]. Furthermore such an ineffective delivery mechanism re-
sults to be unpractical and economically prohibitive for expensive
drugs. One option is given by the downscaling of drug delivery systems
to dimensions, which at the same time can allow a more intimate
contact with the irregular surface of the mucosa and avoid unspeciﬁc
endocytosis. In recent years microtechnology has substantially contrib-
uted with innovative drug delivery systems at the micro- and nano-
scales [3–5]. In particular there has been an increasing interest in
reservoir-based microdevices [6–9] for carriers of water insoluble
compounds and fragile biomolecules. These microdevices are designed
to provide protection against drug degradation, cytoadhesion, and uni-
directional drug release. There are fewworks in thisﬁeldwhich focus on
optimizing the drug loading step. Indeed the fabrication processes in-
vestigated so far require the use of relatively high temperature [10], or
exposure to energetic UV radiation [7,8], which can cause degradation
of the active ingredient [11], andmay give unknown andpossibly harm-
ful products. The active ingredients are loaded by means of techniques
which either require laborious and time-consuming procedures, or in-
clude large waste of chemicals [12]. Moreover, when the drug being
loaded is poorly soluble in water, potentially toxic organic solvents are
used largely.
In this work we present the reproducible drug loading of micro-
containers for oral delivery of a poorly water soluble compound. A
prototype of these devices is made with epoxy resin (SU-8) through a
double step photolithography process. The microcontainers are de-
signed with a circular base, cylindrical walls, and an open top side
with a cylindrical cavity of 50 to 300 μm in diameter. Dimensions can
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easily bemodiﬁed by changing process parameters. For thedrug loading
we sequentially combine inkjet printing and supercritical ﬂuid (sc) im-
pregnation. These two different technologies allow the minimization of
the waste of therapeutic compound used in the loading process and the
provision, at the same time, of a safe, solvent-free and ecologically
friendly solution.
The use of inkjet printing is already established in the ﬁelds of
biotechnology and nanomedicine, mostly for large scale screening
of genomic material [13], for cell culturing [14,15], and surface
functionalization of Bio MEMS [16]. The reason of such a wide use
is mainly due to the so called drop-on-demand (DOD) mode which
allows precise volumes of liquid to be dispensed with a quasi-no-
waste performance. More recently it was also applied in drug deliv-
ery, for example in the production of nanoliter doses of felodipine
in ethanol and DMSO mixtures [17]. In a previous work we demon-
strated that the deposition of aqueous solutions of poly(vinyl pyrrol-
idone) (PVP) by inkjet printing resulted in well deﬁned ﬁlling of
microcontainer cavities, while dispensing of organic solvent-based poly-
mer solutions gave a pronounced spilling out of the microwells [18].
Moreover, our investigation of inkjet printing of several solutions contain-
ing water insoluble drugs showed a low reproducibility of the spotting
performance, as well as low drug loading capacity. Therefore aqueous
solutions are the most suitable for the purpose of drug loading of
microcontainers. This implicates that the poorly soluble drug of interest
cannot be directly spotted in the microwells and another drug loading
step is needed.
In this work inkjet printing is used to dispense water-based so-
lutions of poly(vinyl pyrrolidone) (PVP) in water with precise vol-
umes in the pico up to nanoliter range into microcontainers. PVP is
a non-toxic polymer [19,20], which is widely used as excipient for
oral dosage forms [19], and as solubility enhancer for water insoluble
pharmaceuticals [21].
As a second step, the poorly soluble model drug ketoprofen, is
loaded by means of sc ﬂuid impregnation into the PVP ﬁlled con-
tainers. The sc ﬂuid is a high pressure phase characterized by a
liquid-like density, and a gas-like viscosity and in recent times its
use in the impregnation of polymers has been studied extensively
[22–25]. Carbon dioxide has a critical point of 73.8 bar and 31.1 °C
and is a non-polar, safe, non-ﬂammable and ecologically friendly
chemical, which makes it a versatile solvent for temperature sensi-
tive hydrophobic drugs [26,27]. In this process the crystalline drug
dissolves in the supercritical carbon dioxide (scCO2) and the drug-
enriched ﬂuid swells the polymer matrix acting as a plasticizer for
the polymer chains; in this way the ﬂuid acts both as a dissolution
medium for the drug and as a mixing agent for drug and polymer,
where the solute is physically conveyed into the PVP matrix by con-
vection and diffusion. As the pressure of CO2 is reduced, it ﬂows out
of the polymer matrix due to its high mobility, leaving the drug
molecules entrapped between the polymer chains. By proper choice
of pressure and temperature, it is possible to keep the polymer con-
ﬁned in the micro-wells while the swelling occurs, and at the same
time dissolve and load the drug in the matrix in controlled amounts.
A remarkable aspect of this process is the easy modularity of the
loading: a simple change in pressure and time allows different and
controllable moieties of therapeutic ingredients to be impregnated
into large arrays of containers, allowing potential upscaling of the
process for production.
Drug absorption can be enhanced by improving the dissolution
rate with respect to the retention time of the microdevice across
the GI tract. The use of scCO2 as formulation medium, allows acceler-
ated drug release from polymer–drug solid dispersions [26]. Several
studies [27–29] have showed that impregnated polymers release ac-
tive ingredients faster than comparable conventional tablets. Herein,
we demonstrate that microcontainers loaded using scCO2 release
ketoprofen quicker than microcontainers ﬁlled with solid disper-
sions conventionally used in tablet preparation.
2. Materials and methods
2.1. Fabrication of SU-8 microdevices
2.1.1. Materials for microfabrication
Ketoprofen (N98%, racemate) and polyvinylpyrrolidone (PVP, Mw
10,000) were supplied by Sigma Aldrich. Carbon dioxide was supplied
by BOC (Guildford, UK).
Silicon wafers (4-inch b100N n-type) were supplied by Okmetic
(Vantaa, Finland). SU-8 2075 and SU-8 developer were purchased
from Microresist Technology GmbH (Berlin, Germany). The chromium
mask was designed using L-Edit from Tanner EDA (Monrovia, CA,
USA) and supplied by DeltaMask B.V. (GJ Enschede, The Netherlands).
2.1.2. Microfabrication process
The cylindrical microcontainers were fabricated with a similar pro-
cedure as outlined earlier [18]. Two steps of negative photolithography
with the epoxy-based photoresist SU-8 were performed to deﬁne the
bottom and the walls of the containers, respectively. Fig. 1 shows the
sequence of steps involved in the overall microfabrication process.
Several baking steps on a hotplate, with a ramping rate of 2 °C min−1
leading to the ﬁnal bake temperature of 50 °C were involved in the
microwell fabrication procedure. For the deﬁnition of the bottom of
themicrocontainers, SU-8 2075was dispensed onto 4 inch siliconwafers
by a Liquid Dispenser 1500-XL (Nordson EFD, Bougival, France). The SU-8
was spin coated using a RC8 spin-coater (Karl Süss, Lyon, France)with an
Fig. 1. Schematic representation of the fabrication process of SU-8microcontainers: (a) resist
spin coating on etched Siwafer, (b)mask alignment, UV exposure anddevelopment, (c) spin
coating, mask alignment, exposure of second resist layer and development, (d) inkjet print-
ing of polymer solution, and (e) scCO2 impregnation of the drug (for more details see
Section 2.1.2).
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installed GYRSET rotating cover plate (Fig. 1a). Spin coating was carried
out in two steps, the ﬁrst one with an acceleration of 200 rpm s−1 to a
speed of 1000 rpm maintained for 30 s, followed by an acceleration of
400 rpm s−1 to a speed of 3000 rpmmaintained for 120 s. The resulting
SU-8 ﬁlm thickness was 33.5 ± 0.9 μm. The solvent was then removed
during a soft-bake for 2 h. The SU-8 was then selectively exposed to a
dose of 2 × 250 mJ cm−2 of UV light through a chromiummask in soft-
contact mode (Fig. 1b) with a break of 30 s between the intervals in a
MA6/BA6 mask aligner (Karl Süss, Garching, Germany) equipped with
an I-line ﬁlter (365 nm, 20 nm FWHM). To achieve polymerization of
the exposed areas, a post-exposure bake (PEB) for 6 h followed the
exposure. For the deﬁnition of the container walls, a second step of UV
lithography with SU-8 was included. Spin coating was performed with
an acceleration of 100 rpm s−1 to a speed of 300 rpm maintained for
30 s, followed by an acceleration of 100 rpm s−1 to a speed of 600 rpm
maintained for 60 s (Fig. 1c). The thickness of the second layer of SU-8
as a result of this process was 255 ± 10 μm. Both soft bake and PEB
had a duration of 10 h. UV exposure was performed with a dose of
3 × 250 mJ cm−2 using a second chromium mask in proximity mode.
Finally, the non-polymerized SU-8 was developed by immersion in pro-
pylene glycolmethyl ether acetate (PGMEA) for 40 min, followed by rins-
ing in isopropyl alcohol for 30 s and drying in air. The resulting
microcontainers had inner diameters of 200 ± 3 μm and volumes of
8 ± 0.5 nl, respectively. The silicon wafers supporting the fabricated
microcontainers were ﬁnally parted into squares of 12.8 × 12.8 mm2 by
simple manual cleavage each containing 625 containers. The is enabled
by a preliminary wet etching step in KOH deﬁning trenches, as described
in a previous work [18]. SU-8 is not approved by FDA as a material for
medical use, because it has not shown acceptable non-toxic properties.
In this work it has been used for the fabrication of a prototype
microdevice, because of its simple and relatively fast preparation and to
validate the loading technique presented.
2.2. Deposition of PVP solution in the microcontainers and preparation of
PVP ﬁlms
The microwells were ﬁlled with PVP by means of an inkjet printer
(Fig. 1d) as described previously [18]. PVP was dissolved in DI water
(10 wt.%) and the solution was stirred for 3 h. The viscosity of the solu-
tion (data not shown) was checked with a controlled stress rotational
rheometer (Haake RheoStress 300) equipped with a cone-plate rotor
device, in order to conﬁrm the Newtonian behavior and measure
the viscosity of the liquid which must be below the technical limit
of 5 mPa·s of the inkjet printer.
The inkjet printer is composed of a XYZ movable inkjet head
(Nanoplotter NP 2.1 GeSim, Germany) equipped with a piezo-driven
dispenser with a 70 μm oriﬁce (GeSiM nanotip). The silicon substrate
is placed on the slide tray. The solution is aspired by the pipette from
a well in a titer plate where the liquid is stored at the desired tempera-
ture. The printer works in a semi-automatic mode, since the inkjet head
is monitored by a control unit connected to a computer. The jet direc-
tion, its stability and the droplet size are visualized by means of a stro-
boscope camera (side view). The intensity, duration, and frequency of
the voltage applied to the piezoelectric actuator of the dispenser were
tuned for optimized microcontainer ﬁlling [18]. The optimum set of
parameters is a pulsing voltage of 90 V, a pulse width of 90 μs and a
frequency of 175 Hz for all the solutions and the corresponding droplet
volume is 0.3 nl. After the polymer deposition the chips were left on a
hotplate at 50 °C for 1 h to remove the solvent. The chips were weight-
ed before and after the polymer deposition and the polymer weight per
chip was estimated. Characterization of polymer ﬁlled microcontainers
was done with a Plu Neox 3D Optical Proﬁler (Sensofar) in the confocal
mode.
Polymer ﬁlms were prepared with the same solution used for
the inkjet printing (10 wt.% in DI water). These samples were intended
for spectroscopic characterization studies. The ﬁlms were cast in a
cylindrical cavity of a teﬂon mold (diameter 5 mm, height 0.255 mm)
with the volume equal to the sum of 625 microcontainers. A volume
of 5 μl of solution was dispended in the mold and left on a hotplate at
50 °C for 1 h to remove the solvent.
2.3. Drug loading of microdevices
2.3.1. Supercritical ﬂuid impregnation
The drug was loaded into polymer-ﬁlled microdevices by means of
supercritical carbon dioxide impregnation (Fig. 1e). The operation was
performed in a 100 ml high pressure reactor with sapphire windows
(Thar SFC) in batch conditions, with steady state values of CO2 pressure,
temperature and stirring velocity. Impregnation experiments on
microcontainers were performed at 40 °C, 100 and 200 bar, 1 and 4 h.
Different weights of active ingredient were placed on the bottom of
the high pressure chamber, according to the quantities tested by
Macnaughton et al. [30] to achieve saturation condition at deﬁned pres-
sures of supercritical carbon dioxide. The chip with microcontainers
wasplaced on a steel gridﬁtting the chamber's cross section. The reactor
was sealed and ﬁlled with liquid carbon dioxide by means of a high
pressure pump with a controlled pressure ramp. With the increase of
the pressure, the drug dissolved in the supercritical ﬂuid. Once the
ﬂuid achieved the desired pressure and temperature, the mixing was
activated. PVP ﬁlms in the Teﬂon holder were submitted with the
same procedure to supercritical impregnation at 100 and 200 bar for
1 h. At the end of the experiment the reactor was depressurized at a
controlled rate in 2 and 3 h when the operating pressures were 100
and 200 bar respectively. The CO2 with the excess of active principle
was bubbled through an ethanol solution (99.5%), where the drug is
solubilized and collected. The ketoprofen concentration in the ethanol
solution was measured with a UV spectrophotometer (data not
shown) to cross check the drugmass balance of the operation. Themor-
phology of the impregnatedmicrocontainers was examined using SEM.
The investigationswere carried out using a Nova600 NanoSEM from FEI
(Eindhoven, the Netherlands). Imagingwas performed in low-vacuum-
mode at a pressure of 0.6 mbar and an operation voltage of 5 kV. Prior
to examination, the samples were mounted onto metal stubs and
were tilted by 30°.
2.3.2. Preparation of micro-tablets
PVP–ketoprofen physical mixtures were prepared by gently mixing
the two powders with a mortar (1:9 and drug:polymer weight ratio).
The physical mixtures were ﬁlled into empty microcontainers resulting
in an array of micro-tablets. The residual material in between adjacent
containerswas removed using pressurized air. The chipswereweighted
before and after the ﬁlling. The amorphous drug micro-tablets were
obtained by heating containers ﬁlled with the mixture at 120 °C for
3 min on a hotplate and quenching in liquid nitrogen for 1 min. This
sequence was repeated thrice.
2.4. Spectroscopic characterization and X-ray diffraction
Raman and ATR–IR spectroscopymeasurements were performed on
microcontainers and ﬁlms to investigate the drug–polymer interactions
after supercritical treatment.
Raman spectra were collected from the impregnatedmicrocontainers
24 h after the CO2 treatment with a DXR Ramanmicroscope (Thermo
Scientiﬁc, Germany) equipped with a frequency-stabilized single mode
diode laser (780 nm). The laser power was set to 10 mW at the sample
position (center of the container cavity) and the estimated resolution
was 2.4–4.4 cm−1. An exposure time of 1 s and 40 scans were used.
Because of the strong auto-ﬂuorescence of SU-8, a dedicated correction
was applied to the spectra during the collection.
A Spectrum 100 spectrometer (Perkin Elmer, Germany)with anMIR
source and a TGS detectorwas used tomeasure the ATR–IR spectra from
the impregnated PVP ﬁlms 24 h after preparation. The resolution was
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set to 4 cm−1 and 16 accumulations with a scan speed of 0.2 were
collected.
The X-ray powder diffraction (XRPD) study was carried out to
characterize the physical state of the drug in the impregnated
microcontainers and micro-tablets. All XRPD analyses were performed
using an X'Pert PRO X-ray diffractometer (PANalytical, Almelo, The
Netherlands; MPD PW3040/60 XRD; Cu KR anode; λ = 1.541 Å;
45 kV; 40 mA). A starting angle of 5° 2θ and an end angle of 45° 2θ
were employed for the scans. A scan speed of 0.6565° 2θ/min and a
step size of 0.01313° 2θ were employed. Data were collected using the
X'Pert Data Collector software (PANalytical B.V.).
2.5. In vitro drug dissolution studies
Dissolution of PVP and ketoprofen from loadedmicrocontainers was
measured in 10 ml DI water at 37 °C using a μDISS proﬁler (Pion). Indi-
vidual chips were glued with carbon pads on teﬂon-coated magnetic
stirrers. For the detection of ketoprofen release, the UV probe wave-
length was set at 259 nm. After dissolution, the microcontainers were
checked with an optical microscope to conﬁrm complete emptying.
The amount of drug loaded per chip was estimated by the ﬁnal concen-
tration value in the dissolution proﬁles obtained after 16 h. Solubility of
ketoprofen at 37 °C in aqueous solutions changes signiﬁcantly with pH
between 1 and 7 [31]. The dissolution tests were performed at pH 7
where ketoprofen solubility is N1.4 mg/ml. With ketoprofen being a
weak acid (pKa = 4.5) thepHof thedissolutionmediumdid not change
sensitively during the dissolution tests. Therefore dissolution tests were
performed in sink conditions.
3. Result and discussion
3.1. Fabrication of microcontainers
Cylindrical microcontainers have been fabricated on silicon wafers
as previously described [18]. At ﬁrst, the silicon wafer undergoes a
wet etching step to deﬁne trenches along which it can be cleaved man-
ually after completed processing. The fabrication process is composed of
two steps of photolithography with the negative photoresist SU-8
which is used for the deﬁnition of the micro-wells. In Fig. 1 the fabrica-
tion steps of the overall process are presented. The silicon wafer is then
cleaved into three rectangular slides ﬁtting on the inkjet printer tray.
Each slide holds ten squared chips containing 625 microcontainers
arranged in a 25 × 25 matrix (see Fig. 2). Subsequently the rectangular
slides are manually broken into individual chips for sc impregnation
with the drug. The prototype device has a cavity of approximately
200 μm in diameter and 255 μm in depth. Cavity volume is approx-
imately 8 nl. The dimension can be changed by varying the spin-
coating procedure of photoresist layers.
3.2. Inkjet printing of PVP solutions into microcontainer
Themicrocontainerswereﬁlledwith PVP10wt.% in deionizedwater
solution with an inkjet printer as described in a previouswork [18]. The
printer works in a drop-on-demandmode and the droplet diameter can
be tuned in the range of 50–80 μm. The printer works in a semi-
automatic mode: once the alignment is set, the inkjet head dispenses
controllable volumes of liquid in pre-deﬁned patterns. The number of
droplets to dispense in each container is estimated dividing the cavity
volume by the droplet volume. Three subsequent printing sessions
have been performed on the same array and waiting time between
the sessions has been included in order to enable solvent evaporation
and to avoid spillover. The level of container ﬁlling has been measured
Fig. 2. Picture image of an inkjet tip on a chip containing a 25 × 25 container matrix.
Fig. 3. (a) SEM picture of a polymer ﬁlled microcontainer with outlined cross section,
(b) 2D proﬁles of an empty (dotted line) and ﬁlled microcontainer (solid line) with 64
droplets of PVP 10 wt.% in water scanned with the optical proﬁler.
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with an optical proﬁlometer. Fig. 3 shows the two dimensional proﬁle of
a polymer-ﬁlled container. The measured average thickness is
141 ± 9 μm. The weight of polymer dispensed onto one chip (625
micro-wells) corresponds to 1.6 ± 0.04 mg. The high accuracy of poly-
mer deposition shows that inkjet printing can be used to dispense precise
quantities of polymer with a quasi-no-waste performance. The precise
control of the dispensedpolymermass is important to control the amount
of drug loaded in each microreservoir.
3.3. Loading of ketoprofen into polymer-ﬁlled microreservoirs
After the polymer deposition, silicon slides have been cleaved into
chips. The drug loading is performed on individual chips. The weighted
ketoprofen amounts have been dissolved in scCO2 in saturation condi-
tions, according to the results found by Macnaughton and co-workers
[30]. As shown in several works [30,32] the solubility of ketoprofen in
sc CO2 monotonically increases with the ﬂuid density, hence with
ﬂuid pressure in isothermal conditions [33]. The impregnations were
performed at 100 and 200 bar at 40 °C and for 1 and 4 h in order to in-
vestigate the role of the operating conditions on the drug loading. Fig. 4
shows scanning electron microscopy (SEM) images of microcontainers
subjected to sc impregnation. The ﬂuid pressure during the impregna-
tion has a relevant inﬂuence on the volume of the polymer which in-
creases with rising CO2 pressure, as appears clearly by the comparison
of Fig. 4a and b. This is likely explained by an increase of CO2 uptake
in the PVP matrix with pressure, as shown by Kikic and Vecchione
[34]. As scCO2 acts as a plasticizer for polymers, the viscosity of the
CO2 saturated matrix decreases during the impregnation, causing in
some cases spillages from the containers. This aspect is more pro-
nounced for longer experiments (see Fig. 4c and d). Polymer softening
and swelling play an essential role with respect to the desired quasi-
no-waste performance. For an optimal combination of inkjet printing
and sc impregnation, the PVP must remain conﬁned in the cylindrical
cavity of the micro-well. During impregnations at 200 bar, several
droplets were deposited in the space in between adjacent micro-
containers (see Fig. 4d). This effect was observed when the depressuri-
zation rate at the CO2 critical pressure was higher than 1.1 bar min.
Compared to that, there was a negligible polymer spillage with a con-
stant pressure decay over time. The holes in the de-swelling matrix,
also shown in Fig. 4d, are probably due to the formation of micro-
pores during CO2 release. All the SEM images show no effect of the
supercritical ﬂuid on SU-8 in the micro-scale.
3.4. Controlled in vitro drug release from impregnated microdevices and
Raman characterization
To measure the ketoprofen release from the microcontainers, disso-
lution measurements were carried out on individual chips.
Fig. 5 shows the in vitro dissolution proﬁles of microcontainers load-
ed via scCO2 impregnation at different conditions. As a control experi-
ment, microcontainers without PVP were submitted to ketoprofen
impregnation (at 200 bar 40 °C 4 h). The different amounts of drug re-
leased show that both the sc ﬂuid pressure and the impregnation time
signiﬁcantly inﬂuence the loading. As shown in the release proﬁles in
Fig. 5, the drug uptake increases with an increase in the ﬂuid pressure
and with a larger duration of the impregnation. This suggests that the
polymer swelling and the drug diffusion play a relevant role in the load-
ing. In Table 1 the weights of loaded drug per chip in terms of absolute
value, drug/polymer weight ratio and weight fraction are shown. The
effect of the pressure may be attributed to the fact that both the drug
solubility and the CO2 uptake in the polymer increase with the sc ﬂuid
pressure. At 200 bar a higher number of drug molecules can interact
with the polymer chains, and this results in an enhanced loading. The
effect of time can be explained supposing that the impregnation follows
a diffusion-limited mechanism. A previous work shows that SU-8
microstructures treated with scCO2 undergo only small mechanical
changes [35], which is also conﬁrmed by our SEM micrographs. There-
fore it may reasonably be assumed that SU-8 containers undergo a
Fig. 4. Scanning electron microscopic images of the polymer-ﬁlled microcontainers impregnated with ketoprofen using scCO2 at different conditions: (a) 100 bar 1 h; (b) 200 bar 1 h;
(c) 100 bar 4 h; and (d) 200 bar 4 h.
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negligible swelling by the CO2 compared with that of PVP. As a conse-
quence, we assume that container walls provide a spatial shielding to
the loading and that the drug is mainly conveyed across the interface
PVP/sc ﬂuid. Finally, the combination of these two effects can give an ex-
planation of thedifferent loading gains for impregnation timewhich can
be obtained at the two considered pressures. At 100 bar the CO2moder-
ately swells the polymer chains, the drug diffuseswith difﬁculty and the
gain over time is poor. At 200 bar the CO2 uptake is higher and swollen
polymer offers a larger interfacial area and a reduced resistance to drug
diffusion, resulting in an enhanced loading gain from 1 to 4 h. As shown
in Table 1, at the hardest conditions (200 bar and 4 h) the drug depos-
ited in themicrocontainerswithout PVP, is less than 8% of the drug load-
ed into polymer ﬁlled containers at the same conditions. The control
experiment shows that a negligible amount of drug is absorbed in the
SU-8 container and that the preliminary deposition of the PVP is re-
quired to achieve drug loading. From a technological perspective, the
possibility of tuning the drug loading with a change in ﬂuid pressure
and time of impregnation represents a relevant advantage. The times
of 90% of drug dissolution (t90%) are also shown in Table 1. The samples
impregnated at 100 bar show similar t90% of around 270 min, while the
samples at 200 bar exhibit a markedly faster drug dissolution: for con-
tainers impregnated for 1 h t90% is equal to 60 min, for those impregnat-
ed for 4 h t90% is approximately 180 min. All dissolution proﬁles show a
burst effect, which might be explained by the presence of amorphous
drug coating in the microcontainers after the treatment with the carbon
dioxide. A Raman mapping of containers was carried out just after the
experiments. The Raman spectra are shown in Fig. 6: patterns (a) and
(b) are the spectral ﬁngerprints of crystalline pure ketoprofen and PVP
respectively. The vibrational patterns of all impregnated samples
exhibit characteristic peaks of the drug where untreated PVP does
not show any signal. In particular the band at 1657 cm−1, attributed
to the stretching vibration of the ketoprofen carbonyl ν (C_O) and the
band at 1198 cm−1, regarding the ring CH in plane bending, seem to
have an intensity which is proportional to the impregnation pressure
and, more markedly at 200 bar, with time. This fact seems to conﬁrm
the results of the dissolution tests. In [36] De Carvalho et al. attribute
these two peaks to the amorphization of the drug in the presence of the
excipient.
3.5. Comparison with physical mixtures and XRPD characterization
An important aspect of poorly soluble drugs is their dissolution in
the physiological media, which is slower than the typical retention
times in the intestine. This is primarily due to the presence of drug crys-
tals which have low solubility and slow dissolution rate in water. Typi-
cally, an amorphous drug dissolves faster in water than the crystalline
phase [37]. The amorphous form is an unstable state and the drug
tends to recover to its more stable crystalline form. In pharmacy, a typ-
ical way to improve the release rate of these drugs is to prepare solid
dispersions with a water-soluble polymer and to induce amorphization
of the drug. The polymer stabilizes the amorphous form and slows
down the growth of drug crystals [38], improving the drug solubility
and dissolution rate. In several works scCO2 impregnation is shown
to be suitable to prepare such stabilized drug–polymer dispersions
[28–30]. To investigate whether the impregnation of microcontainers
Fig. 5. Controlled release of themodel drug from polymer-ﬁlledmicrocontainers loaded at
different pressures and times compared to emptymicrocontainers (control; without poly-
mer). Release test on individual chips (625micro-containers) in 10 ml DI water (N = 3).
Table 1
Drug loading of impregnated samples and of physical mix-laden micro-tablets. The drug weight refers to total loaded mass on individual chips (625 microcontainers) and is normalized
with respect to the polymer mass into the micro-wells (N = 3).
Samples Loaded drug per
chip (mg)
Resulted drug/polymer
weight ratio
Drug weight fraction after dissolution
keto/(PVP + keto)
Time at 90% dissolution
t90% (hours)
100 bar 40 °C 1 h 0.33 ± 0.03 0.22 ± 0.04 0.16 ± 0.03 4.46
100 bar 40 °C 4 h 0.41 ± 0.02 0.28 ± 0.02 0.22 ± 0.02 4.63
200 bar 40 °C 1 h 0.61 ± 0.05 0.37 ± 0.05 0.27 ± 0.03 1.0
200 bar 40 °C 4 h 0.82 ± 0.02 0.52 ± 0.03 0.32 ± 0.01 3.3
Empty containers (200 bar 40 °C 4 h) 0.07 ± 0.02 – – 6.0
Physical mix laden micro-tablets (1:9 keto:PVP, 10wt.%) 0.22 ± 0.06 0.18 ± 0.10 0.15 ± 0.07 6.32
Fig. 6.Raman spectra for (a) solid ketoprofen, (b) PVPand(c) polymerﬁlledmicrocontainers
impregnated at 100 bar 1 h, (d) 100 bar 4 h, (e) 200 bar 1 h, and (f) 200 bar 4 h.
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produces similar results, an alternative fabricationmethod based on the
conventional tablet preparation was carried out. Microcontainers were
ﬁlled with a solid dispersion of crystalline ketoprofen and PVP, follow-
ing a procedure shown by Nielsen and co-workers [39]. Solid powders
of polymer and drug were gently mixed in a mortar, distributed and
compressed into microcontainers. Containers ﬁlled with this method
will be called crystalline micro-tablets. In the preparation of micro-
tablets a relevant amount of chemicals was wasted and the procedure
was quite laborious and time-consuming. To get the amorphous form
of the drug a group of physical mixture laden chips underwent an addi-
tional treatment, consisting of a sequence of heating andquench cooling
with liquid nitrogen repeated thrice. This group of samples, containing
amorphous ketoprofen, will be called amorphous micro-tablets. The
solid state of the drug in the physical mixture loaded container was
characterized by mean of XRPD. The diffractograms are shown in
Fig. 7. The silicon chip with empty containers (a) exhibits a broad
scattered band (meaning that the SU-8 is an amorphous material)
with one single peak at θ = 33.3° belonging to the silicon substrate.
The chip ﬁlled with pure fresh crystalline ketoprofen (b) shows deﬁned
peaks emerging from the scattered halo of the containers. The con-
tainers ﬁlled with a physical mixture containing crystalline drug show
a diffractogram with some peaks of the drug with a lower intensity
(c). The samples submitted to melt and quench cooling (d) do not
show distinguishable peaks of ketoprofen. The drug content and the
drug/polymer weight ratios in these samples were cross-checked by
dissolution tests. XRPD measurements were also performed on all im-
pregnated microcontainers (data not shown) and all the samples
showed a scattered pattern similar to 7(d). In Table 1 the drug loading
data in terms of drug/polymer weight ratio are shown. In micro-
tablets the average relative drug content (15wt.%) differs from the orig-
inal physical mixture (1:9, i.e. 10 wt.%) which demonstrates that the
drug and the polymer are demixed during the preparation. The large de-
viation of the 50% variation associated to the data shows that themicro-
tablet ﬁlling method has a lower accuracy than the sc impregnation
where variations are below 18%. Fig. 8 shows the in vitro cumulative
drug release from impregnated microcontainers and the crystalline
and amorphous micro-tablets with a comparable drug content. Due to
the high standard deviation of micro-tablets (see in Table 1), further
tests were done and only those with the drug/polymer weight ratio nu-
merically close to the one for impregnated containers, were considered
for the comparison. The dissolution curve of microcontainers treated at
100 bar (Fig. 8a) overlaps the amorphous micro-tablet proﬁle. Samples
loaded at 200 bar (Fig. 8b) show instead a slightly faster dissolution
than both amorphous and crystalline micro-tablets.
The similarity factor f2 of the cumulative dissolution proﬁles of im-
pregnatedmicrocontainers andmicrotablets was estimated. The results
of the comparison are shown in Table 2.
In all the comparisons the similarity factor is greater than 50 and the
proﬁles can be considered similar according to the FDA regulations.
Di Martino and coworkers [40] showed that already in physical
mixtures of crystalline ketoprofen and PVP K30 (1:1 wt), the drug un-
dergoes a signiﬁcant decrease of crystallinity just after preparation.
That can explain why in general the proﬁles of amorphous and crystal-
line drugs are quite close. Nonetheless impregnated containers show at
both pressures faster dissolution, compared to the correspondent crys-
talline and amorphous mixture laden containers. In the system loaded
at 200 bar this enhancement is more pronounced and 87% of the drug
is dissolved in the medium after only 30 min. This fast drug dissolution
can be explained by the presence of an intimate interaction between
drug and polymer in the scCO2 aided-loading and the dissolution rate
seems to be controlled by the polymer dissolution. A possible mathe-
matical model for the dissolution kinetics of these systems would
have to consider Fick's law, the drug–polymer interactions and the par-
ticular geometry of themicrodevice. For what concerns thematerial as-
pects, for a similar impregnated system PVP K30-ketoprofen, Manna
and coworkers [29] observed a behavior comprehending two dissolu-
tion mechanisms: at low concentrations the drug release rate is fast
and is governed by the PVP dissolution, at higher concentrations a stag-
nant drug-rich layer is formed, and the drug dissolution rate is mainly
Fig. 7. The X-ray diffraction patterns of (a) empty microcontainers, containers ﬁlled with
(b) crystalline ketoprofen, (c) 1:9 (wt) keto:PVP physical mixture with crystalline drug
(crystalline micro-tablets), (d) 1:9 (wt) keto:PVP physical mixture with amorphous
drug (amorphous micro-tablets).
Fig. 8. The enhanced dissolution kinetics of the model drug from impregnated
microdevices (a) 100 bar 1 h and (b) 200 bar 1 h as compared to drug–polymer physical
mixtures laden micro-tablets with similar loaded drug masses. The concentration was
normalized with respect to the total drug loaded in each chip (625 microcontainers)
released in 10 ml DI water (N = 3).
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constant. From a qualitative perspective this trend was also noticed in
our experiments.
3.6. Spectroscopic characterization of impregnated PVP ﬁlms
The impregnated PVP ﬁlms were studied via ATR–IR spectroscopy
in order to investigate the physical state of the drug in the formula-
tion and eventual presence of interactions with the polymer. The
spectra are reported in the ν (C_O) stretching regions in Fig. 9.
Pure crystalline ketoprofen (a) is characterized by two well deﬁned
peaks at 1697 cm−1 and 1655 cm−1, which represent the stretching
vibration of the carbonyl group in the carboxylic and ketonic groups
respectively. The ﬁrst peak indicates the presence of a dimer of
ketoprofen molecules as reported in [29]. In the impregnated ﬁlms
(c and d) this peak is shifted to a higher wavenumber (1723 cm−1)
which indicates, as suggested in [29], the breakage of ketoprofen–
ketoprofen interactions. The intensity of this shifted peak is stronger
for the 200 bar impregnated ﬁlms (see pattern d). This observation
indicates that ketoprofen is molecularly dispersed in the polymer.
A closer analysis of the PVP ν (C_O) region shows that in the
impregnated ﬁlms the appearance of the ν (C_O) band of PVP at
1625 cm−1 is shifted to lower wavenumbers compared to the ν
(C_O) of pure PVP (1652 cm−1). This fact is again more evident in
the impregnation at 200 bar. This shift might be assigned to the forma-
tion of H-bond between the carbonyl group of PVP and the hydroxilic
group of ketoprofen as suggested for the supercritical impregnation of
PVP ﬁlms with ibuprofen in [41]. On the other hand, the peak of virgin
PVP is still strong in the ﬁlms, which suggests that still a portion of the
C_O bonds in the polymer does not interact with the drug.
4. Conclusions
Micro-particle based therapeutics frequently exhibit a large size dis-
tribution, non uniform drug loading and omni-directional release,
entailing a signiﬁcant loss of drug in the lumen.Microfabricated devices
are designed to solve these issues. Nevertheless the current state of the
art of suchmicrodevices still lacks of cost-effective solutions for the drug
loading. This study shows a technological solution for the drug loading
of a reservoir-based microdevice with a poorly soluble model drug.
SU-8 microcontainers with various dimensions are fabricated with a
two step photolithography process. The microwells are ﬁlled with pre-
cisely controlled amounts of aqueous PVP solutions by means of inkjet
printing. The model drug ketoprofen is then loaded through scCO2 im-
pregnation. The drug impregnation is enhanced by increasing either
ﬂuid pressure or time. At 200 bar and 4 h a ketoprofen concentration
of 32 wt.% is obtained, corresponding to a drug:polymer ratio of 1:2.
Raman mapping reveals that there is an amorphous drug-rich phase
in the container surface and a chemical interaction between the compo-
nents. ATR–IR spectroscopy of PVP ﬁlms conﬁrms these evidences,
showing also the presence of H bondings. Impregnated containers
exhibit an enhanced dissolution rate compared to solid dispersion
laden reservoirs, both with crystalline and amorphous drugs. Up to
87% of the drug can be released within 30 min showing that
microdevices can deliver the active ingredient compatibly with the
transit time in the GI tract. The combination of inkjet printing and
scCO2 impregnation allows micro containers to be ﬁlled with precise
doses of drugwith an accuracy of amicrogram. The combination of these
two technologies enables loading of hydrophobic drugs without the use
of organic solvents and with a minimum waste of chemicals in a poten-
tially scalable process. The use of inkjet printing and sc impregnation
shows signiﬁcant improvements and promising perspectives in the
framework of the microfabricated devices for oral therapeutics and
seems particularly suitable for the loading of CO2 soluble-compounds
which are expensive or available only in small amounts.
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